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1.1 Causes and current treatment opportunities of male 
infertility 
Many couples are involuntarily childless because one or both partners suffer from infertility, 
which is defined as the inability of a couple to conceive a pregnancy after 12 month of 
intercourse without the use of any contraception (Gnoth et al., 2005). Between 10-15% of 
couples are faced with fertility problems- in half of these cases due to men- and most of them 
make demands on assisted reproduction treatments (ART), pioneered by Robert Edwards in 
1978, in order to father an own child (Boivin et al., 2007).  
Infertile men are mostly diagnosed with oligoasthenoteratozoospermia (OAT) or 
azoospermia. While patients with OAT possess sperm in a reduced number (oligospermia), 
with a decreased motility (asthenozoospermia) or morphological displastics 
(teratozoospermia) in their ejaculate, patients diagnosed with azoospermia exhibit no sperm 
at all in the semen. Here urologists discriminate between the inability of sperm to reach the 
ejaculate (obstructive azoospermia; OA) and the failure of sperm production at all due to an 
impaired or blocked spermatogenesis (non-obstructive azoospermia; NOA). The underlying 
causes, which result in OAT or azoospermia, determine the possible therapeutical 
approaches, with which childless couples might be able to achieve a pregnancy from their 
own genetic material. The study of Tüttelmann et al. (2011) provides an insight into the major 
causes of azoospermia. They viewed data derived from counselling over 30 years of 
azoospermic patients and determined frequencies of diagnoses in this cohort (Fig. 1). These 
data revealed that 31% of azoospermic men had general andrological diagnoses including 
varicocele and urogenital infections. The infertility was also due to genetic causes. 21% of 
the patients suffered from chromosomal aberrations like the Klinefelter syndrome, 
Y-chromosomal microdeletions or other genetic defects. Malignancies of testicular or 
non-testicular cancer caused infertility in 15% of the patients. Other patients were infertile 
because of obstructions and endocrine or other chronic diseases like diabetes. A 
considerable fraction of 12% was classified as idiopathic infertile and the underlying cause of 




Fig. 1: Frequencies of diagnoses in azoospermic patients. Data derive from Tüttelmann et al., 2011 and 
reflect diagnoses of 1583 azoospermic patients, who were retrospectively examined regarding the underlying 
cause of their azoospermia. The analyses involved medical history, physical examination as well as semen and 
hormone analysis of each patient.  
 
The treatment options are dependent on the diagnosis of male infertility. In some cases 
hormone treatments or other medications are sufficient to improve the semen quality and 
pregnancy can be achieved naturally. If healthy sperm can be isolated from the ejaculate, it 
can be used for ART. However, in most cases the underlying cause of infertility like sperm 
abnormalities of genetic origin cannot be removed. Provided that the patient produces 
healthy sperm at least in a small extent, minimal invasive techniques for sperm retrieval like 
MESA (Microscopic Epididymal Sperm Aspiration), PESA (Percutaneous Epididymal Sperm 
Aspiration) or TESE (Testicular Sperm Extraction) can be used to obtain small amounts of 
sperm from the patient’s testes or epididymides, which can be further used to fertilize 
oocytes using ART (Hsiao et al., 2011). Dependent on the quality of isolated sperm, the 
fertilization can be achieved in vivo by placing the sperm into the woman’s uterus to relieve 
fertilization (Intrauterine Insemination; IUI), in vitro by fusing sperm and oocyte naturally (in 
vitro Fertilization; IVF) or by using a needle (Intracytoplasmic Sperm Injection; ICSI) (Fig. 2, 
top). But these existing reproductive therapies are not suitable to help complete sterile men, 
who do not produce any functional sperm. Here several experimental and promising 
approaches in the research might help to restore or manipulate men’s fertility (Fig. 2, 
bottom). These different treatment options have all one commonality and try to take 
advantage of the potentials derived from cell pluripotency. Researchers worldwide make 
great efforts to use pluripotent stem cells for the derivation of male germ cells, which are 




Fig. 2: Clinical and experimental approaches for treatment of male infertility. (Top) Independent from the 
underlying cause of their infertility, men, who produce any healthy sperm, can currently make use of assisted 
reproduction treatments. (Bottom) Researchers are working on several experimental approaches to treat male 
infertility, including the use of patient-derived testicular tissue for xenotransplantations, organ cultures or 
autotransplantations (orange boxes) and patient-derived SSCs for transplantations. In vitro differentiation of 
haploid germ cells might be possible with patient-specific SSCs and hMGSCs (blue boxes). Patient-derived iPSCs 
are beneficial for infertile men without any spermatogenetic activity to obtain PGC or SSC transplantation or 
functional sperm by in vitro differentiation (red boxes). Theoretically, donor-derived hESCs offer the opportunity 
for in vitro differentiation of SSCs or haploid germ cells (yellow boxes). ICSI: Intracytoplasmic Sperm Injection; 
hMGSCs: human Multipotent Germline Stem Cells; SSC: Spermatogonial Stem Cell; iPSC: induced Pluripotent 





1.2 A journey through years of research: from pluripotent stem 
cells to male germ cells 
In recent years many researchers were dedicated to the derivation of male germ cells and 
applied several approaches to generate different stages of male gametes. The use of 
pluripotent stem cells is a promising method to recapitulate spermatogenesis in vitro (for 
review: Nolte and Engel, 2013; Hou et al., 2014). Their ability of self-renewal without genetic 
changes and their potential to differentiate into any cell type including germ cells makes 
pluripotent stem cells especially suitable for in vitro spermatogenesis (Martin, 1981; West et 
al., 2006).  
Scientists developed several strategies for the establishment of robust and reproducible 
culture systems for the differentiation of mature and functional haploid male germ cells 
derived from mouse and human pluripotent stem cells. Cultivation of these cells under 
differentiating conditions including induction with retinoic acid (RA) and growth factors was 
sufficient to obtain cells at premeiotic and meiotic stages (Drusenheimer et al., 2007; 
Eguizabal et al., 2009, 2011). The embryoid body (EB) differentiation strategy is also a 
frequently used method for male germ cell differentiation. Cultivation of pluripotent stem cells 
in hanging drops without antidifferentiation factors leads to spontaneously three dimensional 
EB formation, which reflects cell differentiation during early mammalian embryogenesis 
(Keller, 1995; Kurosawa, 2007). EB formation derived from different types of stem cells gave 
rise to the generation of various stages of male germ cells (Clark et al., 2004; Tilgner et al., 
2008; Aflatoonian et al., 2009; Imamura et al., 2010). Other groups proposed modified germ 
cell differentiation protocols via EB formation and additional treatment with RA (Geijsen et al., 
2004; Lee et al., 2006; West et al., 2006; Zhu et al., 2012; Cai et al., 2013 ), hormones (Lee 
et al., 2006) or growth factors (Toyooka et al., 2003).  
The differentiation of human germ cell precursors and meiotic cells could also be achieved 
by co-culture of pluripotent stem cells with other cell types such as mouse embryonic 
fibroblasts (MEFs) or human fetal gonadal stromal cells known to support the primary culture 
of germ cells (West et al., 2008; Park et al. 2009). Furthermore, advancement of germ cell 
progression through meiosis and the formation of haploid germ cells and even motile tailed 
sperm could be achieved by the overexpression of germ cell-related genes in stem cells 
during in vitro differentiation (Kee et al., 2009; Yu et al., 2009; Medrano et al., 2012). The use 
of reporter genes for enrichment of premeiotic cells and detection of haploid male germ cells 
represents a further significant method for male germ cell differentiation (Nayernia et al., 
2006). Some studies using such selection strategies in combination with RA induction even 
resulted in the generation of haploid gametes, whose fertility was proven by the birth of 
viable offspring after intracytoplasmic sperm injection (ICSI) (Nayernia et al., 2004; Nolte et 
al., 2010).  
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These different approaches for in vitro spermatogenesis could be successfully applied with 
various types of mouse and human pluripotent stem cells known so far. Mostly embryonic 
stem cells (ESCs) derived from the inner cell mass of a pre-implanted blastocyst were used 
for the efficient generation of haploid gametes. Using an EB approach with growth factor 
treatment Toyooka and colleagues (2003) were the first, who succeeded in the derivation of 
germ cell precursors, the primordial germ cells (PGCs), from mouse ESCs. The expression 
of an endogenous homolog of Vasa, a cytoplasmic protein expressed from premeiotic stages 
onwards (Toyooka et al., 2000), was used for purification of PGCs. After co-culture with 
gonadal cells, the ESC derived PGCs were able to form haploid germ cells in transplanted 
host testis. Just one year later haploid male germ cells were obtained via EB formation with 
RA induction, whose fertility was proven by fertilization of oocytes and further blastocyst 
development (Geijsen et al., 2004). Nayernia and colleagues (2006) reported a further 
breakthrough in the research of in vitro spermatogenesis and presented a double selection 
strategy based on reporter genes for the isolation of premeiotic germ cells and detection of 
mature sperm, which was finally able to give rise to viable offspring after ICSI. The 
prematurely death of the offspring due to global imprinting defects revealed that the 
establishment of correct imprinting during in vitro spermatogenesis is one of the major 
problems, which have to be solved. These imprinting defects could be overcome by a two 
step differentiation approach (Hayashi et al., 2011). After in vitro generation of primordial 
germ cell-like cells (PGCLCs) from mouse ESCs and completion of spermatogenesis in vivo, 
transplanted mice gave rise to fertile offspring with correct imprinting.  
During the same time period PGCs as well as premeiotic, meiotic and even haploid male 
germ cells could also be derived from human ESCs using approaches of EB formation (Clark 
et al., 2004; Tilgner et al, 2008; Aflatoonian et al., 2009), co-culture (West et al., 2008) as 
well as overexpression of germ cell-related genes (Medrano et al., 2012).  
The generation of mouse and human induced pluripotent stem cells (iPSCs) derived from 
somatic cells was a further milestone in the establishment of in vitro culture systems for the 
differentiation of male germ cells (Takahashi et al., 2006; Meissner et al., 2007; Takahashi et 
al., 2007). Both mouse (Imamura et al., 2010; Zhu et al., 2012; Cai et al., 2013) and human 
iPSCs (Park et al., 2009; Panula et al., 2011; Medrano et al., 2012) were successfully 
differentiated into various stages of male germ cells. Especially with regard to the derivation 
of human germ cells, iPSCs provide a promising cell type for in vitro spermatogenesis of 
personalized gametes without ethical concerns. Human iPSC-derived haploid male germ 
cells were obtained within ten weeks (Eguizabal et al., 2011) and even within ten days 
(Easley et al., 2012) by using complex differentiation culture media, which forced the 
progression through meiosis. The possibility to validate the functionality of in vitro derived 
human gametes in the human system is limited. However, methylation studies confirmed 
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also improper imprinting patterns of these male germ cells assuming that these in vitro 
derived gametes could not lead to healthy offspring (Park et al., 2009; Eguizabal et al., 2011; 
Easley et al., 2012). So the acquisition of correct epigenetic marks in sperm emerged to be a 
great problem in in vitro spermatogenesis approaches. Therefore, researchers invest great 
hope in the differentiation of male germ cells derived from natural spermatogonial stem cells 
(SSCs), which ensure the maintenance of spermatogenesis and fertility throughout male life. 
Because SSCs isolated from the testes of different species were used in several approaches 
for in vitro differentiation of male gametes (Feng et al., 2002; Riboldi et al., 2012; Minaee 
Zanganeh et al., 2013), the following introductory part should provide some more details of 
SSCs and their potential to give rise to sperm in vitro. 
 
1.3 The potential of spermatogonial stem cells in in vitro 
spermatogenesis approaches 
SSCs are unipotent adult tissue stem cells, which are located along the basement membrane 
of the highly structured seminiferous tubules of the testis and give rise to spermatogenesis. 
SSCs are characterized by the ability to balance between their self-renewal to maintain a 
life-long pool of SSCs and their differentiation into mature sperm throughout the postpubertal 
life of men. Based on these features SSCs represent a life long storage of male fertility 
during reproductive life carrying the father`s genetic material to subsequent generations 
(Oatley and Brinster, 2008; Orwig and Hermann, 2011).  
Several experimental approaches have addressed the isolation of SSCs and their expansion 
in culture using cell surface markers and defined culture conditions, which is proven to be 
difficult because of the absence of specific markers for the identification and characterization 
of SSCs (Xu et al., 2011; Kossack et al., 2013). Therefore, cell transplantation assays are 
indispensable for the final functional proof of isolated SSCs until now (Brinster et al., 1994). 
So far numerous research groups have reported the isolation and at least short-term culture 
of SSCs from different animal species such as rodents including mice (Kanatsu-Shinohara et 
al., 2003), rats (Hamra et al., 2005) and hamsters (Kanatsu-Shinohara et al., 2008b) as well 
as bovine (Aponte et al., 2008), buffalos (Kala et al., 2012) and pigs (Luo et al., 2006; Kuijk 
et al., 2009). The establishment of long-term SSC cultures remains challenging and becomes 
apparent in the less number of reports, which claimed extended cultivation of SSCs derived 
from mouse, rat or hamster (Kanatsu-Shinohara et al., 2003; Kubota et al., 2004b; Ryu et al., 
2005; Kanatsu-Shinohara et al., 2008b). Based on these insights of SSC long-term cultures, 
several groups have tried to develop strategies for the isolation and culture of human SSCs 
(hSSCs), which is of particular interest in regard to therapeutical approaches to treat male 
infertility due to a disrupted spermatogenesis caused by various reasons (1.1; Fig. 2). Since 
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autotransplantations of isolated SSCs from a wide range of species were successfully 
performed (Brinster and Zimmermann, 1994; Schlatt et al., 2002; Honaramooz et al., 
2003a, b; Izadyar et al., 2003b), in vitro expanded hSSCs isolated from human testicular 
biopsies might be able to repopulate the testis after transplantation and lead to restored 
spermatogenesis in men. Such a clinical application requires established and reliable 
protocols for the in vitro propagation of hSSCs isolated from small testicular biopsies, which 
contain a too small amount of SSCs to repopulate a human testis after autotransplantation. 
The fact that SSCs represents just 0.03% of all male germ cells illustrates the difficulty to 
isolate this small cell fraction and its expansion in culture (Tegelenbosch and de Rooij, 
1993).  
To date, the different attempts to establish long-term cultures of hSSCs have been 
unsuccessful although different isolation methods and culture conditions have been used (He 
et al., 2010; Kokkinaki et al., 2011; Liu et al., 2011; Mirzapour et al., 2012). Some research 
groups were able to expand the culture of hSSCs up to four month. Using a culture method 
of putative hSSCs isolated from human fetal testes with media inspired by the formulation 
used for cultivation of mSSCs and a feeder layer consisting of human embryonic stem cell 
derived fibroblast-like cells was suitable to maintain isolated hSSCs for two month in culture 
(Chen et al., 2009). Sadri-Ardekani and colleagues (2009) were even able to propagate 
germline stem cell clusters derived form adult human testes for four month using medium 
inspired by Kanatsu-Shinohara et al. (2003) and human placental laminin-coated dishes. The 
functionality of these in vitro cultured putative hSSCs could be proven by xenotransplantation 
to mice. This progress shows that long-term culture and in vitro propagation of hSSCs is 
achievable, nevertheless it also illustrates the importance of the less popular basic research 
to identify factors, which might determine the status of proliferating and senescent hSSCs, 
and helps to figure out culture and growth requirements for the long-term culture of hSSCs 
(Yoo et al., 2010).  
The discovery to derive pluripotent cells from testicular cells was a considerable 
breakthrough in stem cell research and created new opportunities in the research field of 
reproductive biology. First Kanatsu-Shinohara and colleagues (2004) succeeded in the 
establishment of ES cell-like cells from SSCs derived from neonatal mouse testis, which 
conformed several pluripotency-related features including the ability to form teratomas and 
germline chimeras, and were termed multipotent germline stem cells (mGSCs). The 
fascinating part of this study was the finding that pluripotency of somatic cells can be induced 
by a physiological method: when removed from their natural environment and cultured under 
standard ESC conditions, neonatal testis cells spontaneously produce ESC-like cells in vitro 
indicating that germ cells retain their pluripotency character. Two years later Guan et al. 
(2006) were able to expand this approach and presented the derivation of pluripotent cells 
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from SSCs isolated from the adult mouse testis, therefore called multipotent adult germline 
stem cells (maGSCs). Here, germline stem cells were enriched using the premeiotic reporter 
gene Stra8-EGFP for fluorescence activated cell sorting (FACSorting), whose SSC character 
was proven by transplantation assays showing regeneration of spermatogenesis in germ cell 
depleted mice. After propagation of EGFP positive cells representing a mouse SSC 
population in culture, these cells were cultured under different conditions revealing that SSCs 
responded to standard ESC culture conditions and displayed ESC properties. The suitability 
of maGSCs derivation from adult mouse testis was further validated by several groups 
(Seandel et al., 2007; Izadyar et al., 2008; Kanatsu-Shinohara et al., 2008a; Ko et al., 2009). 
Furthermore, Nolte and colleagues (2010) proved that maGSCs can also be used for the 
derivation of functional haploid male germ cells. Using the double selection strategy 
published by Nayernia et al. (2006) the researchers established stable premeiotic germ cells 
derived from maGSCs. By culturing these cells without antidifferentiation factors and 
additional RA treatment, the onset of meiosis was induced and haploid male germ cells were 
detected by the expression of the postmeiotic reportergene Prm1-DsRed. The fertility of 
haploid cells was proven by the birth of viable offspring with maGSC origin after ICSI. 
Although up to now this is the only report of male germ cells derived from maGSCs, this 
finding is of great importance if it is possible to implement it into reliable protocols for the 
derivation of human male germ cells. If adult human testicular cells could be reprogrammed 
to pluripotent stem cells, then termed human multipotent germline stem cells (hMGSCs), just 
by culture, they could be used for the derivation of male germ cells instead of human ESCs 
or iPSCs. Consequently, the use of hMGSCs would avoid the ethical concerns using ESCs 
as well as the usage of exogenous pluripotent factors needed for the generation of iPSCs 
from adult somatic cells at the same time. Thus, the risk of cell transformation and tumor 
formation in the patient originating from the use of iPSCs could be also obviated. Moreover, 
the use of patient-derived testicular material for the generation of germ cells greatly reduces 
the likelihood of an immunological response to the transplanted cells and further implies the 
production of personalized gametes to obtain biological identical children.  
Inspired by the idea to develop an alternative therapeutic strategy to treat male infertility, 
many researchers are dedicated to establish stable hSSC lines in culture followed by 
reprogramming into a pluripotent state. Several groups reported the phenomenon of testis-
derived ESC-like cells (Conrad et al., 2008, retracted in 2014; Golestaneh et al., 2009; 
Kossack et al., 2009; Mizrak et al., 2010), but the pluripotency of these cells was called into 
question based on the results of subsequent analyses (Ko et al., 2010; Tapia et al., 2011; 
Chikhovskaya et al., 2012). The so called human ESC-like cells do not fulfil the criteria for 
cellular pluripotency published by the National Institutes of Health. Different reviewers 
complained that in none of the studies these cells revealed a detectable expression of 
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pluripotency markers or the ability to form highly proliferating teratomas. Moreover, whole 
testicular cell suspensions were used instead of established and characterized hSSC cell 
lines and global gene expression analyses could demonstrate similarities to a fibroblast cell 
line suggesting rather a mesenchymal or fibroblast origin of the human ESC-like cells (Ko et 
al., 2010; Tapia et al., 2011). These facts corroborate their non-pluripotent character and 
initiated a still ongoing debate and efforts for novel strategies for the derivation of pluripotent 
cells from human testicular cells. But up to now no research group was able to publish a 
reliable and convincing protocol for the establishment of proliferating hSSC cell lines in 
culture and their reprogramming into a pluripotent cell line without genetic modifications. 
Here, the in vitro imitation of the SSCs’ in vivo environment is the most challenging part and 
implies the investigation of the impact of the testicular environment on the SSCs, which is 
further described in the following introductory part. 
 
1.4 Co-culture- a promising method for SSC culture and 
derivation of male germ cells 
SSCs receive numerous signals from the testicular environment, which is described as the 
spermatogonial stem cell niche (SSC niche) and plays an important role in regulating 
testicular homeostasis and the specific properties of SSCs. In 1978 Schofield introduced a 
concept of a so called stem cell niche, which represents a specialized microenvironment 
consisting of several components, which provide structural features as well as an adequate 
growth factor milieu for tissue-specific stem cells (Schofield, 1978). According to this model a 
niche provides generally all essential factors to sustain a balance between a proliferating 
stem cell pool and the onset of the differentiation to their final cell fate. Consequently, the 
removal of components from the stem cell niche would disrupt its structure accompanied by 
the loss of the identity and the regulated proliferating and differentiating status of the residing 
stem cells (Voog and Jones, 2010). Therefore, the identification and characterization of niche 
properties and their emanating signals would facilitate the establishment of long-term 
cultures of stem cells in general. 
In regard to the culturing of SSCs many studies concentrate on investigating the biology of 
the complex SSC niche. The sertoli cells within the seminiferous tubules, the basement 
membrane and the interstitial cells are the structural constituents of this niche in the testis. 
The fact that sertoli cells are the only somatic cell type within the tubules illustrates their 
special role as one of the most important components in the SSC niche. As a part of the 
epithelium on the inner surface of the basement membrane they have physical contact with 
the self-renewing SSCs, which reside along the basement membrane of the tubules 
connected via adhesion molecules (Tung et al., 1984). Additionally, sertoli cells reach to the 
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lumen of the tubule and escort the differentiating germ cells released to the centre thereby 
providing various nutrients. The connections of sertoli cells via tight junctions form the 
blood-testis barrier and create an immune-privileged environment for differentiating germ 
cells crossing the tight junctions at the onset of meiosis. Due to this sub-
compartmentalization of the tubules into basal and adluminal compartments, SSCs and 
developing germ cells can also be exposed to different factors. The interstitial tissue between 
the seminiferous tubules consists of peritubular cells covering the outer surface of the 
basement membrane, leydig cells, which are mostly arranged in clusters, blood vessels 
maintaining the vascular network as well as immune cells (for review: de Rooij, 2009). These 
structural components of the SSC niche provide a defined milieu for the maintenance of a 
balanced self-renewal of SSCs and differentiation of germ cells by providing physical support 

















Fig. 3: Model of environmental signals within the spermatogonial stem cell niche. The SSC niche consists 
of sertoli cells, the basement membrane and interstitial tissue with blood vessels, mast-, leydig- and peritubular 
cells and provides several directly or indirectly cues for the SSCs residing at the basement membrane indicated 
by arrows. Additionally, some fundamental growth factors released within the SSC niche are indicated. The 
marked signalling as well as the indicated growth factors are not exhaustive. GDNF: Glial cell line-Derived 
Neurotrophic Factor; bFGF; basic Fibroblast Growth Factor; BMP4: Bone Morphogenetic Protein 4; SCF: Stem 
Cell Factor; CSF-1: Colony Stimulating Factor 1. Modified, Mayerhofer, 2013. 
 
In general, the released factors induce directly or indirectly either the proliferation or the 
differentiation of SSCs. Sertoli cells have an outstanding role in producing growth factors 
within the tubules: while GDNF (Glial cell line-Derived Neurotrophic Factor) and bFGF (basic 
Fibroblast Growth Factor) stimulate the self-renewal of SSCs (Tadokoro et al., 2002; Oatley 
et al., 2007; Simon et al., 2007), differentiation of SSCs is initiated by the secretion of 
activin A, BMP4 (Bone Morphogenetic Protein 4) and SCF (Stem Cell Factor) (Ohta et al., 
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2000; Nagano et al., 2003a). The impact of the cells residing in the interstitial tissue is 
surprising because of their distance to the SSCs within the tubules preventing a direct 
contact. Nevertheless, several studies revealed a cross communication between sertoli and 
interstitial cells including leydig- and peritubular cells, which allows the interstitial cells to 
contribute to the SSC niche via the sertoli cells (Skinner et al, 1991). Thus, sertoli cells 
orchestrate the signals of the other SSC niche components. While sertoli cells receive 
testosterone secreted by leydig cells to support spermatogenesis (Skinner et al, 1991), their 
GDNF production is stimulated by FSH (Follicle-Stimulating Hormone), which is highly 
concentrated near the blood vessels (Tadokoro et al., 2002). Moreover, CSF-1 (Colony 
Stimulating Factor 1) was identified as an extrinsic stimulator of SSC self-renewal and 
proliferation produced by leydig and peritubular cells (Ryan et al., 2001, Oatley et al., 2009). 
However, recent work shed some new light on the presumptive role of peritubular cells within 
the SSC niche and demonstrated that human peritubular cells constitutively produce and 
release GDNF, thus indicating an additional role of these cells in survival and maintenance of 
SSCs (Spinnler et al., 2010). Based on these results and the fact that GDNF is suggested to 
be a key player within the niche responsible for SSC maintenance by regulating their self- 
renewal (Meng et al., 2000; Naughton et al., 2006), the peritubular cells may have a direct 
impact on SSCs by their GDNF production. However, these are just a few of the various 
compounds, which are part of the growth factor milieu within the SSC niche. Further are 
discussed later in the context of the results of the presented thesis (4.2.1).  
This continuously increasing insight in the regulating machinery within the SSC niche provide 
the opportunity for researchers to create culture conditions, which resemble the SSC niche 
and promote the homing of isolated SSCs in vitro. The idea is to mimic the SSC niche by 
using specific culture media supplemented with nutrients, growth factors and hormones, 
which are normally provided by the testicular cells, and co-culturing with testicular stromal 
cells. Because of the already described extraordinary role of sertoli cells within the SSC 
niche, it is not surprising that the majority of groups performed co-culture experiments of 
isolated SSCs with sertoli cells. However, co-cultures using different established sertoli cell 
lines as a feeder layer for SSCs revealed contradictory results, although the cells did not 
differ in their growth factor secretion pattern: some sertoli cell lines were not sufficient to 
maintain SSCs in culture (van der Wee et al., 2001; Nagano et al., 2003a), while others 
seemed to have a beneficial effect (van der Wee et al., 2001). In contrast, the use of sertoli 
cells derived from primary cell cultures seems to have a significant effect on SSC 
maintenance and proliferation in vitro. Baazm and colleagues (2013) prepared adult and 
embryonic sertoli cells as feeder layers for co-culture with isolated mouse SSCs and showed 
that these sertoli cells- in combination with medium supplemented with growth factors- have 
a supportive effect on the maintenance of SSCs, whose identity was further proven by 
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regeneration of spermatogenesis after transplantation in germ cell depleted mice. Moreover, 
co-cultures with primary sertoli cells using medium without additional growth factors were 
also sufficient to promote SSC survival and colony formation in vitro (Koruji et al., 2009; 
Mohamadi et al., 2012). The positive effect of primary sertoli cells might be due to their 
natural secreted mix of nutritional and immune protective factors (Huleihel and Lunenfeld, 
2004; Baazm et al., 2013).  
Apart from the in vitro cultivation of isolated SSCs without losing their potential to repopulate 
a testis in a transplantation assay, further studies indicate that co-culture systems are also 
suitable for the in vitro differentiation of SSCs to male germ cells of different species 
(Rassoulzadegan  et al., 1993; Sousa et al., 2002; Izadyar et al., 2003a; Gohbara et al., 
2010). Especially sertoli cells, mostly derived from primary cultures, can stimulate the onset 
of meiosis in vitro. By testing different co-cultures with sertoli cells and media supplemented 
with hormones and vitamins, Minaee Zanganeh and colleagues (2013) examined the 
supportive role of sertoli cells for the production of spermatid-like cells derived from isolated 
mouse SSCs. Also putative human SSCs enriched from testicular biopsies revealed in vitro 
differentiation of haploid cells after co-culture with patient-derived sertoli cells (Riboldi et al., 
2012). 
Certainly because of the outstanding role of sertoli cells, the investigation of co-culture 
systems not only based on these cells was unfortunately neglected during the last years. But 
especially the latest finding of GDNF production by human peritubular cells (Spinnler et al., 
2010) suggest an underestimated role of these and possibly other testicular cells for in vitro 
co-culture systems and encourage research groups to check also co-culture systems based 
on primary testicular cells. Using such a system, recently Mäkelä and colleagues (2014) 
demonstrated a “spontaneous reconstruction of testicular cellular microenvironments” 
(Mäkelä et al., 2014) based on the culture of primary and mitotically active mouse 
seminiferous tubule cells consisting of spermatogonia as well as sertoli- and peritubular cells. 
Based on these results co-culture systems seem to be a suitable and promising method for 
the cultivation of SSCs and their further improvement will definitely include more testicular 











1.5 Objectives of the presented PhD thesis 
1. Establishment of proliferating human SSC cell lines from infertile men and their in 
vitro differentiation into haploid male germ cells 
Several studies already proved that ESCs are suitable for the in vitro derivation of male 
gametes using different strategies. Since it was shown that mouse SSCs can also be 
reprogrammed into a pluripotent state and successfully used for in vitro spermatogenesis 
experiments, many researchers failed to establish a similar approach for the reprogramming 
of human SSCs. Therefore, one aim of this thesis was to generate proliferating human SSC 
cell lines using testicular biopsies from infertile men, which should be further used for direct 
differentiation to haploid male germ cells. Here it should be also examined if the failure in 
sperm production associated to different causes in the patients could be overcome during in 
vitro differentiation of haploid cells from the isolated human SSCs. 
 
1.1 Generation of hiPSCs from infertile men for further in vitro differentiation of 
human SSCs 
Numerous studies also revealed great difficulties in the establishment of long-term 
cultures of human SSCs. Therefore, in a second approach human pluripotent stem 
cells should be used for in vitro differentiation of human SSCs. Firstly, human iPS 
cells had to be generated for this approach and established from somatic cells 
derived from infertile men.  
 
2. Establishment of a co-culture system for the generation of putative SSCs from 
mouse ESCs 
The co-culture of species-derived SSCs using testicular stromal cells was shown to be a 
suitable culture system for the cultivation of functional SSCs as well as their differentiation 
into male gametes. In the presented thesis it was analyzed if a co-culture system has also 
the potential to support the generation of SSC-like cells from mouse ESCs. For this approach 
a multi-species co-culture system using mouse ESCs and human testicular stromal cells 
should be tested and characterized. 
 
3. Role of Stra8 during in vitro spermatogenesis of mouse ESCs 
A strategy for the in vitro differentiation of male gametes derived from mouse ESCs was 
established in this Institute (Nayernia et al., 2006; Nolte et al., 2010). Nevertheless, the 
prematurely death of the offspring derived from the in vitro produced haploid cells draws the 
attention on their improper imprinting pattern. Since the premeiotic gene Stra8 (Stimulated by 
Retinoic Acid Gene 8) is known to be essential for the induction of meiosis (Baltus et al., 
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2006; Anderson et al., 2008) and is suggested to interact with chromatin remodelling 
proteins, which are regulators of imprinting control regions (Pantakani, unpublished data), it 
should be tested here, if a Stra8 overexpression during in vitro spermatogenesis can 
enhance the progression of meiosis and support correct imprinting.  
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2 Materials and methods 
2.1 Material 
2.1.1 Chemicals, biochemicals and cytokines 
Chemical, biochemical, cytokine Manufacturer 
2-Mercaptoethanol     Gibco, Eggenstein 
Acetic Acid   Merck, Darmstadt 
Activin A Sigma-Aldrich, Deisenhofen 
Agar  Carl Roth, Karlsruhe 
Agarose      Carl Roth, Karlsruhe 
Ampicillin      Carl Roth, Karlsruhe 
Ampuwa      Fresenius, Bad Homburg 
Barricidal      Interchem Hygiene, Zürich, Switzerland 
Biofreeze      Biochrom AG, Berlin 
Boracid MP Biomedicals, Ohio, USA 
Bovine Serum Albumine (BSA)    Serva, Heidelberg 
BrdU (5-Bromo-2′-deoxyuridine)   Sigma-Aldrich, Deisenhofen 
Busulfan      Sigma-Aldrich, Deisenhofen  
Cacodylic Acid     Serva, Heidelberg 
Chloroform      J.T. Baker, Griesheim 
Citrinin       Sigma-Aldrich, Deisenhofen 
Colcemid      Biochrom AG, Berlin 
Collagenase, from Clostridium histolyticum  Sigma-Aldrich, Deisenhofen 
cOmplete Protease Inhibitor Cocktail Tablet Roche, Mannheim 
Coomassie Brilliant Blue R250   Sigma-Aldrich, Deisenhofen 
CryoStem™ Freezing Mediuim   Stemgent, Cambridge, USA 
DAPI       Sigma-Aldrich, Deisenhofen 
Developer      AGFA HealthCare, Bonn 
Dimethylformamide Carl Roth GmbH, Karlsruhe 
Dimethylsulfoxide (DMSO)    Carl Roth GmbH, Karlsruhe 
 Sigma-Aldrich, Deisenhofen 
DNaseI, from bovine pancreas   Sigma-Aldrich, Deisenhofen 
dNTPs      Invitrogen, Karlsruhe 
Eosin       Sigma-Aldrich, Deisenhofen 
       Carl Roth, Karlsruhe 
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Ethanol      J.T. Baker, Griesheim 
Ethidium Bromide     Inno-Train Diagnostik, Kronberg am Taunus 
Ethylenediaminetetraacetic Acid (EDTA)  Carl Roth, Karlsruhe 
Eukitt       Fluka, Deisenhofen 
Fetal Calf Serum (FCS)    PAN, Aidenbach 
Formaldehyde     Invitrogen, Karlsruhe 
Formamide      Sigma-Aldrich, Deisenhofen 
Gelatine      Sigma-Aldrich, Deisenhofen 
Geniticin (G418)     Gibco, Eggenstein 
Giemsa      Merck, Darmstadt 
Glutaralaldeyde Carl Roth, Karlsruhe 
Glycerol      Carl Roth, Karlsruhe 
Glycine      Carl Roth, Karlsruhe 
Hank's Balanced Salt Solution (HBSS)  Gibco, Eggenstein 
hbFGF       Invitrogen, Karlsruhe 
 Peprotech, Rocky Hill, USA 
Hematoxylin      Merck, Darmstadt 
 Carl Roth, Karlsruhe 
Hematoxylin QS      Biozol, Eching  
hGDNF      Gibco, Eggenstein 
 Miltenyi Biotec, Bergisch Gladbach 
Hyaluronidase, from bovine testes   Sigma-Aldrich, Deisenhofen 
Hybond™-C Extra     GE Healthcare, Freiburg 
Hydrochloric acid (HCl)     Merck, Darmstadt      
Isopropanol      J.T. Baker, Griesheim 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) Carl Roth, Karlsruhe 
Kanamycin      Carl Roth, Karlsruhe 
L-Glutamine  Gibco, Eggenstein 
LIF       Millipore, Billerica, USA 
Lipofectamine® RNAiMAX Transfection 
Reagent  
Invitrogen, Karlsruhe 
Loading Buffer (10x)     Invitrogen, Karlsruhe 
Magnesium Chloride (MgCl2)   Merck, Darmstadt 
Methanol      J.T. Baker, Griesheim 
Milk powder      Carl Roth, Karlsruhe 
Mitomycin C     Sigma, Deisenhofen   
Natriumchloride (NaCl)   Carl Roth, Karlsruhe 
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Non-Essential Amino Acids (NEAA, 100x)  Gibco, Eggenstein 
Paraformaldehyde     Sigma, Deisenhofen 
Paraffin     Carl Roth, Karlsruhe 
Penicillin      Carl Roth, Karlsruhe  
Peptone      Carl Roth, Karlsruhe 
Phenol       Biomol, Hamburg 
Phenylmethylsulfonfluorid (PMSF)  Sigma, Deisenhofen 
Phosphate Buffered Saline (PBS)   PAN, Aidenbach 
Picric acid      Fluka, Deisenhofen 
Plasmocure   InvivoGen, San Diego, USA 
Potassium Chloride (KCl)   Carl Roth, Karlsruhe 
Proteinase K      Carl Roth, Karlsruhe 
Puromycin      Sigma, Deisenhofen 
Rapid Fixer      AGFA HealthCare, Bonn 
Restriction endonucleases    Invitrogen, Karlsruhe 
 New England Biolabs, Frankfurt am Main 
Retinoic Acid      Sigma, Deisenhofen 
Reverse Transcriptase    Invitrogen, Karlsruhe 
       Bioline, Luckenwalde 
RNase A      Sigma, Deisenhofen 
Roti®Mount Aqua     Carl Roth, Karlsruhe 
Roti® Nanoquandt     Carl Roth, Karlsruhe 
Saccharose      Sigma, Deisenhofen 
S.O.C Medium   Invitrogen, Karlsruhe 
Sodium Acetate (NaAc)    Merck, Darmstadt 
Sodium Chloride (NaCl)    AppliChem, Darmstadt 
Sodium Citrate     Carl Roth, Karlsruhe 
Sodium Dodecyl Sulfate (SDS)   Serva, Heidelberg 
Sodium Pyruvate   Gibco, Eggenstein 
StemPro® Accutase   Gibco, Eggenstein 
Stop solution      Sigma, Deisenhofen 
Streptomycin      PAN, Aidenbach 
Talarozole (R115866)    Active Biochemicals, HongKong, China 
Tris       AppliChem, Darmstadt 
Triton X-100      Serva, Heidelberg 
Trypan Blue Solution (0.4 %)    Sigma, Deisenhofen 
Trypsin/EDTA      Invitrogen, Karlsruhe 
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Trypton      Carl Roth, Karlsruhe 
Tween® 20      Carl Roth, Karlsruhe 
Vectashield with DAPI    Vector Laboratories, Burlingame, USA 
X-Gal       AppliChem, Darmstadt 
Xyline       Carl Roth, Karlsruhe 
Y-27632 (ROCK-Inhibitor)    Miltenyi Biotec, Bergisch Gladbach 
Yeast extract      Carl Roth, Karlsruhe 
 
2.1.2 General equipment 
Equipment Manufacturer 
Cover slides   Thermo Scientific, Schwerte 
Cuvette, 10 mm     Hartenstein, Würzburg 
E-cups       Sarstedt, Nümbrecht 
Gloves       Rösner-Mautby Meditrade, Kiefersfelden 
PCR cups      Invitrogen, Karlsruhe 
Petri dishes      Sarstedt, Nümbrecht 
Pipette tips     Eppendorf, Hamburg 
qRT-PCR plates     4titude, Berlin 
qRT-PCR Adhesive Clear Seals   4titude, Berlin 
Serological pipettes  
2 ml, 5 ml and 10 ml   Sarstedt, Nümbrecht 
25 ml      Greiner Bio-one, Frickenhausen  
Superfrost® Plus slides    Thermo Scientific, Schwerte  
Transfer pipettes      Sarstedt, Nümbrecht  
Tubes, 13 mL      Sarstedt, Nümbrecht 
Tubes, 15 mL      Greiner Bio-one, Frickenhausen 
Tubes, 50 mL      Greiner Bio-one, Frickenhausen 
 
2.1.3 Equipment for Cell Culture 
Equipment Manufacturer 
Cell culture flasks    
25 cm2, 75 cm2 with filter  Sarstedt, Nümbrecht 
75 cm2 without filter  Greiner CELLSTAR®, Frickenhausen 
300 cm2   Techno Plastic Products, Switzerland 
Cell culture plates  
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 96-well , 24-well    Greiner Bio-one, Frickenhausen 
 12-well Greiner CELLSTAR®, Frickenhausen 
 6-well      Sarstedt, Nümbrecht 
 5 cm, 10 cm      Greiner Bio-one, Frickenhausen 
Cell scraper      Sarstedt, Nümbrecht 
Cell strainer (40 µm)      BD Biosciences, Erembodegem, Belgium 
Centrifuge: Biofuge™ Primo    Heraeus, Hanau 
Counting chambers, bright-lined (Neubauer)  Sarstedt, Nümbrecht  
Cryovials      Greiner Bio-one, Frickenhausen 
CultureSlides (2-well, 4-well, 8-well)   BD Biosciences, Erembodegem, Belgium 
Disposable syringes     BD Biosciences, Erembodegem, Belgium 
Filter (Ø 0.20 µm, Ø 0.45 µm)   Th. Geyer, Renningen 
Incubator (normoxia, hypoxia)    Sanyo, Munich  
Inverted Routine Microscope Primovert  Zeiss, Göttingen 
MACS® MS Columns Miltenyi Biotec, Bergisch Gladbach 
MACS™ Separator  Miltenyi Biotec, Bergisch Gladbach 
Media  
DMEM   Gibco, Eggenstein 
DMEM/F12   Gibco, Eggenstein 
EMEM   ATCC, Manassas, USA 
Knockout™ DMEM   Gibco, Eggenstein 
KnockOut™ Serum Replacement  Gibco, Eggenstein 
M2      Sigma-Aldrich, Deisenhofen  
MEM   Gibco, Eggenstein 
Opti-MEM®  I + GlutaMAX TM I  Gibco, Eggenstein 
Opti-MEM® Reduced Serum Medium Gibco, Eggenstein 
StemPro®-34 SFM Complete Medium Gibco, Eggenstein 
Mr. Frosty™ Freezing Container   Thermo Fisher Scientific, Hennef 
Pasteur pipettes   Greiner Bio-One GmbH, Frickenhausen 
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2.1.4 Technical equipment 
Equipment Manufacturer 
7900HT Fast Real-Time PCR System  Applied Biosystems Deutschland 
Accu Jet  Brand, Wertheim 
Autoclave  Webeco, Bad Schwartau 
Automatic Processor Curix 60    AGFA HealthCare, Bonn   
Biophotometer   Eppendorf, Hamburg 
Centrifuges  
Centrifuge 5415 D  Eppendorf, Hamburg 
Heraeus Fresco 21 microcentrifuge  Heraeus, Hanau 
Heraeus Megafuge 16R  Heraeus, Hanau 
Heraeus Megafuge X3R  Heraeus, Hanau 
Heraeus Pico microcentrifuge  Heraeus, Hanau 
Genetic analyzer ABI3500 XL  Applied Biosystems, Darmstadt 
Incubators  
for bacteria (37°C)  Memmert, Schwabach 
for paraffin (60°C)  MWG Biotech, Ebersbach 
Magnetic stirrer  IKA, Staufen 
Microscopes  
Confocal laser scanning microscope Olympus, Hamburg 
Fluorescence microscope BX60  Olympus, Hamburg 
Inverse microscope IX71   Olympus, Hamburg   
Nanodrop 2000  Thermo Scientific, Schwerte 
Oven  Memmert, Schwabach 
pH Meter  Sartorius, Göttingen 
Pipettes Gilson 
Semi-Dry Blotter  Biometra GmbH, Göttingen 
Sonifier  Branson, Dietzenbach 
SpeedVac concentrator   Schuett, Göttingen 
SynergyMx plate reader   BioTek, Friedrichshall 
Thermocycler  
Advanced Primus 96  Peqlab, Erlangen 
Thermal cycler 2720  Applied Biosystems Darmstadt 
Thermomixer  Eppendorf, Hamburg 
UV Solo TS Imaging System  Biometra, Göttingen 
Vortexer-Genie® 2  Scientific Industries 
Waterbath   Julabo, Seelbach 
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2.1.5 Sterilization 
Solutions and buffers were sterilized for 20 min in the vapour autoclave (Webeco; Bad 
Schwartau; Germany) at 120°C and 105 Pa. Heat sensitive solutions were sterile filtrated 
using filtration units of 0.2-0.45 µm pore size. Laboratory equipment was either autoclaved as 
mentioned above or heat sterilized for 8-12 h at 180°C (Memmert; Schwabach, Germany). 
 
2.1.6 Buffers, solutions and reagents 
Buffer / Solution / Reagent Composition 
Activin A 10 µg/ml in 0.1% BSA/PBS 
  
Ampicillin Stock Solution 100 mg/ml Ampicillin in ddH2O 
  
Blocking Solution 0,2% BSA 
(Immunoflourescence staining) 0.1% Tween20 
 in PBS 
  
Blocking Solution  100 mM Tris-HCl, pH 7.5 
(Western Blotting) 0.1 % Tween20 
 5% milk powder 
 in ddH2O 
  
Bouin’s Solution Picric acid : Formaldehyde : Acetic acid 
(15:5:1) 
  
Collagenase, from Clostridium histolyticum 1 mg/ml in HBSS 
  
DNaseI, from bovine pancreas 1 U/µl in 0.15 M NaCl 
  
dNTP Solution  10 µl 100 mM dATP 
 10 µl 100 mM dCTP 
 10 µl 100 mM dGTP 
 10 µl 100 mM dTTP 
 60 µl Ampuwa 
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Fixative Solution  Methanol : Acetic Acid (3 : 1)  
(Chromosomal Analysis)  
  
Fixative Solution  1% Paraformaldehyde 
(EM Analysis) 3% Glutaralaldeyde 
 in 0.1 M Cacodylic Acid 
  
Giemsa Solution 2 ml Giemsa filtered in 75 ml Phosphate 
Buffer 
  
hbFGF  10 µg/ml in 0.1% BSA/PBS 
  
hGDNF 10 µg/ml in 0.1% BSA/PBS 
  
Hyaluronidase, from bovine testes 50 mg/ml in PBS 
  
Hypotonic Solution 2 g / 500 ml Sodium Citrate  
(Chromosomal Analysis) 2,96 g / 500 ml Potassium Chloride  
  
IPTG 100 mM in ddH2O 
  
Kanamycin Stock Solution 25 mg/ml Kanamycin in ddH2O 
  
Lysis Buffer  100 mM Tris-HCl, pH 8.5 
(for cell culture) 5 mM EDTA 
 0.2% SDS 
 200 mM NaCl 
 100 µg/ml Proteinase K 
  
Lysis Buffer  50 ml Tris-HCl, pH 8.0 
(for tissue) 100 mM EDTA 
 0.5% SDS 
  
MACS Buffer 1:20 MACS BSA Stock Solution 
 in autoMACS Rinsing Solution 
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mEGF 10 µg/ml in 0.1% BSA/PBS 
  
Phosphate Buffer 5.92 g (Na2HPO4)2 H2O 
 4.5 g KH2PO4 
 in 1000 ml ddH2O, pH 6.8 
  
Protein Lysis Buffer  10 mM Tris-HCl, pH 8.0 
(Western Blotting) 1 mM EDTA 
 2.5% SDS 
 1 mM PMSF (in isopropanol) 
 cOmplete Protease Inhibitor Cocktail Tablets 
(Roche); 1 tablet / 10 ml 
 in ddH2O 
  
Puromycin 10 mg/ml in ddH2O 
  
Talarozole (R115866; Cyp26 inhibitor) 1 mM in DMSO 
  
TBE (Tris-Borate-EDTA, 5x) 450 mM Tris-HCl 
 450 mM Boric Acid 
 10 mM EDTA, pH 8.5 
  
Transfer Buffer  25 mM Tris-HCl, pH 8.3 
(Western Blotting, 10x) 150 mM Glycin 
 20% Methanol 
  
Washing Solution 0.1 M Cacodylic acid 
(EM Analysis) 0.1 M Saccharose 
 in ddH2O 
  
Washing Solution  100 mM Tris-HCl, pH 7.5 
(Western Blotting) 0.1 % Tween20 
 2% milk powder 
 in ddH2O 
Material and methods  
24 
  
X-Gal Solution 2% X-Gal in Dimethylformamide 
  
Y-27632 10 mM in DMSO 
 
2.1.7 Ready-to-use reaction systems 
Reaction System Manufacturer 
BigDye® Terminator Sequencing Kit Invitrogen, Karlsruhe 
  
ECL Prime Western Blotting Detection 
Reagent  
GE Healthcare, Munich 
  
Leukocyte Alkaline Phosphatase Kit Sigma-Aldrich, Deisenhofen 
  
Mini / Midi Plasmid Kit Qiagen, Hilden 
  
NucleoSpin® RNA II Macherey & Nagel, Düren 
  
PE Annexin V Apoptosis Detection Kit I BD Biosciences, Heidelberg 
  
QIAquick PCR Purification Kit Qiagen, Hilden 
  
Stemgent® mRNA Reprogramming System Stemgent, Cambridge, USA 
  
VECTASTAIN Universal Quick Kit, R.T.U. Vector Laboratories, Burlingame, USA 
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2.1.8 Plasmids and Vectors 
Plasmid / Vector Source 
Integrin β1-tev-BHCys  Addgene 
  
pEBTetD  Bach et al., 2007 
  
pGEM®-T Easy Vector System  Promega, Wisconsin, USA 
  
phEF1α-mStra8 Dr. Jessica Nolte-Kaitschick, Institute of 




Escherichia coli DH5α Invitrogen, Karlsruhe 
 
2.1.9.1  Media and plates for bacteria culture 
Medium / Plate Composition 
LB Medium 10 g / 1l Trypton 
 10 g / 1l NaCl 
  5 g / 1l Yeast Extract 
  
LB/Ampicillin 0.1% mg/ml Ampicillin in LB Medium 
  
LB/Kanamycin 0.05% mg/ml Kanamycin in LB Medium 
  
LB/OJA 0.4% X-Gal 
 0.1% mg/ml Ampicillin 
 100 µM IPTG 
 in LB Medium 
  
LB Plates 10 g / 1l Trypton 
 10 g / 1l NaCl 
   5 g / 1l Yeast Extract 
 15 g / 1l Agar 
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2.1.10 Mouse strains 
The used mice were obtained from the animal house of the Institute of Human Genetics 
(Göttingen) or the Max-Planck-Institute for Experimental Medicine (Göttingen). Mice were 
kept at a 12 hours light/dark cycle at 22°C and 55 ± 5% relative humidity and fed with animal 
food provided by the company Ssniff (Soest). Mice were sacrificed either by CO2 
asphyxiation or cranial dislocation and all experiments were conducted according to the 
European and German protection of animals act.  
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2.1.11.1 Media for cell culture  
Medium Composition 
BJ medium EMEM 
 10% FCS 
 1 mM P/S 
  
ESC medium DMEM 
 20% FCS 
 0.1 mM NEAA 
 1 mM Sodium Pyruvate 
 0.2 mM 2-ME 
 2 mM L-Glutamine 
 1 mM P/S 
 1000 U/ml LIF 
  
Fibroblast medium  DMEM 
(FB medium) 10% FCS 
 2 mM L-Glutamine 
 1 mM Penicillin/Streptomycin 
  
hiPSC-M3 DMEM/F12 
 15% KO™-SR 
 5x NEAA 
 5x GlutaMAX™ 
 1.25% P/S 
 25 µM 2-ME 
 10 ng/ml hbFGF 
  
hiPSC medium  DMEM/F12 
(hiPSC-M4) 15% KO™-SR 
 5x NEAA 
 5x GlutaMAX™ 
 1.25% P/S 
 25 µM 2-ME 
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 5 ng/ml hbFGF 
  
KSOM medium 80 ml KO™-DMEM 
 20 ml KO™-SR 
 0.1 mM NEAA 
 1 mM Sodium Pyruvate 
 0.2 mM 2-ME 
 2 mM L-Glutamine 
 1 mM P/S 
 1000 U/ml LIF 
  
NuFF medium DMEM 
 10% FCS 
 1x GlutaMAX 
 1 mM Penicillin/Streptomycin 
  
StemPro+3 medium StemPro®-34 + supplement 
(Smorag et al., 2012) 1% FCS  
 0.1 mM NEAA 
 2 mM L-Glutamine 
 1 mM Sodium Pyruvate 
 1 mM Penicillin/Streptomycin 
 100 µM 2-ME  
 1000 U/ml LIF  
 50 µg/ml Vitamin C  
 10 ng/ml hbFGF  
 20 ng/ml mEGF  
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2.1.11.2 Freezing media 
Freezing medium Composition 
ESC freezing medium 20% DMSO 
 30% culture medium 
 50% FCS 
  
Fibroblast freezing medium 20% DMSO  
 30% culture medium 
 50% FCS 
  
hiPSC freezing medium CryoStem™ Freezing Medium  
 or 
 90% KO™-SR 
 10% DMSO 
 10 µM Y-27632 
2.1.12 Antibodies 
2.1.12.1 Primary antibodies 
antigen company code species clonality dilution 
Actin/Sma Sigma-Aldrich, Deisenhofen A2547 mouse monoclonal 1:1000 
α-Tubulin Sigma-Aldrich, Deisenhofen T5168 mouse monoclonal 1:10.000 
BrdU Abcam, Cambridge, UK ab6326 rat monoclonal 1:100 
Dazl Abcam, Cambridge, UK ab34139 rabbit polyclonal 1:300 
Ddx4 Abcam, Cambridge, UK ab13840 rabbit  polyclonal 1:100 





Abcam, Cambridge, UK ab28080 rat monoclonal 1:50 
α6-Integrin 
 
Santa Cruz Biotechnology, 
Heidelberg 
sc-6597 goat polyclonal 1:15 to 1:25 
Oct4 Millipore, Billerica, USA MAB4419 mouse monoclonal 1:200 to 1:1000 
Plzf Santa Cruz Biotechnology, 
Heidelberg 
sc-28319 mouse monoclonal 1:20 to 1:50 
Sall4 Abcam, Cambridge, UK ab29112 rabbit polyclonal 1:100 
Vim Santa Cruz Biotechnology, 
Heidelberg 
sc-5565 rabbit polyclonal 1:50 
StemLight™ Pluripotency Surface Marker Antibody Kit (Cell Signaling, Danvers, MA, USA) 
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2.1.12.2 Secondary antibodies 
antibody company code 
Anti-Biotin MicroBeads Miltenyi Biotec,  
Bergisch Gladbach 
130-090-485 
Anti-mouse IgG, HRP-linked Antibody Cell Signaling, Danvers, MA, USA 7076 
Anti-rabbit IgG, HRP-linked Antibody Cell Signaling, Danvers, MA, USA 7074 
Anti-Rat IgG (whole molecule)–FITC antibody produced in 
goat 
Sigma-Aldrich, Deisenhofen F6258 
Cy3 Streptavidin BioLegend, San Diego, USA 405215 
F(ab')2-Goat anti-Mouse IgG (H+L) Secondary Antibody, 
Alexa Fluor® 488 conjugate 
Invitrogen, Karlsruhe A11017 
F(ab')2-Goat anti-Rabbit IgG (H+L) Secondary Antibody, 
Alexa Fluor® 488 conjugate 
Invitrogen, Karlsruhe A11070 
Goat anti-Mouse IgG (H+L) Secondary Antibody,  
Cy3 conjugate 
Invitrogen, Karlsruhe A10521 
Goat anti-Rabbit IgG (H+L) Secondary Antibody,  
Cy3 conjugate 
Invitrogen, Karlsruhe A10520 
Monoclonal Anti-Biotin–Cy3™ antibody produced in mouse Sigma-Aldrich, Deisenhofen C5585  
 
2.1.13 Synthetic oligonucleotides 
All synthetic oligonucleotides were purchased from Eurofins MWG Operon, Ebersberg. 
Primer stocks at a final concentration of 100 pmol/µl dissolved in Ampuwa were stored at 
-20°C. Primers were used for PCR experiments at a concentration of 10 pmol/µl.  
 
2.1.13.1 Synthetic Oligonucleotides for RT-PCR experiments 
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2.1.13.3 Synthetic Oligonucleotides for genotyping PCR experiments 
 
 
2.1.14 Molecular Weight Standards 
Application Standard and Manufacturer 
DNA molecular weight standards GeneRuler 1 kb DNA Ladder (250 to 
10,000 bp; Thermo Scientific, Illinois, USA) 
 
 GeneRuler 100 bp DNA Ladder (100 to 
1000 bp; Thermo Scientific, Illinois, USA) 
 
 DNA molecular weight standards were diluted 
with stop solution according to 
manufacturer`s protocol. 
 
Protein molecular weight standards SeeBlue® Plus2 Pre-stained Protein 









Analysis of nucleotide sequences Ensembl v32 
http://www.ensembl.org 
 




Sequence alignments Basic Local Alignment Search Tool (BLAST) 
provided by NCBI 
http://blast.ncbi.nlm.nih.gov/Blast.cgi 
 
Analysis of  restriction sites DNA restriction mapper tool NEB Cutter 2.0 
http://tools.neb.com/NEBcutter2/index.php 
 
Designing of plasmid maps http://www.bioinformatics.org/savvy/ 
  





2.2.1 Molecular biology methods 
2.2.1.1 Isolation of nucleic acids 
2.2.1.1.1 Isolation of genomic DNA from tissue (Laird et al., 1991)  
For isolation of genomic DNA (gDNA) from tissue, the tissue was mixed with 700 µl tissue 
lysis buffer (2.1.6) and 40 µl proteinase K (10 µg/µl) and incubated at 55°C on a thermo 
mixer overnight. After centrifugation at 13.000 x rpm for 10 min, the supernatant was 
transferred into a new e-cup, mixed with 700 µl phenol-chloroform (1:1) and centrifuged at 
13.000 x rpm for 10 min. The upper aqueous phase was transferred into a new e-cup and 
mixed with 700 µl chloroform. After centrifugation at 13.000 x rpm for 10 min, the upper 
aqueous phase was transferred into a new e-cup, mixed with 700 µl isopropanol and 
centrifuged at 13.000 x rpm for 15 min. The supernatant was discarded and the DNA pellet 
was incubated with 1 ml 70% EtOH for 10 min at room temperature. The mixture was 
centrifuged at 13.000 x rpm for 5 min and the supernatant was discarded. The DNA pellet 
was dissolved in 100 µl Ampuwa and incubated for 10-20 min at 60°C on a thermo block with 
opened lid and further stored at 4°C.  
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2.2.1.1.2 Isolation of genomic DNA from cultured cells 
For isolation of genomic DNA from cultured cells, cells were seeded on gelatine coated 
24-well plates. When the cells reached 100% confluence, the cells were washed once with 
PBS and cultured with 500 µl cell lysis buffer (2.1.6) and 5 µl proteinase K (10 µg/µl) at 37°C 
and 5% CO2 overnight. The next day the cell suspension was transferred into a sterile e-cup 
and mixed with 500 µl isopropanol. After centrifugation at 13.000 x rpm for 15 min the 
supernatant was discarded and the DNA pellet was incubated with 1 ml EtOH for 10 min at 
room temperature, followed by a centrifugation at 13.000 x rpm for 5 min. The supernatant 
was carefully discarded and the DNA pellet was resuspended in 40-80 µl Ampuwa. After 
incubation for 10-20 min at 60°C on a thermo block with opened lid, the isolated DNA was 
stored at 4°C.  
 
2.2.1.1.3 Mini-preparation of plasmid DNA  
The isolation of plasmid DNA from bacteria in an analytic scale was performed with the 
ready-to-use reaction system for Mini Plasmid Preparation (Qiagen). After inoculation of 5 ml 
LB medium containing the appropriate antibiotic with a single colony or a sample from a 
glycerol stock, the culture was incubated for 12-16 h at 37°C with shaking at 150 rpm. For 
preparation of a glycerol stock 700 µl of the overnight culture were mixed with 300 µl sterile 
glycerol and immediately stored at -80°C. The rest of the overnight culture was centrifuged at 
4000 x g for 10 min at 4°C and the pellet was resuspended in150 µl buffer P1. After addition 
of 150 µl buffer P2, the solution was mixed by inverting, incubated for 5 min at room 
temperature and neutralized with 150 µl neutralization buffer P3. The solution was mixed 
vigorously before centrifugation at 13.000 x g for 15 min at room temperature. The 
supernatant was transferred to a new e-cup. DNA was precipitated with 1 volume of 
isopropanol and centrifuged at 13.000 x g for 20 min at room temperature. The pellet was 
washed with 1 ml 70% EtOH, resuspended in 30 µl Ampuwa and incubated for 15 min with 
shaking at 55°C. The isolated DNA was stored at -20°C. 
 
2.2.1.1.4 Endotoxin-free midi-preparation of plasmid DNA  
The isolation of plasmid DNA from bacteria in a large scale was performed with the 
ready-to-use reaction system for Midi Plasmid Preparation (Qiagen). After inoculation of 
100 ml LB medium containing the appropriate antibiotic with a single colony or a sample from 
a glycerol stock, the culture was incubated for 12-16 h at 37°C with shaking at 150 rpm. After 
centrifugation for 15 min at 4000 x g and 4°C, the cell pellet was resuspended in 4 ml buffer 
P1, further mixed with 4 ml buffer P2 thoroughly by inverting up to 6 times and incubated at 
room temperature for 5 min. Then 4 ml buffer P3 were added and the suspension was mixed 
Material and methods  
35 
thoroughly by inverting up to 6 times. After incubation on ice for 10 min and centrifugation for 
10 min at 4000 x g and 4°C, the supernatant was applied to an equilibrated QIAGEN column. 
Subsequently the QIAGEN column was washed two times with 10 ml buffer QC. The DNA 
was eluted with 4 ml buffer QF and further precipitated by adding 6 ml isopropanol. After 
thoroughly mixing, the suspension was centrifuged for 60 min at 4000 x g and 4°C and the 
supernatant was carefully discarded. The DNA pellet was washed once with 2 ml 70% EtOH 
and centrifuged for 10 min at 4000 x g and 4°C. The airdried pellet was resolved in an 
appropriate volume of Ampuwa and stored at -20°C.  
 
2.2.1.1.5 Isolation of total RNA from cultured cells 
The ready to use reaction kit “NucleoSpin® RNA II” (Macherey & Nagel) was used for total 
RNA isolation from cultured cells. Fresh or at -80°C stored cell pellets were mixed with lysis 
buffer provided by the kit, which immediately inactivates RNases. The further RNA isolation 
was performed according to manufacturer’s protocol. RNA was eluted with supplied RNAse 
free H2O, which was preheated at 37°C before adding to the column for RNA elution. After 
incubation for 1 min at room temperature the column was centrifuged. The elution was put 
back on the column for a second centrifugation. The finally eluted RNA was stored at -80°C.  
 
2.2.1.1.6 Determination of nucleic acid concentration 
Nucleic acid concentrations and purities were determined by measuring the absorption at 
260 nm using the Thermo Scientific NanoDrop Spectrophotometer. Protein and salt 
contaminations were estimated with the absorbance ratios of A260/280 and A260/230, 
respectively.  
 
2.2.1.2 Polymerase Chain Reactions 
2.2.1.2.1 Amplification of DNA  
The Polymerase Chain Reaction (PCR) represents an in vitro amplification of specific DNA 
fragments (Saiki et al., 1988). A typical PCR program for the exponential multiplication of 
selected DNA region consists of the denaturation of DNA strands, the annealing of specific 
primers and the synthesis of DNA. The PLATINUM® Taq DNA Polymerase (Invitrogen, 
Karlsruhe) as well as the IMMOLASE™DNA Polymerase (Bioline, Luckenwalde) with the 
supplied reagents were used for DNA amplification.  
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The annealing temperature and cycle numbers were individually adapted to the used primer 
pairs. 2.1.13 provides an overview of the used primers and their annealing temperature and 
cycle numbers. Further analysis of synthesised DNA fragments was performed using 
agarose gel electrophoresis of DNA (2.2.1.3). 
 
2.2.1.2.2 Reverse transcription 
Prior to transcription of mRNA into cDNA using a reverse transcriptase, a DNAse digestion 
(Sigma-Aldrich, Deisenhofen) was performed in order to remove remaining DNA. 5 µg RNA 
in a total volume of 8 µl Ampuwa were treated with 1 µl DNaseI and carefully mixed with 1 µl 
10x buffer by pipetting. After 15 min at room temperature, the reaction was stopped by the 
addition of 1 µl stop solution and further incubation for 10 min at 70°C. Subsequently the 
cDNA synthesis was directly performed using SuperScript® II Reverse Transcriptase 
(Invitrogen, Karlsruhe) or Tetro Reverse Transcriptase (Bioline, Luckenwalde), respectively, 
or the DNaseI digested RNA was stored at -80°C. 
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For the use of SuperScript® II Reverse Transcriptase, DNaseI digested RNA was mixed with 
1 µl oligo(dT)-primer and 1 µl 10 mM dNTPs and incubated for 5 min at 65°C. Further 
4 µl 5x First-Strand buffer and 2 µl 0.1 M DTT were added and the reagents were carefully 
mixed by pipetting. After an incubation of 2 min at 42°C, 1 µl SuperScript® II Reverse 
Transcriptase were added and carefully mixed. The mixture was incubated for 50 min at 
42°C for the final reverse transcription, which was subsequently inactivated at 70°C for 
15 min. 
For cDNA synthesis using Tetro Reverse Transcriptase, DNaseI digested RNA was mixed 
with 1 µl oligo(dT)-primer and incubated for 5 min at 70°C. Afterwards 1 µl 10 mM dNTPs, 
1 µl Tetro Reverse Transcriptase, 2.75 µl Ampuwa and 4 µl 5x buffer were added. The 
sample was mixed carefully by pipetting and incubated at 42°C for 30 min. The reaction was 
stopped by incubation at 95°C for 5 min.  
The successful cDNA amplification was verified by PCR analysis using specific primers for 
the ubiquitously expressed housekeeper gene mouse HPRT (Hypoxanthine-guanine 
phosphoribosyltransferase) or human TBP (TATA-Binding Protein). The cDNA was stored at 
-20°C.  
 
2.2.1.2.3 Quantitative Real-Time PCR 
A quantitative Real-Time PCR (qRT-PCR) analysis is used to quantify the relative mRNA 
expression levels of a certain gene of interest by using fluorescent labelled dNTPs for PCR 
reactions. The fluorescent intensity of labelled double stranded DNA is measured after each 
PCR cycle using the ABI Prism 7900T Sequence Detection System. A threshold value of 
PCR cycles during the exponential phase is determined in a Ct value, which determines the 
PCR cycle with the best PCR conditions and is used for further quantification of relative 
mRNA expression. This evaluation was performed with the SDS 2.2.1 software (Applied 
Biosystems) using the ΔΔ-Ct method. The mRNA expression of the mouse housekeeping 
gene HPRT was used for normalization. 
qRT-PCR experiments were carried out in 10 µl reactions with 1 µl of 1:20 in Ampuwa diluted 
cDNA, 1 µl of each primer (3 µM; 0), 2 µl Ampuwa and 5 µl KAPA™ SYBR® FAST (Peqlab) 
or SYBR® Green PCR Master Mix (Qiagen) on 7900HT Fast Real-Time PCR System using 



















All reactions were performed in triplicate on one 384-well plate and at least repeated twice as 
technical replicates.  
 
2.2.1.2.4 Sequencing analysis (Sanger et al., 1977) 
Based on the chain-terminating Sanger sequencing this analysis was performed in order to 
determine the nucleotide sequence of a DNA fragment of interest.  
For the sequencing analysis using the BigDye® Terminator Sequencing Kit (Invitrogen, 
Karlsruhe) 1 µl DNA, 1 µl forward or reverse primer, 1 µl BigDye® Terminator Mix, 2 µl 
BigDye® Terminator buffer and 5 µl Ampuwa were pipetted into a PCR reaction tube and a 









After the PCR reaction each sample was mixed with 10 µl Ampuwa. The final sequencing 
analysis using ABI3500 XL was performed in house sequencing service (Institute of Human 
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2.2.1.3 Agarose gel electrophoresis of DNA 
Standard agarose gel electrophoresis is used for the separation of DNA fragments after PCR 
reactions, restriction digestions or ligations. The DNA fragments are separated within an 
electric field according to their length.  
Depending on the expected separated DNA fragments, a 0.5-2% agarose gel was prepared. 
The appropriate amount of agarose was dissolved in 100 ml of 0.5x Tris-Borate-EDTA (TBE) 
buffer (2.1.6) by boiling in the microwave. In order to visualize later the DNA under UV light, 
ethidium bromide was added before the mixture was poured into a horizontal gel chamber. 
After polymerization, samples were loaded to the gel next to a DNA length standard (2.1.14), 
which is needed for the determination of DNA fragment lengths. The application of an electric 
field (70-120 V) yielded in the separation of DNA fragments, which were visualized using the 
UVsolo TS Imaging System (Biometra, Göttingen). 
 
2.2.1.3.1 Purification of DNA fragments from agarose gels 
The purification of DNA fragments from agarose gels was performed using the ready to use 
reaction systems QIAquick PCR Purification Kit (Qiagen, Hilden) or Wizard® SV Gel and 
PCR Clean-Up System (Promega, Wisconsin, USA). After separation of nucleic acids to 
identify DNA-fragments of interest, the DNA fragment was excised from the gel with a sterile 
scalpel on an UVtranslluminator and transferred to an e-cup and weighed. The appropriate 
buffer was added according to the weight of the excised fragment. The further purification 
was performed according to manufacturer’s protocol. The final eluted DNA was stored at 
-20°C.  
 
2.2.1.4 Cloning techniques 
2.2.1.4.1 Restriction of plasmid DNA 
Enzymatic cleavage of plasmid DNA was performed with restriction endonucleases derived 
from different companies including Invitrogen and New England BioLabs. Generally, 1 µg 
DNA were incubated with 5-10 units of enzyme in 1x appropriate buffer and 1 µg BSA at 
37°C for at least 2 h, preferentially over night, in a total volume of 10-100 µl. A digestion with 
two different enzymes was performed using a buffer compatible for both. The digestion of 
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2.2.1.4.2 Ligation of PCR products  
For ligation of a DNA fragment- the insert- into a target vector both were prepared using 
appropriate restriction enzymes. The insert was amplified using a PCR reaction with primers 
providing the essential restriction sites or it was cut out from another vector. The target 
vector was linearized by digestion using the appropriate restriction enzymes. In a total 
reaction volume of 10 µl, 1 µl linearized vector, 2.5 µl insert DNA, 5 µl ligase buffer and 0.5 µl 
Ampuwa were mixed and incubated at 65°C for 5 min. After 5 min on ice, 1 µl ligase 
(Promega, Wisconsin, USA) was added and the reaction was incubated at 16°C overnight.  
 
2.2.1.4.3 Subcloning of PCR products using TA cloning  
The pGEM®-T Easy Vector System (Promega, Wisconsin, USA) provide a convenient 
system for the TA cloning of PCR products, which are amplified using polymerases providing 
a terminal transferase activity. Due to this activity a single deoxyadenosine (A) is added to 
the 3' end of the PCR product, which is recognized by the complimentary 3´ deoxythymidine 
(T) residues of the linearized pGEM®-T Easy Vector and results in an efficient ligation of 
insert and vector.  
The ligation reaction was performed in a total volume of 10 µl containing an insert to vector 
ratio of 3:1. For this reaction 50 ng pGEM®-T Easy, 150 ng insert DNA, 1 µl T4 DNA ligase 
10x buffer and 1 µl T4 ligase were mixed with an appropriate amount of Ampuwa and 
incubated at 16°C overnight.  
 
2.2.1.4.4 Transformation of competent cells with plasmid DNA (modified to 
Hanahan, 1983) 
For transformation of competent bacteria 50 µl E.coli DH5α competent cells and plasmid 
DNA were placed on ice for 10 min. The cells were carefully mixed by pipetting. Further 5 µl 
plasmid DNA were added and the mixture was incubated for 15-20 min on ice. After a heat 
shock at 42°C for 1 min, the mixture was placed on ice for 5 min. Further 950 µl SOC 
outgrowth medium were added and the bacteria were slightly shaking incubated for 1 h at 
37°C on a thermo mixer. The transformed bacteria were seeded on a LB agar plate providing 
the appropriate antibiotic for bacteria selection and incubated at 37°C overnight.  
 
2.2.2 Protein manipulation methods 
2.2.2.1 Protein isolation from eukaryotic cells 
For protein isolation cells were harvested from 6-well plates. After washing once with PBS, 
according to the size of the cell pellet 200-500 µl protein lysis buffer (2.1.6) were added. The 
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cell suspension was incubated on ice for 1 h. After a brief sonification, the mixture was 
centrifuged for 20 min at 13.000 rpm and 4°C to pellet cell debris. The supernatant 
containing the proteins was transferred to a new e-cup and stored at -20°C, while it was kept 
at -80°C for long term storage.  
 
2.2.2.2 Measurement of protein concentration (Bradford, 1976) 
Protein concentrations were determined according to the method of Bradford (1976), which 
bases on the usage of the Coomassie Brilliant Blue dye and its property to bind unspecifically 
to proteins in acidic solution. This is accompanied by a shift of its absorption maximum from 
465 nm to 595 nm. Standard protein concentrations using bovine serum albumine are used 
to generate a calibration curve in order to calculate the measured protein concentrations.  
For measurement of protein concentration 20 ml Roti® Nanoquant (Carl Roth, Karlsruhe) 
were mixed with 80 ml ddH2O. After proteins were diluted 1:100, triplicates of 50 µl of this 
dilution were mixed with 200 µl diluted Roti® Nanoquant. After incubation for 5 min at room 
temperature, the absorptions were measured using the SynergyMx plate reader (BioTek, 
Friedrichshall) and calculated with the appropriate Gene5 software.  
 
2.2.2.3 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
(Laemmli, 1970) 
Separation of proteins was performed using Sodium Dodecyl Sulfate Polyacrylamide Gel 
Electrophoresis (SDS-PAGE), which bases on the use of gels and buffers with an operating 
pH of 7.0 yielding in an increase of stability of proteins and gels and consequently in a better 
result of electrophoresis.  
Protein samples were prepared with 0.4 volume of 4x NuPAGE® LDS sample preparation 
buffer (Invitrogen, Karlsruhe) in a total volume of 30 µl, incubated at 70°C for 10 min and 
subsequently placed on ice for 5 min. After centrifugation for 10 min at 13.000 rpm and room 
temperature, samples were loaded onto a gradient gel (NuPAGE™ 4-12% Bis-Tris Gel, 
Invitrogen, Karlsruhe) next to a prestained molecular weight protein standard (2.1.14) to 
determine the size of separated proteins. Depending on the molecular weight of the proteins, 
electrophoresis was performed in 1x NuPAGE® MOPS SDS Running Buffer (Invitrogen, 
Karlsruhe) for 15 min at 80 V and further at 120-150 V.  
 
2.2.2.4 Western Blotting (Gershoni and Palade, 1983) 
Transfer of proteins from a SDS-PAGE to a nitrocellulose membrane (Hybond™-C Extra, GE 
Healthcare, Freiburg) was performed with the semi-dry technique. One membrane and six 
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sheets of Whatman GB003 filter paper (Schleicher & Schull, Dassel) were cut to the size of 
the polyacrylamide gel. The membrane was activated by rinsing in 100% methanol for 
5-10 sec and equilibrated in transfer buffer (2.1.6) for 10 min. Whatman GB003 filter papers 
were placed in transfer buffer. The components were placed on the anode of the semi-dry 
electro blotter (Biometra, Göttingen) according to a sandwich model: three sheets of 
Whatman paper, membrane, polyacrylamide gel and three sheets of Whatman paper. The 
protein transfer was performed at 150 mA for 15 min and further at 250 mA for 1-2 h.  
 
2.2.2.5 Staining of polyacrylamide gels 
After semi-dry blotting, the protein transfer efficiency onto the nitrocellulose membrane was 
checked by staining of the polyacrylamide gel with Coomassie-Brilliant Blue R-250 for 10 min 
at room temperature. After this incubation the gel was destained in ddH2O until the desired 
staining of proteins was visible.  
 
2.2.2.6 Protein detection on nitrocellulose membranes using antibodies 
After protein transfer onto a nitrocellulose membrane, unspecific binding sites were blocked 
by incubating the membrane with blocking solution containing 5% milk powder (2.1.6) for at 
least 1 h at room temperature followed by incubation with the primary antibody (2.1.12.1) 
diluted in washing buffer (2.1.6) overnight at 4°C. Next day the membrane was extensively 
washed three times for 20 min at 4°C with washing buffer to remove unbound primary 
antibody and further incubated with the appropriate secondary antibody conjugated with 
horseradish peroxidase (HRP; 2.1.12.2) diluted in washing buffer for approximately 2 h at 
room temperature. The membrane was washed three times for 20 min at 4°C with washing 
buffer and 5 min in PBS. The ECL Prime Western Blotting Detection Reagent (GE 
Healthcare, Freiburg) was used for the detection of chemi-luminescent signals. The detection 
solution was prepared according to manufacturer’s protocol protected from light. The 
membrane was placed on a plastic film, covered with prepared detection solution, enclosed 
in the plastic film and placed in a film cassette. After an incubation of 3 min protected from 
light, a X-ray film was placed on the membrane in a dark room and the film cassette was 
closed. Depending on the intensity of the signal, the incubation varied from seconds from 
minutes followed by the development using the Automatic Processor Curix 60 (AGFA 
HealthCare, Bonn). 
After development, the bound antibodies could be removed by an incubation of the 
membrane with 0.1 M glycine solution for 1 h at room temperature and the membrane could 
be used for a further protein detection using antibodies.  
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2.2.3 Histological methods 
2.2.3.1 Fixation of cells on slides 
For histological analyses cells were grown on BD Falcon™ CultureSlides providing two, four 
or eight chambers. Before seeding of cells, slides were coated with gelatine (2.2.4.1.1) or 
MEF feeder layer (2.2.4.2.1) depending on the cultured cell type. 
Before further histological analysis, cells were washed three times with PBS and fixed with 
4% PFA for 10 min at 4°C. Cells were carefully washed three times with PBS and further 
treated according to the intended analysis. 
 
2.2.3.2 Fixation of organs and tissues 
Organs prepared from sacrificed mice were fixed in 4% PFA under slightly shaking at 4°C for 
2-3 days or in Bouin’s solution (2.1.6) without shaking at room temperature for 2-3 days.  
Organs fixed in PFA were washed in 70% EtOH overnight at room temperature. Next day the 
organs were dehydrated using an ethanol series (70% EtOH for 15 min, 80% EtOH for 
20 min, 90% EtOH for 30 min, 96% EtOH for 30 min and 100% EtOH for 20 min) at room 
temperature and were kept slightly shaking in isopropanol overnight at room temperature. 
Next day organs were incubated in isopropanol:xylene mixtures for each 30 min (75:25, 
50:50 and 25:75 isopropanol:xylene) and kept in 100% xylene overnight at room 
temperature. Next day organs were incubated two times in paraffin at 60°C for 3 h and kept 
in paraffin at 60°C overnight.  
Organs fixed in Bouin’s solution were washed under slightly shaking two times in 70% EtOH 
for 1 h at room temperature. Afterwards, organs were incubated in 80% EtOH containing 
1% Ammonia solution under slightly shaking. The solution was changed several times until it 
was not stained anymore by remaining Bouin’s solution. The organs were further incubated 
in 80% EtOH containing 1% Ammonia solution under slightly shaking overnight at room 
temperature. Next day organs were incubated two times in 90% EtOH for 1 h at room 
temperature and kept slightly shaking in 100% EtOH overnight at room temperature. Next 
day organs were incubated slightly shaking in 100% xylene for 2-2.5 h at room temperature 
and kept in xylene:paraffin (1:1) overnight at 60°C. Next day the organs were incubated in 
pure paraffin at 60°C, which was changed several times, and kept in pure paraffin overnight 
at 60°C.  
Finally, paraffin treated organs were embedded in paraffin blocks using the Shandon 
HistoCentre 2.  
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2.2.3.3 Preparation of paraffin sections 
For further histological analysis the tissue was cut into 3-6 µm sections using the Leica RM 
2035 BioCut Microtome. Sections were placed on prewarmed water (58°C) and afterwards 
on slides, which were kept at 30°C on a heating plate for at least 30 min and further stored at 
room temperature.  
Before further histological analysis sections were incubated three times in 100% xylene for 
5 min under slightly shaking in order to remove paraffin, watered using an ethanol series 
(100% EtOH, 90% EtOH, 80% EtOH and 70% EtOH) at room temperature each for 2 min 
and rehydrated in ddH2O for at least 3 min.  
 
2.2.3.4 Hematoxylin-Eosin staining of tissue sections 
For Hematoxylin-Eosin (H&E) counterstaining sections were rinsed in ddH2O for several 
times and incubated in concentrated Hematoxylin (Carl Roth, Karlsruhe) for 2-3 min. After 
washing in ddH2O for 2 min, sections were rinsed with running tap water for at least 10 min. 
The slides were placed shortly in 0.3% HCl/ 70%EtOH to take out excess Hematoxylin and 
immediately put in ammonia H2O (0.25% NH3) for several times. After rinsing with running 
tap water, sections were incubated in Eosin (Carl Roth) with freshly added 0.3% C2H4O2 
(Acetic Acid) for 4-5 min and washed in ddH2O for several times. Sections were dehydrated 
through several changes of ethanol, each for 1 min (70%, 80%, 90% and 100%), cleared in 
xylene for 10 min and mounted with Eukitt® quick-hardening mounting medium (Fluka).  
 
2.2.3.5 Immunohistochemical analysis using VECTASTAIN Universal Quick 
Kit, R.T.U. 
For immunohistochemical analysis sections were shortly washed in 0.1% Tween20/ PBS, 
boiled in 1% Tween20/ 10 mM EDTA (pH 8) buffer for 6 min and cooled on ice for 10 min. 
Afterwards sections were washed in 0.1% Tween20/ PBS and further incubated in 30% H2O2 
and 100% methanol (ratio: 1:10) for 15 min at room temperature to remove any endogenous 
peroxidase. The following staining was performed with VECTASTAIN Universal Quick Kit, 
R.T.U. (Vector Laboratories, USA). After blocking with prediluted horse serum provided by 
the kit for 10 min, the sections were incubated with primary antibody diluted in prediluted 
horse serum and 0.1% Tween20/ PBS (ratio: 1:1) in a humidity chamber overnight at 4 °C. 
The next day the sections were incubated for 60-90 min at room temperature, followed by a 
washing step in 0.1% Tween20/ PBS and incubation with prediluted biotinylated panspecific 
universal secondary antibody provided by the kit for 10 min at room temperature. After 
washing in 0.1% Tween20/ PBS, the sections were incubated with ready-to-use 
streptavidin/peroxidase preformed complex for 5 min at room temperature. The sections 
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were washed in 0.1% Tween20/ PBS and incubated with DAB (Roche) diluted 1:10 in 
provided buffer for 2 min until the colour of sections turned to brown. After washing in 0.1% 
Tween20/ PBS, the sections were counterstained with Hematoxylin QS (Biozol, Eching) and 
mounted with Roti®Mount Aqua (Carl Roth, Karlsruhe).  
 
2.2.3.6 Immunofluorescence staining 
Before immunoflourescence staining, cells were fixed (2.2.3.1) and sections were watered 
and rehydrated (2.2.3.3), respectively, and further washed three times with PBS. Unspecific 
binding sites were blocked by incubation with blocking solution (2.1.6) for at least 1 h at room 
temperature. Cells or sections were incubated with the appropriate primary antibody 
(2.1.12.1) diluted in PBS in a humidity chamber overnight at 4°C. Next day, cells or sections 
were washed three times with PBS and incubated with the appropriate secondary antibody 
(2.1.12.2) diluted in PBS in a humidity chamber for 1.5-2 h at room temperature. Afterwards, 
cells and sections were washed three times with PBS and shortly air-dried. Cells or sections 
were mounted with DAPI, sealed with nail polish and stored at 4°C.   
 
2.2.3.7 Electron Microscopy 
Analyses using Electron Microscopy (EM) were performed by Prof. Dr. Andreas Meinhardt 
from the Department of Anatomy & Cell Biology of the Justus Liebig University in Giessen. 
The cells were fixed as described in (2.2.3.7.1) and send to Giessen for further preparation 
and EM analysis.  
 
2.2.3.7.1 Fixation of cells for EM analysis  
After trypsin/EDTA treatment and centrifugation (2.2.4.3.4), cells were washed once in PBS 
and incubated in fixation solution (2.1.6) for 8-12 h at 4°C on a rolling platform. Afterwards, 
cells were washed three times in washing solution (2.1.6) at 4°C and additionally washed two 
times in PBS. Cells were finally stored in PBS and send to Giessen for EM analysis.  
 
2.2.4 Cell culture methods 
2.2.4.1 Coating of culture vessels 
2.2.4.1.1 Preparation of gelatine coated culture vessels 
Depending on the size of used culture vessels, they were coated with 1-10 ml sterile 0.1% 
gelatine and incubated for at least 30 min at 37°C and 5% CO2. Before use the gelatine 
solution was aspirated and the cells were seeded on the culture vessel. 
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2.2.4.1.2 Preparation of matrigel coated plates 
BD Matrigel™ Basement Membrane Matrix (BD Bioscience, Heidelberg) was used for 
preparation of matrigel coated plates. Chilled serological pipettes and culture plates were 
used during working with matrigel. After thawing on ice, aliquots were prepared at 4°C and 
further stored at -20°C. Before use, one aliquot was thawed on ice and diluted 1:100 in ice 
cold DMEM/F12. One 6-well vessel was covered with 1 ml diluted matrigel and kept at room 
temperature for at least 2 h, but preferentially overnight. Before seeding cells, the matrigel 
solution was carefully removed from the 6-well vessels. 
 
2.2.4.2 Mitomycin C treatments 
2.2.4.2.1 Mitomycin C treatment of murine embryonic fibroblasts 
Murine embryonic fibroblasts (MEFs, 2.2.4.3.2) were treated with 10 µg/ml mitomycin C 
diluted from a 50x stock solution in FB medium. After 3 h incubation at 37°C and 5% CO2, 
the cells were washed twice with PBS and detached from the culture vessels by trypsin 
treatment. Because mitomycin C treated cells can not adhere to culture vessels, the cells 
have to be fixed to the culture vessels by gelatine. Therefore the mitotically inactivated 
embryonic fibroblasts were seeded on gelatine coated vessels. 
 
2.2.4.2.2 Mitomycin C treatment of neonatal human foreskin fibroblasts 
Neonatal Human Foreskin Fibroblast (NuFF) cells were cultured in NuFF medium and 
passaged to confluence on a total of three 300 cm2 culture vessels. Cells were treated with 
10 µg/ml mitomycin C diluted in NuFF medium. After 3 h incubation at 37°C and 5 % CO2, 
the cells were washed twice with PBS and detached from the culture vessels by trypsin 
treatment. After centrifugation at 1000 x g for 5 min, cells were cryopreserved in 1 ml FB 
freezing medium at a cell density of 8 x 106 cells per stock and stored at -80°C. Cells were 
thawed according the protocol for thawing of eukaryotic cells (2.2.4.3.5). Because 
mitomycin C treated cells can not adhere to culture vessels, cells have to be fixed to the 
culture vessels by gelatine. Therefore the mitotically inactivated NuFF cells were seeded on 
gelatine coated vessels before their further use.  
 
2.2.4.3 Culture of eukaryotic cells 
2.2.4.3.1 Culture of murine embryonic stem cells 
In order to keep embryonic stem cells (ESCs) in their undifferentiated state, they were 
continuously cultured on mitotically inactivated mouse fibroblasts (MEF feeder layer; 
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2.2.4.2.1) and in ESC medium containing the cytokine LIF (Leukemia Inhibitory Factor; 
2.1.11.1).  
 
2.2.4.3.2 Culture of murine embryonic fibroblasts 
Feeder cells are indispensable for the culture of ESCs. These are mitotically inactivated 
murine embryonic fibroblasts (MEFs), which are homogenously seeded on gelatine treated 
culture vessels and cultured in FB medium (2.1.11.1). A treatment with mitomycin C leads to 
the non dividing status of these cells (Martin and Evans, 1975). 
 
2.2.4.3.3 Isolation of murine embryonic fibroblasts 
Mouse embryos were isolated from gestating mice at stage 13.5-15.5 days post coitum (dpc) 
and washed in PBS. After opening of the abdomen and removal of organs, the heads were 
separated and the bodies were shredded. The cell suspension was transferred in a glass 
bulb with glass pellets and 20 ml Trypsin/EDTA and 1 ml DNAse were added. After 30 min 
incubation at 37°C with mixing, the cell suspension was centrifuged by 270 x g for 10 min. 
The supernatant was discarded and then resuspended in FB medium. The cells were seeded 
in appropriate culture vessels. After approximately 24 h of cultivation the medium was 
changed to remove not adherent cells. After further cultivation of approximately 3 days, the 
cells were passaged in a ratio 1:3. The cells were then cryopreserved after 3-5 days in 
passage No. 1.  
 
2.2.4.3.4 Passaging of eukaryotic cells 
Depending on the cell line and cell density, the cells were cultured for 2 to 4 days until they 
reached confluence for passaging. The cells were washed with PBS and further treated with 
1-5 ml trypsin/EDTA, depending on the size of the culture vessel. After 3-5 min at 37°C and 
5% CO2, all cells were detached from the culture vessel, which was controlled unter the light 
microscope. An equal volume of appropriate culture medium was added to inactivate the 
trypsin/EDTA treatment. The cell suspension was centrifuged at 1000 x g for 5 min. After the 
supernatant was discarded, the cell pellet was resuspended in appropriate culture medium 
(2.1.11.1) and seeded on an appropriate number of culture vessels. After approximately 24 h 
of cultivation at 37°C and 5% CO2, the medium was changed to remove not adherent cells. 
 
2.2.4.3.5 Cryopreservation and thawing of eukaryotic cells 
Cells were cryopreserved from a confluent culture vessel. After washing with PBS, the cells 
were treated with 1-5 ml trypsin/EDTA, depending on the size of the culture vessel, and 
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cultured for 3-5 min at 37°C and 5% CO2. Under the light microscope, it was controlled that 
cells were detached from the culture vessel. The effect of the trypsin/EDTA treatment was 
inactivated by an equal volume of appropriate culture medium and the cell suspension was 
centrifuged at 1000 x g for 5 min. After the supernatant was discarded, the cell pellet was 
resuspended in 500 µl appropriate culture medium (2.1.11.1) and subsequently mixed with 
500 µl appropriate freezing medium. The mixture was transferred into well labelled cryovials, 
which were immediately frozen at -80°C. After 24 h at -80°C, the cryovials were placed at -
152°C for long term storage.  
Because the DMSO contained in the freezing medium is toxic for cells at room temperature, 
the procedure of thawing has to be done quickly. The cryovial was placed in a water bath at 
37°C until the cells were almost completely thawed. The cells were mixed with a bigger 
volume of appropriate culture medium in order to dilute the DMSO and then centrifuged at 
1000 x g for 5 min. After removal of the supernatant, the cells were resuspended in 
appropriate culture medium and seeded on a culture vessel. After approximately 24 h of 
cultivation at 37°C and 5% CO2, the medium was changed to remove not adherent cells.  
 
2.2.4.3.6 Culture of Human Testicular Feeder 
Human Testicular Feeder (HTF) cells were derived from MACSortings (2.2.4.7.2) with human 
testicular biopsies from infertile men. During this procedure the flow through was captured in 
an e-cup, which was stored on ice, if HTF cells had to be established. The cell suspension 
was centrifuged at 1000 x rpm for 5 min, resuspended in 2 ml FB medium, seeded on one 
6-well vessel coated with 0.1% gelatine and cultured at 37°C and 5% CO2. During further 
culture, cells were expanded, routinely passaged (2.2.4.3.4) and cryopreserved using FB 
freezing medium (2.2.4.3.5).  
 
2.2.4.3.7 Digestion of human testicular material 
Testicular biopsies were obtained simultaneously during surgery for testicular sperm 
extraction (TESE) for the diagnosis of male fertility from patients as previously described 
(Jezek et al., 1998; Schulze et al., 1999; Feig et al., 2007). TESE was performed by Prof. 
Schulze at the Department of Andrology, University Hospital Hamburg-Eppendorf in 
Hamburg. Ethic Committee Approval to Prof. Schulze was obtained (OB/X/2000) and the 
study was performed according to the ethical guide lines of the current Declaration of 
Helsinki. 
Testicular tissue was kept in medium at ~32°C during the transport to the Institute of Human 
Genetics in Göttingen. Upon arrival testicular biopsies underwent a two-step enzymatic 
digestion procedure. Testicular biopsy was placed in culture plates containing HBSS and 
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was washed in HBSS by using forceps. Further it was transferred into culture plates 
containing HBSS supplemented with 1 mg/ml collagenase and 2 U/ml DNaseI. Tissue was 
mechanically dissociated into small pieces by using forceps, transferred into a 15 ml falcon 
tube and digested for 15 min at 37°C. During the incubation time testicular pieces were 
occasionally mixed by shaking. After centrifugation at 1000 x rpm for 5 min, the supernatant 
was carefully removed and the pellet was resuspended in HBSS supplemented with 
1 mg/ml collagenase, 2 U/ml  DNaseI and 0.5 mg/ml hyaluronidase. The suspension was 
carefully mixed six times by pipetting using a glass pasteur pipette and digested for 10 min at 
37°C. During the incubation time the tissue was occasionally mixed by shaking. After addition 
of 1 ml FCS to inactivate enzymes, the tissue solution was extensively mixed by pipetting 
using a glass pasteur pipette and transferred with a 10 ml serological pipettes on a nylon 
mesh cell strainer (40 µm pore size) to remove cell debris. The cell suspension was captured 
in a falcon tube, centrifuged at 1000 rpm for 5 min and the supernatant was discarded. The 
cell pellet was washed once in PBS and centrifuged at 1000 rpm for 5 min. For isolation of 
human spermatogonial stem cells these cells underwent a MACSorting (2.2.4.7.2). 
 
2.2.4.3.8 Culture of Scrotal Human Fibroblasts 
Scrotal Human Fibroblasts (SHF) were derived from scrotal skin from infertile men. Scrotum 
biopsies were obtained simultaneously during surgery for testicular sperm extraction (TESE) 
for the diagnosis of male fertility from patients at the Department of Andrology, University 
Hospital Hamburg-Eppendorf in Hamburg, embedded in medium containing vials and send 
by mail to the Institute of Human Genetics in Göttingen for further study. Ethic Committee 
Approval to Prof. Schulze was obtained (OB/X/2000) and the study was performed 
accordingl to the ethical guide lines of the current Declaration of Helsinki. On arrival scrotal 
skin samples were cultured on 0.1% gelatin-coated culture dishes in FB medium at 37°C and 
5% CO2. During culture, the cells expanded from scrotal skin and started to proliferate. 
These so called SHF cells were expanded, routinely passaged (2.2.4.3.4) and cryopreserved 
using FB freezing medium (2.2.4.3.5).  
 
2.2.4.3.9 Co-culture of mouse ESCs with HTF cells 
Mouse ESCs were cultured under standard ESC culture conditions at 37°C and 5% CO2. 
Using FB medium co-culture experiments were performed with 100.000 mESCs seeded on 
mitotically active HTF cells, which reached nearly 80% confluence. First medium change was 
performed 3 days at the earliest after starting the co-culture, subsequently every second to 
third day. After 10-12 days in co-culture cells were passaged in a ratio of 1:2-1:3 on 0.1% 
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gelatine-coated culture dishes and further cultured for at least 8-10 days. These cells were 
used for further analysis.  
 
2.2.4.3.10 Cultivation and passaging of hiPSCs 
Generally, established hiPSCs were cultured in hiPSC medium (2.1.11.1) on 6-well vessels 
providing a MEF feeder layer (2.2.4.2.1) at 37°C, 5% CO2 and 5% O2 (hypoxia). Every 
second day cells were washed once with PBS and covered with equilibrated hiPSC medium.  
hiPSCs had to be passaged when colonies filled in the size observed through a 10x objective 
of the light microscope, colonies physically contacted each other and/or the MEF feeder layer 
was older than 7 days. Depending on the confluence, hiPSCs cultured on one 6-well vessel 
were passaged in a ratio of 1:2 – 1:4.  
For passaging, hiPSCs were washed once with PBS and covered with 1 ml accutase for 
enzymatic cell detachment. Cell dissociation was observed under the light microscope. When 
the colonies started to dissociate from the culture well and the edges of colonies were 
detached, the accutase was carefully removed from the frame of the culture well and cells 
were immediately covered with equilibrated hiPSC medium. hiPSC colonies were collected 
by scratching the surface of the 6-well vessel with a serological pipette and simultaneously 
rinsing with medium. Remaining colonies were collected with a cell scraper. Collected cells 
were pelleted by gently centrifugation (300 x g, 5 min) and carefully resuspended in an 
appropriate volume of equilibrated hiPSC medium supplemented with 10 µM Y-27632 (2.1.6) 
without making a single cell suspension. According to the passaging ratio hiPSCs were 
seeded on one ore more 6-well vessels coated with MEF feeder layer and the 6-well plate 
was placed in the incubator at 37°C, 5% CO2 and 5% O2, where it was gently rocked from 
side to side and front and back to distribute the hiPSC aggregates across the well. The first 
medium change was performed 48 h after passaging procedure.  
 
2.2.4.3.11 Cryopreservation and thawing of hiPSCs 
The procedure for cryopreservation and thawing of hiPSCs had to be established in the 
presented thesis. The establishment was carried out by testing different ways of enzymatic 
cell detachment, cell collection, centrifugation, compositions of freezing media and freezing 
procedures, which is summarized in Tab. 7 in the corresponding result part (3.2.3). 
The survival of hiPSC colonies cryopreserved by the tested procedures was evaluated by 
counting the number of emerged colonies after replating on MEF feeder layer. The presence 
of Rho associated kinase (ROCK) inhibitor Y-27632 is known to increase hiPSC colony 
formation (Watanabe et al., 2007) and to improve the recovery and further growth of 
cryopreserved hiPSCs by exhibiting anti-apoptotic activity  (Claassen et al., 2009). Because 
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of these findings, thawed hiPSCs were always cultured in appropriate hiPSC medium 
supplemented with Y-27632 (10 µM) for 48 h after replating on MEF. Additionally, the impact 
of pre-incubation of hiPSCs with Y-27632 before cell detachment was tested. Cell 
detachment was performed with or without using cell dissociation. Enzymatic cell detachment 
was performed using collagenase or accutase, while cell dissociation was observed under 
the light microscope. Finally, hiPSC colonies were collected by using a needle, scratching 
with a serological pipette and cell scraper or rinsing with medium followed by scratching with 
a cell scraper. Collected cells were pelleted by gently centrifugation (200-500 x g, 3-5 min) 
and carefully resuspended in appropriated freezing medium. To asses the best freezing 
medium, hiPSCs were frozen in freezing media according to Wagner and Welch (2010), 
containing KO™-SR and DMSO (90:10) with or without Y-27632 as well as in commercial 
cryopreservation media (CryoStem™ Freezing Medium; Biofreeze and hiPSC medium 
(90:10) with Y-27632). For cryopreservation vials were frozen directly in -80°C or cooled 
-1°C/min (using Mr. Frosty™ Freezing Container) in -80°C. After 2-3 days stocks were 
transferred to -152°C for long term storage. Cryopreserved stocks were recovered by 
thawing frozen hiPSCs in a 37°C water bath until the vials’ content was almost, but not 
completely thawed, and diluted with at least 4 ml hiPSC medium in a 15 ml falcon tube. After 
centrifugation (200-500 x g, 3-5 min), the cell pellet was gently resuspended in appropriate 
hiPSC medium supplemented with Y-27632 without making a single cell suspension and 
finally repleated on MEF feeder layer. Different freezing/thawing methods led to the 
emergence of hiPSC colonies after cryopreservation. Nevertheless, enzymatic cell 
detachment using accutase revealed better efficiencies of colony formation. The survival rate 
of hiPSCs could be increased by using Y-27632 in freezing medium containing KO™-SR and 
DMSO (90:10). However, the best survival rate of cryopreserved hiPSCs was achieved using 
commercial CryoStem™ Freezing Medium, in which cells were frozen gradually -1°C/min in 
-80°C. In general, formation of small clusters with a compact morphology could be observed 
earliest three days after replating on MEF feeder layer. Final hiPSC colony formation with 
clear borders could take up to 14 days.  
After testing these different conditions, hiPSCs were cryopreserved using freezing medium 
containing KO™-SR and DMSO (90:10) supplemented with 10 µm Y-27632 as well as using 
CryoStem™ Freezing Medium. For the purpose of cryopreservation, hiPSCs were 
pre-incubated with equilibrated hiPSC medium supplemented with 10 µM Y-27632 for 1 h at 
37°C, 5% CO2 and 5% O2. Then hiPSCs were treated with accutase and pelleted according 
to the protocol for passaging of hiPSCs (2.2.4.3.10). After centrifugation the pellet was 
resuspended in either 1 ml ice cold CryoStem™ Freezing Medium and the cryopreservation 
vial was directly cooled -1°C/min in -80°C using Mr. Frosty™ Freezing Container or in 1 ml 
freezing medium containing KO™-SR and DMSO (90:10) supplemented with 10 µM Y-27632 
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and the cryopreservation vial was frozen directly in -80°C. After 2-3 days stocks were 
transferred to -152°C for long term storage. 
For thawing of cryopreserved hiPSCs, the cryovial was placed in a water bath at 37°C until 
the cells were almost completely thawed. The cells were mixed with a bigger volume of 
hiPSC medium in order to dilute the freezing medium and then centrifuged at 300 x g for 
5 min. After removal of the supernatant, the cells were carefully resuspended in an 
appropriate volume of equilibrated hiPSC medium supplemented with 10 µM Y-27632 and 
seeded on one 6-well vessel prepared with MEF feeder layer. The 6-well plate was placed in 
the incubator at 37°C, 5% CO2 and 5% O2, where it was gently rocked from side to side and 
front and back to distribute the hiPSC aggregates across the well. The first medium change 
was performed 48 h after thawing procedure.  
 
2.2.4.4 Transfection 
2.2.4.4.1 Preparation of constructs for transfection 
Constructs used for transfection were linearized in order to support integration. First 100 µg 
DNA were digested in a total volume of 100 µl with 80-100 U of suitable digestion enzyme at 
37°C overnight. To confirm complete DNA digestion 2-3 µl of the reaction volume were 
resolved by agarose gel electrophoresis.  
Purification of digested DNA was performed by phenol-chloroform extraction. The reaction 
volume was filled up to 400 µl with Ampuwa, mixed with 400 µl phenol-chloroform (1:1) and 
centrifugation at 12.000 x rpm for 15 min. The upper aqueous phase was transferred into a 
new e-cup, mixed with 400 µl chloroform by inverting for 3 min and centrifuged at 
12.000 x rpm for 15 min. Further work was performed under the sterile bench. After 
centrifugation the upper aqueous phase was transferred into a new e-cup, mixed with 350 µl 
isopropanol and centrifuged at 12000 x rpm for 15 min. The supernatant was carefully 
discarded and the DNA pellet was washed twice with 70% EtOH, followed by resuspension 
in 100 µl sterile PBS and stored at 4°C. After at least 24 h at 4°C, 2 µl of linearized and 
purified DNA were analysed by agarose gel electrophoresis 0.8%. 
 
2.2.4.4.2 Electroporation 
For electroporation exponentially growing cells were detached from the culture vessels by 
trypsin/EDTA treatment. The cell pellet was washed once with PBS by centrifugation at 
1000 x g for 5 min. Afterwards the cells were resuspended in 600 µl PBS and mixed with 
100 µg linearized and purified plasmid DNA in an electroporation cuvette. After 5 min on ice, 
the electroporation was performed by 240 V and 500 µF at room temperature. The 
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electroporated cells were kept on ice for 20 min and then seeded on appropriate culture 
dishes prepared with feeder layer.  
 
2.2.4.5 Culture of single clones 
2.2.4.5.1 Selection, picking and culture of single clones 
The constructs used for electroporation contained a neomycin or puromycin resistance gene 
cassette for identification of transfected cells by positive selection for the resistance of 
geneticin (G418) or puromycin. After electroporation the cells were cultured in selection 
medium with increased antibiotic concentration (G418: 350 µg/ml; 1.25 µg/ml puromycin: ) for 
4 days. Further cultivation was performed with appropriate medium with decreased antibiotic 
concentration (G418: 100 µg/ml; 0.75 µg/ml puromycin). After 8-10 days of selection the 
resistant clones had a sufficient size to be isolated and separated. The positive clones were 
picked mechanically under the light microscope, which was disinfected and put under the 
opened sterile bench. During the working procedure a surgical mask was worn in order to 
minimize the risk of contamination. The cells were washed with PBS and covered with fresh 
PBS. The single clones were separated from the feeder layer with a 20 µl Gilson pipette and 
an appropriate pipette tip and transferred in a 96-well-plate. Within this plate the clones were 
treated with trypsin/EDTA, separated into single cells by resuspending and seeded on 24-
well-plates prepared with feeder layer. The picked clones were cultured in appropriate 
medium with decreased antibiotic concentration, which was changed every 24 h. After 4 to 7 
days the cells reached 100% confluence and replica plating was performed. 
 
2.2.4.5.2 Replica plating 
When the cells reached 100% confluence, they were treated with trypsin/EDTA, seeded on 
two gelatine coated 24-well plates and cultured till 100% confluence. From one plate, cells’ 
DNA or RNA was isolated for genotyping by PCR or expression analyses by qRT-PCR, 
respectively. On the second gelatine coated plate, seeded cells were treated with freezing 
medium and stored at -80°C. The positive clones identified by genotyping PCR or expression 
analysis were thawed and further cultured.  
 
2.2.4.6 Cell induction with retinoic acid 
Retinoic acid (RA) is a metabolite and high effective form of vitamin A and affects 
proliferation and differentiation of several cell types. Induction of cells was performed with RA 
at a concentration of 10-6 M, which was added directly from a stock solution of 10-3 M to fresh 
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culture medium, after the cells were washed with PBS. During induction the medium 
supplemented with RA was changed every 24-48 h. The duration of RA treatment was 
dependent on the experiment. 
 
2.2.4.7 Cell sortings 
2.2.4.7.1 Fluorescence Activated Cell Sorting  
Cells can be sorted according to their size, granularity and different fluorescence by flow 
cytometry using Fluorescence Activated Cell Sorting (FACSorting). Here the sorting of cells 
was carried out according to their expression of EGFP. EGFP expressing cells can be 
excited at 510 nm with an argon-ion laser, which emits blue-green light at 488 nm.  
The cells were washed with PBS, treated with trypsin/EDTA, centrifuged at 1000 x g for 
5 min and once more washed with PBS, followed by the cell sorting by flow cytometry. A 
non-EGFP expressing cell line was used as a negative control. The FACSorting was 
performed in the Cell Sorting Facility of the University Medical Center, Göttingen (Prof. Dr. 
Gerald Wulf). After sorting EGFP positive cells were pelletized by centrifugation and once 
washed with PBS. The cells were resuspended in appropriate volume of culture medium and 
seeded on prepared culture vessels. 
 
2.2.4.7.2 Magnetic Activated Cell Sorting 
Magnetic Activated Cell Sortings (MACSortings) were performed using the MACS® Cell 
Separation provided by Miltenyi Biotech GmbH. MACSorting was carried out using MACS 
buffer (2.1.6), which was freshly prepared and stored on ice throughout the MACSorting 
procedure.  
Before MACSorting, cells were washed once with PBS and centrifuged at 1000 x rpm for 
5 min. Then cells were incubated with the primary antibody (1:50 α6-Integrin, biotin conj.; 
2.1.12.1) diluted in MACS buffer for 15 min at 4°C. During the incubation time cells were 
occasionally mixed by shaking. Afterwards, 2 ml MACS buffer were added to dilute unbound 
primary antibody and cells were centrifuged at 1000 x rpm for 5 min. The supernatant was 
carefully discarded and cells were incubated with secondary antibody (1:5 anti-Biotin 
MicroBeads; 2.1.12.2) diluted in MACS buffer for 20 min at 4°C. During the incubation time 
cells were occasionally mixed by shaking. Unbound secondary antibody was diluted by the 
addition of 2 ml MACS buffer. After centrifugation at 1000 x rpm for 5 min, the supernatant 
was carefully discarded and cells were resuspended in 500 µl MACS buffer. A MACS® MS 
Column was fixed in a MACS™ Separator providing a strong magnetic field and was 
equilibrated with 500 µl MACS buffer. The cell suspension was put onto the equilibrated 
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MACS® MS Column and the flow through was captured in an e-cup, which was stored on 
ice, if HTF cells had to be established (2.2.4.3.6). Further the MACS® MS Column was 
washed three times with 500 µl MACS buffer. For elution of retained cells of interest, the 
MACS® MS Column was removed from the MACS™ separator and cells were eluted with 
1000 µl MACS buffer using the provided syringe and captured in an e-cup. Cells were 
centrifuged at 1000 x rpm for 5 min and the supernatant was carefully discarded. Cells were 
resuspended in an appropriate volume of StemPro+3 medium (2.1.11.1) and seeded on 
gelatine (2.2.4.1.1) or MEF feeder layer (2.2.4.2.1) coated culture plates. 
 
2.2.4.8 Cell transplantation in germ cell depleted mice (Ogawa et al., 1997) 
The transplantation of cells in germ cell depleted testis of busulfan treated mice is used to 
test if cells are capable to colonize within the testis and regenerate spermatogenesis to 
develop functional sperm. For generation of germ cell depleted mice, busulfan was 
intraperitoneally injected in 6 to 8 weeks old male mice at a concentration of 40 mg/kg body 
weight (diluted in DMSO). This busulfan treatment destroys all germ cells within the testis. 4 
to 6 weeks after treatment one mouse was sacrificed and paraffin sections of the testes were 
prepared (2.2.3.3). The absence of any germ cells was checked by H&E staining (2.2.3.4). 
The remaining mice were mated with wild type females for at least 4 weeks in order to prove 
that there is no endogenous spermatogenesis left, if they begot no offspring. 3 to 4 month 
after busulfan treatment cells were transplanted into the seminiferous tubules.  
Before transplantation the cells underwent a MACSorting (2.2.4.7.2) using an α6-Integrin 
antibody (2.1.12.1) to remove any HTF. The MACS elution fraction was cultured in 
StemPro+3 medium (2.1.6). Cells were either directly used for transplantation or cultured on 
MEF feeder layer at 37°C and 5% CO2 overnight and the feeder was removed before 
transplantation. Approximately 30-40 µl of the cell suspension (~1 x 108 cells/ml) were 
transplanted via rete testis into seminiferous tubules of one testis, whereas the 
non-transplanted testis served as an internal control. Analgesic, anesthetic and antisedan 
used for transplantation procedure were provided and prepared by workers of the animal 
house. 
At certain time points recipient mice were sacrificed and the testes prepared for further 
analysis by genotyping PCR or immunohistochemistry. All experiments were performed 
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2.2.4.9 Teratoma assay 
The ability of pluripotent cells to form teratomas is generally accepted as one of the reliable 
proof of pluripotency. The teratoma assay was performed by Prof. Dr. Ralf Dressel, Institute 
for Cellular and Molecular Immunology in Göttingen.  
For teratoma assay, hiPSCs were detached from the culture vessels (2.2.4.3.10) and 
washed once with PBS. After centrifugation, hiPSCs were resuspended in medium consisting 
of 1:1 PBS and matrigel (diluted 1:100 in DMEM/F12, 2.2.4.1.2) and stored on ice until 
transplantation. 1 x 106 – 2 x 106 cells were injected under the skin of immunodeficient 
NOD/SCID mice. The following weeks the transplanted mice were monitored by Prof. 
Dressel. In the case of observable incidence of tumors, both the size of tumors had to be 
recorded and the teratoma had to be histologically processed and analysed. The teratoma 
assay was stopped, when 3 month after cell injection no teratoma formation was observed. 
 
2.2.4.10 Generation of mouse ES cell lines 
Blastocysts were isolated from gestating mice sacrificed at stage 3.5 dpc, whose uteri were 
flushed with M2 medium. Blastocysts were cultured in groups in KSOM medium (2.1.11.1) on 
plates coated with MEF feeder layer at 37°C and 5% CO2. Within ~1 week of culture the 
outgrowth of the inner cell mass of the blastocysts was observed, which was manually 
picked, disaggregated by trypsinization and further seeded in ESC culture medium (2.1.11.1) 
on 24-wells coated with fresh MEF feeder layer. Medium was changed every second day. 
During further culture cells grew in colonies and revealed a mouse ES cell like morphology. 
Cells were expanded by routinely passaging (2.2.4.3.4) and cryopreservation (2.2.4.3.5). 
 
2.2.4.11 “Feeder Free“ mRNA/miRNA Reprogramming of human fibroblasts 
The generation of integration free human iPSCs was performed with the mRNA 
reprogramming method, which bases on the repeated delivery of mRNA encoding for 
pluripotency associated transcription factors. The Stemgent® mRNA Reprogramming 
System served as a basis, but was modified in several aspects in order to achieve a 
successful reprogramming of the human target cells. In the following the final working 
reprogramming approach for “Feeder Free” mRNA/miRNA Reprogramming is described in 
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2.2.4.11.1 Material preparation  
2.2.4.11.1.1 Preparation of media supplements 
The media used during the “Feeder Free” mRNA/miRNA Reprogramming had to be 
supplemented with different reagents supplied by the Stemgent® mRNA Reprogramming 
System. During preparation of aliquots it was important to thaw the supplements on ice, to 
work sterile and quickly and to put prepared aliquots directly on dry ice before their final 
storage at -80°C to minimize protein degradation. Especially, the B18R Recombinant Protein 
(B18R) is very sensitive and its addition to the medium was fundamental during the mRNA 
transfection series. Pluriton™ Supplement (P™S) as well as B18R were thawed on ice and 
each aliquotted in ready-to-use vials of 4 µl volumes and stored at -80°C. 
 
2.2.4.11.1.2 Preparation of basis medium Pluriton™ Medium  
Media used during the “Feeder Free” mRNA/miRNA Reprogramming had to be prepared 
with Pluriton™ Medium, which was supplied by the Stemgent® mRNA Reprogramming 
System. Pluriton™ Medium was thawed completely within 2 days at 4°C, supplemented with 
5 ml penicillin/streptomycin (100x) and thoroughly mixed by pipetting. Aliquots of 40 ml 
Pluriton™ Medium were prepared and stored at -20°C. Before use aliquots were thawed at 
4°C overnight and could be stored at 4°C for up to 2 weeks.  
 
2.2.4.11.1.3 Preparation of NuFF-conditioned Pluriton™ Medium 
According to the protocol for the Stemgent® mRNA Reprogramming System, NuFF-
conditioned Pluriton™ Medium supports the reprogramming process during the transfection 
series. In the modified “Feeder Free” mRNA/miRNA Reprogramming protocol this medium 
was used during the whole transfection period and should be prepared before the start of 
reprogramming. For the preparation of NuFF-conditioned Pluriton™ Medium 
4 x 106 inactivated NuFF cells (2.2.4.2.2) were seeded on a gelatine coated T75 flask in 
25 ml of NuFF culture medium and incubated at 37°C and 5% CO2 overnight. After 24 h 
adherent cells were washed once with PBS and further cultured in 25 ml Pluriton™ Medium 
supplemented with 4 ng/ml bFGF at 37°C and 5% CO2. The NuFF-conditioned Pluriton™ 
Medium was collected with a sterile pipette after 24 h incubation and replaced with fresh 
25 ml Pluriton™ Medium supplemented with 4 ng/ml bFGF. This procedure was repeated 
daily and the collected NuFF-conditioned Pluriton™ Medium was stored in a sterile 50 ml 
falcon tube at -20°C. The seeded NuFF cells were used for ten collections. All aliquots with 
NuFF-conditioned Pluriton™ Medium were thawed at 4°C overnight one day before the final 
collection, pooled and sterile filtered (0.22 µm pore size). NuFF-conditioned Pluriton™ 
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Medium was further stored in 40 ml aliquots at -20°C and thawed at 4°C overnight before its 
use. Defrosted NuFF-conditioned Pluriton™ Medium was stable for 3 days at 4°C.   
 
2.2.4.11.1.4 Preparation of NuFF-conditioned Pluriton™ Reprogramming 
Medium 
For the preparation of NuFF-conditioned Pluriton™ Reprogramming Medium 10 ml NuFF-
conditioned Pluriton™ Medium (2.2.4.11.1.3) were equilibrated for at least 2 h in a 10 cm 
dish at 37°C, 5% CO2 and 5% O2. Just before use the equilibrated medium was 
supplemented with 200 ng/ml B18R (= 4 µl B18R; 2.2.4.11.1.1) and bFGF (= 4 µl P™S; 
2.2.4.11.1.1) to a final concentration of 20 ng/ml. 
 
2.2.4.11.1.5 Preparation of miRNA cocktail with miRNA cluster 302-367 
The following miRNAs (Thermo Scientific Dharmacon®) were used for miRNA transfections: 
miRIDIAN Mimic Human hsamiR302a 
miRIDIAN Mimic Human hsamiR302b 
miRIDIAN Mimic Human hsamiR302c 
miRIDIAN Mimic Human hsamiR302d 
miRIDIAN Mimic Human hsamiR367 
During all working steps it was important to thaw miRNAs on ice, to work sterile and quickly 
and to put prepared aliquots directly on dry ice before their final storage at -80°C. 
For each miRNA a 20 µM stock with RNase free H2O was prepared under sterile conditions 
and stored in 10 µl aliquots at -80°C. The master miRNA cocktail was prepared of an 
equivolume mixture with 4 µM of each individual miRNA: 10 µl of each miRNA were mixed 
and stored at -80°C. Ready-to-use aliquots were prepared with 3.5 µl master miRNA cocktail 
and stored at -80°C. 
 
2.2.4.11.1.6 Preparation of mRNA cocktail 
The master mRNA cocktail encoding for the pluripotency associated transcription factors was 
prepared according to the protocol of the Stemgent® mRNA Reprogramming System. In 

















Ready-to-use aliquots were prepared with 10 µl master mRNA cocktail and stored at -80°C. 
 
2.2.4.11.2 Procedure of reprogramming 
The procedure of the “Feeder Free” mRNA/miRNA Reprogramming is illustrated in Tab. 1. 
The reprogramming process was performed at 37°C, 5% CO2 and 5% O2. All media were 
equilibrated under these conditions for at least 2 h before their usage.  
 
Tab. 1: Overview oft the procedure of “Feeder Free” mRNA/miRNA Reprogramming. 
day action medium 
d-3 
preparation of matrigel coated 
plates 
- 
d-2 seeding of target cells appropriate cell culture medium 
d-1 miRNA transfection  
NuFF-conditioned Pluriton™ Medium supplemented 
with bFGF to finally 20 ng/ml 
d0 
4 h preincubation  NuFF-conditioned Pluriton™ Reprogramming Medium 
mRNA transfection - 
d1 
3 h preincubation  NuFF-conditioned Pluriton™ Reprogramming Medium 
mRNA transfection - 
medium change after 4 h NuFF-conditioned Pluriton™ Reprogramming Medium 
d2 / d3 
mRNA transfection - 
medium change after 4 h NuFF-conditioned Pluriton™ Reprogramming Medium 
d4 
mRNA/miRNA co-transfection - 
medium change after 4 h NuFF-conditioned Pluriton™ Reprogramming Medium 
d5 + 
mRNA transfection - 
medium change after 4 h NuFF-conditioned Pluriton™ Reprogramming Medium 
d: day of reprogramming; h: hours; d5 +: d5 of reprogramming until the emergence of hiPSC colonies.  
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2.2.4.11.2.1 Seeding of target cells  
At day -2 of reprogramming target cells were seeded on matrigel coated 6-well vessels 
(2.2.4.1.2), which were freshly prepared the day before. For reprogramming of slowly 
proliferating cell lines such as the used scrotal human fibroblasts (SHFs; 2.2.4.3.8) were 
seeded in a high cell density of 100.000 cells per 6-well vessel, whereas fast proliferating cell 
lines were seeded in a cell density of 20.000 cells per 6-well vessel. Target cells were 
seeded in appropriate culture medium (2.1.11.1) and attached overnight at 37°C, 5% CO2 
and 5% O2.  
 
2.2.4.11.2.2 miRNA transfection 
At day -1 of reprogramming target cells were transfected with miRNA cluster 302-367 
(2.2.4.11.1.5). Cell were washed once with PBS and covered with 2 ml per 6-well vessel  
equilibrated NuFF-conditioned Pluriton™ Medium (2.2.4.11.1.3) supplemented with bFGF 
(= 4 µl P™S in 10 ml medium) to a final concentration of 20 ng/ml.  











All components of each tube were pipetted together and mixed carefully. The content of 
tube 2 was transferred in tube 1, mixed carefully by pipetting and further incubated for 15 min 
at room temperature. The 100 µl transfection mixture was mixed carefully by pipetting the 
solution three times up and down and subsequently distributed on the target cells of one 
6-well vessel in a dropwise fashion. The 6-well plate was gently rocked from side to side and 
front and back to distribute the transfection mix across the well. Cells were further cultured at 
37°C, 5% CO2 and 5% O2. 
 
2.2.4.11.2.3 mRNA transfection series 
In order to maintain a constant level of delivered mRNA in the cells, the mRNA transfection 
had to be performed always at the same time. 
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At day 0 of reprogramming target cells were transfected with mRNA (2.2.4.11.1.6). Before 
mRNA transfection the medium was discarded without washing with PBS and directly 
replaced with NuFF-conditioned Pluriton™ Reprogramming Medium (2.2.4.11.1.4). The cells 
were incubated for 4 h at 37°C, 5% CO2 and 5% O2 before mRNA transfection. The following 









The transfection mix was prepared like for miRNA transfection (2.2.4.11.2.2) and distributed 
on the preincubated target cells in a dropwise fashion. The 6-well plate was gently rocked 
from side to side and front and back to distribute the transfection mix across the well. Cells 
were further cultured at 37°C, 5% CO2 and 5% O2. 
The next day (day 1 of reprogramming) 3 h before mRNA transfection the medium was 
discarded without washing with PBS and directly replaced with NuFF-conditioned Pluriton™ 
Reprogramming Medium. The cells were incubated for 3 h at 37°C, 5% CO2 and 5% O2 
before mRNA transfection, which was performed as described above. Medium was replaced 
with NuFF-conditioned Pluriton™ Reprogramming Medium 4 h after mRNA transfection and 
cells were further cultured at 37°C, 5% CO2 and 5% O2. 
On day 2 and day 3 the preincubation was omitted and the mRNA transfections as well as 
medium change 4 h after transfection were performed as on day 1 of reprogramming.   
A mRNA/miRNA co-transfection was performed on day 4 of reprogramming. The following 
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The transfection mix was prepared as already described and distributed on the cells in a 
dropwise fashion. The 6-well plate was gently rocked from side to side and front and back to 
distribute the transfection mix across the well. Cells were further cultured at 37°C, 5% CO2 
and 5% O2. A medium change with NuFF-conditioned Pluriton™ Reprogramming Medium 
was performed 4 h after co-transfection and cells were further cultured at 37°C, 5% CO2 and 
5% O2. 
On the following days, cells were further transfected with mRNAs as described above until 
human iPSC colonies emerged.  
 
2.2.4.11.2.4 Splitting of target cells during the reprogramming process  
If target cells exhibited a high proliferation rate during reprogramming, they needed to be split 
to prevent an over-confluence of cells, which would reduce the reprogramming efficiency 
because of a decreased mRNA delivery. If splitting of target cells was necessary, it was 
preferentially performed between day 6 and 8 of the transfection series and cells were 
replated in a lower cell density.  
Cells, which had to be split, were transfected with mRNA and the medium was changed 4 h 
after transfection as already described (2.2.4.11.2.3). After 2 h at 37°C, 5% CO2 and 5% O2, 
cells were washed once with PBS and covered with 0.5 ml Trypsin/EDTA. After 10 min at 
37°C, 5% CO2 and 5% O2, cell detachment and dissociation were stopped by the addition of 
0.5 ml FB medium. Detached cells were transferred with a serological pipette in a 15 ml 
falcon tube containing 2 ml NuFF-conditioned Pluriton™ Reprogramming Medium 
supplemented with 10 µM Y27632 (2.1.6). After centrifugation at 200 x g for 2 min, the cell 
pellet was washed once with PBS to remove the FB medium completely. The cells were 
centrifuged at 200 x g for 2 min, resuspended in 4 ml NuFF-conditioned Pluriton™ 
Reprogramming Medium supplemented with 10 µM Y27632, seeded on two matrigel coated 
6-wells (2.2.4.1.2) and further cultured at 37°C, 5% CO2 and 5% O2. The next day the 
transfection series was continued according to the plan (Tab. 1) and passaged cells were 
further cultured in NuFF-conditioned Pluriton™ Reprogramming Medium supplemented with 
10 µM Y27632 till the end of reprogramming.  
 
2.2.4.11.2.5 Picking and passaging of emerged hiPSC colonies 
When hiPSC colonies exhibited their characteristic morphology with defined colony edges, 
they were picked on MEF feeder layer (2.2.4.2.1) in order to expand them and to establish 
hiPSC cell lines. During the working procedure a surgical mask was worn in order to 
minimize the risk of contamination. Cells were washed once with PBS and covered with 
appropriate medium. Observed under the light microscope, which was disinfected and put 
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under the opened sterile bench, hiPSC colonies were broken into 4-8 fragments and 
detached manually from the culture plate by using a needle. Here it was important to avoid 
single cell suspensions. Colony fragments were transferred in appropriate medium on freshly 
prepared MEF feeder layer using a serological pipette and placed in the incubator at 37°C, 
5% CO2 and 5% O2, where the plate was gently rocked from side to side and front and back 
to distribute the hiPSC aggregates across the well. The first medium change was performed 
48 h after picking of cells.  
First hiPSC colonies were cultured in NuFF-conditioned Pluriton™ Medium (2.2.4.11.1.3) 
supplemented with bFGF (= 4 µl P™S in 10 ml medium) to a final concentration of 20 ng/ml 
and hiPSC-M3 mixed in a ratio of 50:50, which was reduced stepwise during further culture 
in order to reach 100% hiPSC-M3 (2.1.11.1). After culturing in pure hiPSC-M3 this medium 
was replaced with final hiPSC medium (2.1.11.1) in order to expose hiPSCs to a reduced 
bFGF concentration of 5 ng/ml, which decreases the risk of spontaneous differentiation of 
hiPSCs. Furthermore the culture of picked hiPSCs was stepwise propagated on 12-well, 
followed by the use of 6-well vessels. 
 
2.2.4.12 Chromosomal analysis 
For a chromosomal analysis cells have to be arrested in the metaphase of mitotic cell 
division. Therefore cells were incubated with 190 µl colcemid in 5 ml medium for 4 h at 37°C 
and 5% CO2. After washing with PBS, cells were treated with trypsin/EDTA, transferred into a 
glass tube and centrifuged at 1000 x g for 5 min. The supernatant was discarded except for 
1 cm medium above the pellet, which was resuspended in the remaining medium carefully by 
vortexing. Subsequently 10 ml preheated hypotonic solution (2.1.6) were added slowly. The 
suspension was incubated for 16 min at room temperature. During the incubation the 
suspension was mixed carefully by pipetting. After centrifugation at 1000 x g for 5 min, the 
supernatant was discarded except for 1 cm medium above the pellet and the pellet was 
resuspended carefully by vortexing. Afterwards 10 ml ice cold fixative solution was added 
during carefully rotation of the glass tube. After incubation for 5 min at room temperature, the 
mixture was centrifuged at 1000 x g for 5 min. The fixation was repeated three times without 
incubation after addition of fixative solution (2.1.6). Finally the supernatant was discarded 
except for 1 cm medium above the pellet, which was carefully resuspended in the remaining 
fixative solution. Fixed cells were dropped on degreased slides from a height of nearly 30 
centimeters. Slides were air dried completely, stained for 3 min in Giemsa solution and 
washed under tap water. The chromosomes were analysed with light microscopy and 
karyotyping was performed using the Leica MCK software. 
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2.2.4.13 Apoptosis assay using PE Annexin V Apoptosis Detection Kit I 
The investigation of cell apoptosis was performed with the PE Annexin V Apoptosis 
Detection Kit I (BD Biosciences, Heidelberg). This kit bases on the use of the phospholipd 
binding protein Annexin V, which has a high affinity to the membrane phospholipid 
phosphatidylserine (PS). PS is translocated to the outer leaflet of the plasma membrane in 
cells, which undergo apoptosis. Thus the use of Annexin V conjugated with a fluorochrome 
like Phycoerythrin (PE) allows the measurement of apoptotic cells by flow cytometry. In this 
kit Annexin V is used in combination with the vital dye 7-Amino-Actinomycin (7-AAD) to 
distinguish between vital, early and late apoptotic cells.  
One cell line was treated with 200 µM citrinin (diluted in DMSO) for 24 h to induce apoptosis 
and used as a positive control for apoptotic cells as well as for the settings of the flow 
cytometry system.  
First cultured cells were detached from the culture vessels by trypsin/EDTA treatment and 
washed twice with ice cold PBS by centrifugation at 1000 x g for 5 min. After resuspending at 
a concentration of 1 x 106 cells/ml in 1x Binding Buffer provided by the kit, 100 µl of cell 
suspension were transferred to a 5 ml FACS tube and stained with 5 µl Annexin V-PE and 
5 µl 7-AAD and vortexed gently. Unstained cells, cells stained only with Annexin V-PE as 
well as cells stained only with 7-AAD were used as references. After incubation for 15 min at 
room temperature in the dark, 400 µl 1x Binding Buffer was added and the mixture was 
analyzed by flow cytometry within 1 h. Flow cytometric analysis weas performed by Prof. Ralf 
Dressel, Institute for Cellular and Molecular Immunology in Göttingen. 
 
2.2.4.14 BrdU based proliferation assay 
5-Bromo-2′-deoxyuridine (BrdU) is a thymidine analog, which can be incorporated into DNA 
during the synthesis phase of cell cycle instead of thymidine (Givan, 1992; Leif et al., 2004). 
Therefore it can be used as a marker of proliferating cells.  
The cells were seeded on chamber slides and cultured with 20 µg/ml BrdU (Sigma; 
10 mg/ml stock in Ampuwa) for 48 h at 37°C and 5% CO2. Then cells were washed three 
times with PBS and fixated with 4% PFA for 10 min at room temperature. After washing with 
PBS for three times, cells were incubated with 2 M HCl for 60 min at 37°C for DNA 
denaturation into single strands allowing antibody access to the BrdU. Cells were washed 
three times with PBS and incubated with blocking solution containing 
0.2% BSA/ 0.1%Tween20 in PBS for 60 min at room temperature. Incubation with anti-BrdU 
antibody (2.1.12.1) diluted 1:100 in blocking solution was performed in a humidity chamber 
overnight at 4°C. Next day cells were washed three times with PBS and further incubated 
with the appropriate secondary antibody (2.1.12.2) diluted 1:200 in blocking solution in a 
humidity chamber for 2 h at room temperature. After three times washing with PBS, cells 
Material and methods  
65 
were counterstained with DAPI and mounted with Eukitt® quick-hardening mounting medium 
(Fluka).  
  
2.2.4.15 Alkaline Phosphatase - staining 
Alkaline Phosphatase (AP) - staining can be used to detect specifically not differentiated 
cells. In contrast to most cells, pluripotent stem cells express AP at a highly increased level, 
which allows the discrimination between pluripotent and differentiated cells.  
AP-Staining was performed with the Leukocyte Alkaline Phosphatase Kit (Sigma-Aldrich, 
Deisenhofen). Fixative containing citrate, acetone and formaldehyde as well as staining 
solution containing sodium nitrite, FBB-Alkaline and Naphthol AS-BI Alkaline were prepared 
according to manufacturer’s protocol. After washing with PBS, cells were fixed for 30 sec at 
room temperature. Cells were washed with ddH2O for 45-60 sec and incubated with staining 
solution for 15 min at room temperature. After washing with ddH2O for 2 min, cells were 
counterstained with Neutral Red solution for 10-20 sec, washed with tap water and air dried.  
 
2.2.5 Methylation- and imprinting studies 
The analysis of the methylation status of imprinted genes was performed in collaboration with 
Prof. Ulrich Zechner (Institute of Human Genetics, University of Mainz). For this study 
genomic DNA samples were isolated from the samples of interest (2.2.1.1.2) and send by 
mail to Mainz. Because bisulfite pyrosequencing of DNA samples as well as data evaluation 
was performed by the Zechner group, here the principle of this analysis is briefly described 
(Tost and Gut, 2007).  
DNA methylation represents a form of epigenetic modifications, which occur at the 5´position 
of cytosine in the context of the dinucleotide CpG. Here the analysis of DNA methylation was 
performed using the bisulfite treatment of genomic DNA as a chemical reaction to translate 
this epigenetic information into sequential information, which is further analyzed by 
pyrosequencing. This represents a sequencing-by-synthesis method, which utilizes the 
release of pyrophosphate (PPi) molecules during the stepwise incorporation of unmodified 
deoxynucleoside triphosphates (dNTPs) and the further conversion into bioluminometric 
signals.  
In order to analyse the DNA methylation status, first a sodium bisulfite conversion of genomic 
DNA is necessary to distinguish between unmethylated and methylated cytosines within the 
sequence. For this targeted exchange of bases, single-stranded DNA is treated with sodium 
bisulfite and unmethylated cytosine (C) becomes deaminated to uracil, while methylated 
cytosine (mC) remains unchanged. In a subsequent PCR reaction methylated and 
non-methylated DNA can be discriminated, because the uracils are amplified as thymines, 
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while mCs are further unaltered amplified as cytosines. So after this PCR amplification an 
exchange of CG basepairs to TA basepairs at non-methylated DNA positions has taken 
place. Further a comparison of DNA sequences, with and without bisulfite treatment can 
provide information about the cytosine methylation patterns. The DNA sequences are 
determined by pyrosequencing, whose template derives from PCR amplification with 
biotinylated and non-biotinylated primer. The pyrosequencing is performed using the 
biotinylated single-stranded DNA, four different enzymes including a DNA polymerase, an 
ATP sulfurylase, the luciferase and an apyrase as well as the substrates D-luciferin and 
adenosine 5’ phosphosulfate (APS). After annealing of the sequencing primer and addition of 
one of the four unmodified dNTPs, the added nucleotide is incorporated by the DNA 
polymerase, if it is complementary to the template DNA. During this incorporation PPi is 
released, which is converted into ATP by the ATP sulfurylase using APS. This reaction 
provides the energy for the luciferase to oxidize D-luciferin, which is generated in an excited 
state and can be detected by a charge-coupled device camera depicted as a peak in the 
used program. Before adding the next nucleotide non-incorporated nucleotides are degraded 
by the apyrase. Afterwards, the process is repeated by the addition of a further dNTP. The 
nucleotide dATP acts as a natural substrate for luciferase. In pyrosequencing analyses the 
modified α-S-dATP (2'-Deoxyadenosine-5'-O-(1-Thiotriphosphate)) is used as a nucleotide 
for primer extension, which is equally incorporated by the polymerase, but is not recognized 










3.1 Isolation and culture of human spermatogonial stem cells 
3.1.1 Human testicular biopsies used for hSSC isolation 
Testicular biopsies were obtained simultaneously during surgery for testicular sperm 
extraction (TESE) for the diagnosis of male fertility from patients and were used for isolation 
of hSSCs by Magnetic Activated Cell Sorting (MACSorting; 2.2.4.7.2). TESE was performed 
by Prof. Schulze at the Department of Andrology, University Hospital Hamburg-Eppendorf in 
Hamburg. Ethic Committee Approval to Prof. Schulze was obtained (OB/X/2000) and the 
study was performed according to the ethical guide lines of the current Declaration of 
Helsinki. Tab. 2 gives an overview of samples derived from TESE.  
 
Tab. 2: Overview of human testicular samples used for hSSC isolation experiments. 
 
#: patient number; mJ-Score: modified Johnsen Score (de Kretser & Holstein, 1976); n.c.: spermatogenesis 
phenotype was not communicated by Prof. Schulze; MEF: MEF feeder layer; 
StemPro+3 / StemPro+4 / Pluriton+3: media used for culture; media compositions are listed in 3.1.3, Tab. 3; 
normoxia: culture at  37°C, 5% CO2; hypoxia: culture at 37°C, 5% CO2, 5% O2; Gel: elution fraction cultured on 
gelatine coated vessels; MEF: elution fraction cultured on MEF feeder layer; M: elution fraction cultured on 
matrigel coated vessels; HTF: cultivation of flow-through factions as Human Testicular Feeder; n.u.: samples 




The table provides information of the spermatogenesis phenotype of the patients, which was 
classified according to the modified Johnsen Score (de Kretser & Holstein, 1976) and also 
evaluated by Prof. Schulze (personal communication). Moreover, the calculated cell numbers 
in the elution fraction after MACSorting and the conditions for further culturing of the cells are 
listed. Cells were either seeded on MEF feeder layer, on gelatine or matrigel coated vessels 
as indicated. Cultivation was performed with different media, whose compositions are listed 
in Tab. 3 (3.1.3), and under normoxia (37°C, 5% CO2) or hypoxia (37°C, 5% CO2, 5% O2). 
Furthermore Tab. 2 explains the nomenclature of samples, which were used in the presented 
thesis: cells derived from the elution fraction of MACSorting were named according to the 
matrix, which was used as growth layer, namely MEF feeder layer (MEF), gelatine (Gel) and 
matrigel (M). Collected flow-through fractions, which were used in reprogramming (3.2) and 
co-culture experiments (3.3), were labelled as Human Testicular Feeder (HTF) cell lines. 
 
3.1.2 Isolation of hSSCs by MACSorting 
In general SSCs can be isolated from testis tissue mainly by three different approaches: 
differential plating method, Fluorescence Activated Cell Sortings (FACSortings) and 
Magnetic Activated Cell Sortings (MACSortings). The sorting efficiency depends on the 
specificity of the antibody used for enrichment of SSCs. In the presented thesis the hSSC 
isolation was performed using MACSorting with a specific antibody against α6-Integrin, which 
is described as a surface marker of murine and human SSCs (Shinohara et al., 1999; 2000; 
Valli et al., 2014). The MACSorting method was established in the institute for successful 
isolation of mSSCs (Smorag et al., 2012).  
In general MACSorting (Miltenyi Biotech GmbH) is a method for cell separation using 
MicroBeads for magnetic cell labelling (Fig. 4). These nano-sized, superparamagnetic 
particles are non-toxic, biodegradable and do not effect the functionality of cells. During 
MACSorting the cells of interest are selected by a specific antibody recognizing a particular 
surface protein of these cells. For direct sorting this primary antibody is conjugated to 
MicroBeads, while for indirect sorting a MicroBeads labelled secondary antibody binds to the 
primary antibody. After magnetic labelling of the cells, the cell suspension is put onto a 
column, which is placed in a separator offering a strong magnetic field. This retains magnetic 
labelled cells in the column, while not-labelled cells are flushed out. If the column is removed 
from the magnetic field, the labelled cells are eluted as positively selected cells. During the 
cell separation three fractions are collected: the flow-through, which can be collected as 
negative fraction depleted of labelled cells, the washing fraction, which should contain only a 
small amount of the other cell types and the elution fraction, containing the labelled cells. The 
















Fig. 4: Principle of Magnetic Activated Cell Sorting. The column providing a strong magnetic field is loaded 
with cell suspension containing a mixture of not labelled as well as magnetically labelled cells (A). In the presence 
of the magnetic field labelled cells retain in the column, while not-labelled cells are flushed out (B), which are 
finally eluted as positively selected cells when removed from the magnetic field (C). modified; Thiel et al., 1998. 
 
In brief, prior to MACSorting the testicular tissue sample (40 - 112 mg) was mechanically 
disaggregated and prepared as a single cell suspension, which was obtained using a two 
step enzymatic digestion with collagenase and DNaseI followed by additional treatment with 
hyaluronidase (2.2.4.3.7). Further the digested testicular cell suspension was incubated 
within a two step procedure with a specific biotinylated α6-Integrin antibody, which was 
labelled with MicroBeads binding to biotin in a second step. The elution fractions consisted of 
~5.5 x 104 -1.2 x 106 cells / ml (Tab. 2) and the eluted α6-Integrin positive cells were 
resuspended in the appropriate culture medium and seeded on a one 6-well culture vessel 
providing a ~9.5 cm2 surface area.  
 
3.1.3 Cultivation of hSSCs 
To date, a validated protocol for the long term culture of hSSCs has not been published. 
Nevertheless, several mouse and human studies revealed the importance of growth factors 
such as FGF (Fibroblast Growth Factor), GDNF (Glial cell line-Derived Neurotrophic Factor), 
EGF (Epidermal Growth Factor) and LIF (Leukemia Inhibitory Factor) for culturing isolated 
SSCs to provide the essential stem cell niche factors for the maintenance of SSC 
self-renewal, proliferation and differentiation (Kanatsu-Shinohara et al., 2003, 2005, 2011; 
Kubota et al., 2004a, b; He et al., 2008, 2010; Sadri-Ardekani et al., 2009; Lim et al., 2010; 
for review: Guo et al., 2014). Therefore, these growth factors seem to be indispensable and 
were included in the different media compositions, which were tested for culturing α6-Integrin 
positive cells derived from MACSortings (Tab. 3) at normoxia or hypoxia in order to obtain 
optimal culture conditions.  
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Tab. 3: Media compositions used for hSSC culture.  
 StemPro+3 StemPro+4 Pluriton+3 
    
FCS 1% 1% - 
NEAA 1x 1x - 
L-Glutamine 2 mM 2 mM - 
Sod. Pyr. 1 mM 1 mM - 
P/S 1% 1% 1% 
2-ME 100 µM 100 µM - 
LIF 1000 U/ml 1000 U/ml - 
VitC 50 µg/ml 50 µg/ml - 
hbFGF 10 ng/ml 10 ng/ml 10 ng/ml 
mEGF 20 ng/ml 20 ng/ml 20 ng/ml 
hGDNF 10 ng/ml 10 ng/ml 10 ng/ml 
activin A - 10 ng/ml - 








FCS: Fetal Calf Serum; NEAA: Non-Essential Amino Acids; Sod. Pyr.: Sodium Pyruvate; P/S: 
Penicillin/Streptomycin; 2-ME: 2-Mercaptoethanol; LIF: Leukemia Inhibitory Factor; VitC: Vitamin C; hbFGF: 
human basic Fibroblast Growth Factor; mEGF: mouse Epidermal Growth Factor; hGDNF: human Glial cell line-
Derived Neurotrophic Factor. 
 
Beside these growth factors StemPro+3 medium, consisting of StemPro®-34 medium with 
StemPro® supplement, also included fetal calf serum and vitamin C (Smorag et al., 2012). 
StemPro+4 medium additionally contained activin A, which is known to promote proliferation 
of spermatogonia as a TGF-β family member (Mather et al., 1990). Pluriton+3 medium was 
composed of Pluriton™ Medium (2.2.4.11.1.2) from the Stemgent® mRNA Reprogramming 
System (3.2.2.1) supplemented with the growth factors FGF, GDNF and EGF. Some hSSC 
cultures were incubated in hypoxic environment. With all tested culture media α6-Integrin 
positive cells developed into typical SSC clusters with grape-like structures, whereas 
culturing of cells using StemPro+3 medium at 37°C and 5% CO2 yielded in the best 
proliferation of cell clusters. However, clear differences in cell attachment were obtained 
using MEF feeder layer or other coated culture wells. 
 
3.1.3.1 Culture of putative hSSCs on MEF feeder layer 
Feeder layers are known to contribute to maintenance of an undifferentiated cell state of 
isolated SSCs and might facilitate cell attachment (Nagano et al., 2003a) Therefore after 
MACSorting α6-Integrin positive cells of MEF-1 and MEF-2 (Tab. 2) were cultured in 
StemPro+3 on MEF feeder layer at 37°C and 5% CO2. Small cell clusters could be observed 
five days after seeding and revealed characteristic morphologies with grape-like structures 
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described for SSCs (Fig. 5). During further culture cells proliferated visibly into increasing 
cluster sizes, but detached from MEF feeder layer before they achieved a sufficient cell 
density for passaging.  
 
Fig. 5: Brightfield pictures of α6-Integrin positive cell clusters cultured on MEF feeder layer at day 5 after 
MACSorting. (A+B) MEF-1- and (C+D) MEF-2-derived cells were both cultured in StemPro+3 on MEF feeder 
layer at 37°C and 5% CO2 and revealed SSC characteristic grape-like structures (arrows). Brightfield pictures 
were taken at day 5 after MACSorting. Scale bars: 100 µm. 
 
3.1.3.2 Culture of putative hSSCs on gelatine coated culture wells 
Other protocols propose a feeder-free culture condition using for example gelatine (Kanatsu-
Shinohara et al., 2003) or laminin (Sadri-Ardekani et al., 2009) coated culture wells. This 
coating of plastic surfaces offers a matrix for enhanced cell attachment to the surface and 
cell proliferation (Goharbakhsh et al., 2013). Therefore α6-Integrin positive cells were 
cultured in StemPro+3 on 0.1% gelatine coated culture wells at 37°C and 5% CO2 and 
revealed a better propagation during culture, which could be repeated for α6-Integrin positive 
cells derived from different testicular biopsies.  
Fig. 6 shows the development of cells derived from MACSorting with testicular biopsies from 


















































Fig. 6: Morphological changes of α6-Integrin positive cell clusters cultured on gelatine coated culture 
wells after MACSorting. Gel-1- and Gel-2-derived cells were cultured in StemPro+3 medium on gelatine coated 
culture wells at 37°C and 5% CO2. (A+C) Gel-1 revealed small cell clusters 4 days after MACSorting, (E, G, I) 
which did not proliferate during further culture. (B+D) Gel-2-derived cells showed a higher cell density 4 days after 
MACSorting, (F+H) which initially decreased. (J) Remaining cell clusters clearly proliferated and revealed an 
increasing cluster size 15 days after MACSorting. Indicated regions in A and B are shown in a higher 
magnification in C and D, respectively. Arrows mark SSC-like structures. d: day after MACSorting. Scale bars: 
A+B: 200 µm; C-J: 100 µm.  
 
Isolated cells adhered to the gelatine coated culture wells. Although the procedure of testis 
biopsies including mechanical disaggregation, enzymatic digestion and MACSorting was 
performed in parallel, Gel-1- and Gel-2-derived cells revealed obviously differences in 
attached cell densities. While Gel-1 cells formed just small clusters consisting of a few cells 
(Fig. 6 A+C) and did not proliferate as much as needed for passaging (Fig. 6 E, G, I), Gel-2 
cells revealed a higher cell density (Fig. 6 B+C), which initially decreased (Fig. 6 F+H), but 
remaining cell clusters clearly proliferated, which was visible in increasing cluster size at day 
15 after MACSorting (Fig. 6 J). 
The seeded elution fraction also contained other cells with a morphology comparable to 
fibroblasts (Fig. 7 A). In spite of several washing steps during MACSorting these cells 
apparently remained within the column and were flushed out together with the putative 
hSSCs. Their density increased during culture and provided a natural testicular feeder for 




Fig. 7: Development of natural testicular feeder during culture of putative hSSCs on gelatine coated 
culture wells. (A+B) Gel-1- and Gel-2-derived cells cultured in StemPro+3 medium on gelatine coated culture 
wells at 37°C and 5% CO2 at day 4 after MACSorting showing fibroblast-like cells (arrows). (C+D) These cells 
proliferated during culture providing a natural testicular feeder for cell clusters. Indicated regions in C and D are 
shown in a higher magnification in E and F, respectively. d: day after MACSorting. Scale bars: 100 µm.  
 
Successful enrichment of putative hSSCs and their propagation cultured in StemPro+3 on 








Fig. 8: Brightfield pictures of Gel-9-derived cells cultured on gelatine coated culture wells at day 15 after 
MACSorting. (A, C, E) Gel-9-derived cells, cultured in StemPro+3 medium on gelatine coated culture wells at 
37°C and 5% CO2, revealed SSC characteristic grape-like structures (arrows). (B, D, F) Magnifications of 
indicated regions in A, C and E, respectively. Scale bars: A, C, E: 100 µm; B, D, F: 10 µm.  
 
3.1.3.3 Culture of hSSCs on matrigel coated culture wells 
Matrigel is known as another effective feeder free surface for the cultivation of stem cells and 
plays an important role in the maintenance of ESC self renewal and pluripotency (Mallon et 
al., 2006). It is extracted from the Engelbreth-Holm-Swarm mouse sarcoma consisting of 
many extracellular matrix (ECM) proteins and is often used to mimic the ECM in cell culture. 
By providing several components like laminin and collagen as well as growth factors such as 
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FGF, EGF, IGF-1 (Insulin-like Growth Factor 1), TGF-β (Transforming Growth Factor β) and 
PDGF (Platelet-Derived Growth Factor), it facilitates cell attachment and proliferation. The 
cultivation of isolated mSSCs as well as embryonic stem cell-like cells derived from human 
testis on matrigel have already been reported (Mizrak et al., 2010; Choi et al., 2014). 
Therefore, it was suggested that cultivation of isolated α6-Integrin positive cells on matrigel 
coated culture wells might yield in an improved enrichment of putative hSSCs, which was 
achieved so far using gelatine coated surfaces. After MACSorting α6-Integrin positive cells 
were cultured in StemPro+3 on matrigel coated culture wells at 37°C and 5% CO2 (M-1 and 
M-2, Tab. 2) as well as in hypoxic environment (M-3, Tab. 2). At first a high number of cells 
seemed to attach to the culture surface in both culture conditions. Nevertheless, the cells did 
not reveal a healthy phenotype and detached from the culture surface during minor 
movements of the culture plate. Addition of activin A to the medium did not yield in any 
improvement, but resulted in a high percentage of dead cells and just a less number of 
adhered cells, which did not proliferate well (M-4 and M-5, Tab. 2). In consideration of these 
observations the use of matrigel coated culture wells was not a suitable alternative to 
gelatine coated culture wells for the cultivation of putative hSSCs.  
 
3.1.3.4 Passaging of putative hSSCs 
Passaging of putative hSSCs on MEF feeder layer represents one of the most difficult steps 
during their culture. The cell clusters have to be detached, separated and seeded on new 
culture wells in order to generate a proliferating cell line. In the presented thesis the 
efficiency of cell attachment as well as further proliferation on new culture wells of the 
isolated cells was very low. When cell clusters reached high density (Fig. 9 A), these clusters 
were detached from the mother plate by using a pipette with 200 µl volume for mechanical 
dissociation. The detached cells were rinsed with appropriate medium and transferred on 
freshly prepared MEF feeder layer, which should facilitate cell adherence in the absence of 
their natural testicular feeder (Fig. 7). Passaged cells were further cultured in StemPro+3 at 
37°C and 5% CO2. Cell clusters were visible, but did not reach proliferation or a cluster 
density comparable to the mother plate (Fig. 9 B-E). In summary, no proliferating cell line 
representing hSSCs derived from MACSorting of testicular biopsies could be established in 





Fig. 9: Gel-2-derived putative hSSCs three days after passaging on MEF feeder layer. (A) Mother plate with 
putative hSSC clusters, which had to be passaged. (B) Just a few cells attached and formed SSC-like clusters 
three days after passaging on MEF feeder layer cultured in StemPro+3 medium at 37°C and 5% CO2, but did not 
reach proliferation and cluster density in comparison to the mother plate. (C-D) Arrow marked colonies in B are 
shown in a higher magnification. Scale bars: 100 µm.  
 
3.1.3.5 Characterization of enriched putative hSSCs 
The developing cell clusters could not be established in proliferating cell lines, so that no 
adequate characterization of the enriched α6-Integrin positive cells could be performed. 
Nevertheless, some cells (Gel-4, Gel-5, Tab. 2) were directly seeded for 
immunocytochemical analysis after MACSorting in order to check if the cells isolated from 
testicular biopsies indeed represented hSSCs. α6-Integrin positive cells were cultured in 
StemPro+3 medium on gelatine coated cover slips (Gel-4) or chamber slides (Gel-5) at 37°C 
and 5% CO2. Immunocytochemical analyses were performed with the already described SSC 
markers PLZF (Promyelocytic Leukaemia Zinc Finger; He et al., 2010), FGF3 (Fibroblast 
Growth Factor Receptor 3; Kopylow et al., 2012) and PGP9.5 (Protein Gene Product 9.5; von 
Kopylow et al., 2010). These analyses were complicated by technical problems, because 
many cells detached from the culture surface during the procedure of immunostaining, which 
includes several washing steps. Although those were performed very carefully, after staining 
Results  
78 
with FGF3 and PGP9.5 no cells were left on the surface, which could be analyzed, while a 
very small number of PLZF stained cells were left for microscopy (Fig. 10). A sequential 
image series of a cell cluster was taken in order to record the full depth of the cluster. These 
images revealed some PLZF stained cells within the cell cluster (Fig. 10). Surrounding 
immunonegative cells served as an internal negative control.  
 
Fig. 10: PLZF staining of putative hSSCs derived from Gel-5. (A-C) Three consecutive images (no. 13-15) of 
a cell cluster derived from Gel-5, which was analyzed by taking 20 sequential images after immunostaining with a 



































3.2 Generation of hiPSCs from infertile men 
3.2.1 Cell lines used for hiPSC generation 
Two different types of cells were used for the generation of hiPSCs from infertile men. In 
addition to HTF cell lines, which were derived from MACSortings with human testicular 
biopsies from infertile men (2.2.4.3.6; 3.1.1), Scrotal Human Fibroblast (SHF) cell lines 
derived from scrotal skin samples were used for reprogramming experiments (2.2.4.3.8). 
Altogether 25 SHF cell lines derived from patients characterized with different 
spermatogenesis phenotypes were generated and are available in a cryopreserved SHF cell 




Tab. 4: SHF cell lines established from scrotal skin tissue from men with different spermatogenesis 
phenotypes.  
SHF spermatogenesis phenotype proliferation 
1 hypergonadotropic NOA with dominant SCO tubuli ~ 
2 
NOA with dominant SCO tubuli; 
sporadic tubuli with hypospermatogenesis 
+ 
3 spermatogenesis-arrest at the level of primary spermatocytes + 
4 OA; after vasectomy; moderate hypospermatogenesis + 
5 pronounced hypospermatogenesis + 
6 dominant SCO; sporadic detection of spermatogonia + 
7 dominant SCO;  sporadic tubuli with hypospermatogenesis ~ 
8 NOA; mixed atrophy; sporadic tubuli with hypospermatogenesis + 
9 OA; intact spermatogenesis + 
10 OA; predominant intact spermatogenesis + 
11 NOA; dominant SCO; 1 tubule with hypospermatogenesis + 
12 cryptozoospermia; tubuli with hypospermatogenesis + 
13 SCO ~ 
14 OA; predominant intact spermatogenesis + 
15 dominant SCO;  sporadic tubuli with hypospermatogenesis + 
16 OA; intact spermatogenesis + 
17 spermatogenesis-arrest at the level of primary spermatocytes ~ 
18 widely intact spermatogenesis ~ 
19 intact spermatogenesis + 
20 dominant SCO; sporadic detection of spermatogonia + 
21 SCO + 
22 SCO ~ 
23 SCO + 
24 SCO ~ 
25 dominant SCO; sporadic tubuli sections with spermatogenesis + 
 
 
Diagnoses were confirmed by Prof. Schulze, Department of Andrology, University Hospital Hamburg-Eppendorf in 
Hamburg. The proliferation rate was assessed by observation during cultivation. SHF: Scrotal Human Fibroblast; 
NOA: Non Obstructive Azoospermia; OA: Obstructive Azoospermia; SCO: Sertoli Cell Only Syndrome; ~: slow 







3.2.2 Establishment of mRNA reprogramming 
The generation of hiPSCs from infertile men was performed using the mRNA reprogramming 
method, which offers an efficient, non-integrative strategy for hiPSC derivation by repeated 
administration of mRNA encoding for the transcription factors hOct4, hKlf4, hSox2, hc-Myc 
and hLin28 (hOKSML) (Warren et al., 2010; Yakubov et al., 2010). The used synthetic 
mRNA includes modifications in order to increase ectopic protein expression in transfected 
cells, to improve their viability as well as to decrease the antiviral responses of the cells to 
the repeated application of synthetic mRNA (Warren et al., 2010). Based on these findings, 
the Stemgent® mRNA Reprogramming System provides a self-described validated protocol 
for reprogramming human fibroblasts, which was planned to be used in the presented thesis. 
In the course of practical work, the original mRNA reprogramming protocol published by 
Stemgent had to be modified in order to successfully reprogram fibroblasts of infertile men. 
These modifications tested within four trials of reprogramming are described below. Here the 
main focus is on the performed transfections as well as the used hiPSC media for culturing 
emerged hiPSC colonies. Finally Tab. 5 outlines all different parameters used in the four 
trials of hiPSC generation by mRNA reprogramming.  
 
Tab. 5: Overview of reprogramming trials for the generation of hiPSCs. 
 
BJ: Stemgent® BJ Human Fibroblasts and culture medium for BJs; HTF: Human Testicular Feeder cell line; SHF: 
Scrotal Human Fibroblast cell line; P: passage number of cell line used for reprogramming trial; FB: Fibroblast 
Medium; NuFF: Mitomycin treated Neonatal Human Foreskin Fibroblasts; d: day; ≥d: from day onwards; 
hiPSC-M: hiPSC medium according to Tab. 6; NuFF-C-P: NuFF-conditioned Pluriton™ Reprogramming Medium. 
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The different tested hiPSC media are specified in Tab. 6. 
 
Tab. 6: hiPSC media compositions tested during establishment of hiPSC culture.    
 hiPSC-M1 hiPSC-M2 hiPSC-M3 hiPSC-M4 
     
FCS - 15% - - 
KO™-SR 25% 5% 15% 15% 
NEAA 1x 5x 5x 5x 
L-Glutamine 2.5 mM - - - 
GlutaMAX™ - 5x 5x 5x 
P/S 1.25% 1.25% 1.25% 1.25% 
2-ME 62.5 µM 25 µM 25 µM 25 µM 
hbFGF 20 ng/ml 20 ng/ml 10 ng/ml 5 ng/ml 
     
medium DMEM/F12 DMEM/F12 DMEM/F12 DMEM/F12 
hiPSC-M: hiPSC medium; FCS: Fetal Calf Serum; KO™-SR: Knock Out-Serum Replacement; NEAA: 
Non-Essential Amino Acids; P/S: Penicillin/Streptomycin; 2-ME: 2-Mercaptoethanol; hbFGF: human basic 
Fibroblast Growth Factor. 
 
3.2.2.1 Stemgent® mRNA Reprogramming System 
The first mRNA reprogramming (1st trial; Tab. 5) was performed according to Stemgent`s 
protocol (www.stemgent.com; Fig. 11).  
 
 
Fig. 11: Schematic overview of the Stemgent® mRNA Reprogramming System. According to Stemgent`s 
protocol the mRNA reprogramming of human fibroblasts includes cell preparation with seeding of the target cells 
on NuFF feeder layer, a hOKSML-mRNA transfection series on 18 consecutive days, identification of hiPSCs and 
further establishment of stable hiPS cell lines. During the reprogramming process cells are cultured in different 
provided media at 37°C and 5% CO2. d: day; hiPSC-M1: hiPSC medium 1.  
 
In brief, target cells were seeded on NuFF feeder layer and transfected on six consecutive 
days with hOKSML-mRNA in provided Pluriton™ Reprogramming Medium consisting of 
Pluriton™ Medium supplemented with 20 ng/ml bFGF and 200 ng/ml B18R. The protein 
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B18R, a Vaccinia virus decoy receptor for Type I interferons (Symons et al., 1995), is 
described to further increase cell viability during RNA transfections in some cell types 
(Warren et al., 2010). Further transfections until day 17 were performed in NuFF-conditioned 
Pluriton™ Reprogramming Medium with 200 ng/ml B18R (NuFF-C-P +), generated by 
culturing NuFF feeder layer with provided Pluriton™ Medium supplemented with 
20 ng/ml bFGF. Because at this point of reprogramming the original NuFF feeder layer did 
not provide all required nutrients for the target cells anymore, this change to NuFF-C-P + was 
indispensable in the support of cells undergoing reprogramming. First hiPSC colonies might 
be seen as early as day 8, and should be finally identified between day 18 and day 20. Since 
day 18 cells were cultured in NuFF-conditioned Pluriton™ Reprogramming Medium 
supplemented with 20 ng/ml bFGF, but without B18R (NuFF-C-P -). The hiPSC colonies 
were picked manually since day 21 onto MEF feeder layer and cultured in adequate hiPSC 
medium. The first mRNA reprogramming experiment was carried out with a human testicular 
feeder cell line (HTF-2; 1 x 105 cells; Fig. 12 C) derived from a MACSorting with a human 
testicular biopsy from an infertile man with a spermatogenesis classified at modified Johnsen 
Score 10 (3.1.1). Stemgent® BJ Human Fibroblasts (BJs), established from normal human 
foreskin and characterized by a long lifespan and high proliferation rate, were used in two 
different cell densities (1 x 104 cells; 1 x 105 cells; Fig. 12 A, B) as a reprogramming control 





Fig. 12: Morphology changes of BJs and HTF-2 cells during mRNA reprogramming using the Stemgent® 
mRNA Reprogramming System (1
st
 trial). (A-C) The morphology of target cells BJs and HTF-2, seeded in a 
density of 1 x 10
4
 cells / 1 x 10
5
 cells and 1 x 10
5
 cells, respectively, was checked on day 0 before the start of 
hOKSML-mRNA transfection series. (D-F) Uniform nGFP expression confirmed successful transfection of BJs 
and HTF-2 cells on day 3. (G-I) BJs revealed morphology changes with final colony formation of iBJs (arrows) and 
further nGFP expression in surrounding cells. HTF-2 cells still showed uniform nGFP expression without any iPS 
colony formation. d: day. iBJ: BJ-hiPSC. Representative scale bars are shown in C, F and I. Scale bars: 
A-C: 200 µm; D-I: 100 µm.  
 
The transfected cells were observed daily. In addition to the transcription factors (hOKSML) 
the mRNA cocktail contained mRNA encoding nGFP thereby offering the opportunity to 
assess the cells transfection efficiency by nGFP expression. The transfected BJ- as well as 
HTF-2 cells showed nGFP expression uniform throughout the culture dish since day 3 (Fig. 
12 D-F). During the transfection series BJ cells underwent morphology changes and formed 
small, compact clusters distinguishable from the NuFF feeder layer. Finally these changes 
ended up in the formation of BJ-hiPSC (iBJ) colonies with their typically defined colony edges 
(Fig. 12 G+H). In contrast to cells within iBJ colonies, surrounding cells further expressed 
nGFP indicating ongoing application of mRNA cocktail. This morphology development was 
not observed with HTF-2 cells, whereas transfection efficiency was confirmed by nGFP 
expression until the end of the transfection series (Fig. 12 I). The striking difference between 
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BJ- and HTF-2 cells was the proliferation rate during the reprogramming process. In 
comparison to BJ cells, HTF-2 cells exhibited a very low proliferation rate. 
iBJ colonies were picked manually since day 21 on freshly prepared MEF and NuFF feeder 
layer, respectively (Fig. 13 A+B), and cultured in hiPSC medium 1 (hiPSC-M1; Tab. 6) 
prepared according to Stemgent’s protocol. Because there was no notable difference in the 
use of MEF and NuFF feeder layer, further culture was performed using the more available 
MEF feeder layer. iBJs could be propagated in some culture dishes (Fig. 13 C) and cultured 
until passage No. 4 (Fig. 13 D-E), but could not be successfully cryopreserved before iBJs 
were lost.  
 
Fig. 13: Manually picking and expansion of iBJ colonies. iBJ colonies (iBJs) of different passage numbers 
cultured on MEF or NuFF feeder layer are shown. Passage (P) numbers are indicated within the pictures. (A + B) 
Emerged iBJs were picked manually on MEF and NuFF feeder layer, respectively, since day 21 of reprogramming 
time table, (C) could be propagated in some culture wells and (D-F) cultured until passage No. 4 using hiPSC-M1 
and MEF feeder layer. Representative scale bar in F: 200 µm.  
 
During the attempt of culture establishment, iBJs revealed a positive AP-staining as well as 
OCT4 (Octamer-binding Transcription Factor 4) staining demonstrating their pluripotent 




Fig. 14: AP- and OCT4 staining demonstrating the pluripotent character of iBJ colonies. (I) iBJ colonies 
(iBJ) revealed a positive AP-staining. Arrow marked colonies (A) are shown in a higher magnification in B and C. 
(II) Immunocytochemical staining was performed with iBJs using a specific antibody for the nuclear pluripotency 
marker OCT4 (A-C). Representative overlay image is shown in C. Incubation with IgG instead of first antibody 
was used as negative control (D-F). Representative scale bars in C and F: 100 µm. 
 
3.2.2.2 “Feeder Free” mRNA/miRNA Reprogramming 
The successfully generation of iBJs proofed the functionality of the used Stemgent® mRNA 
Reprogramming System, whereas it was not sufficient for the generation of hiPSCs from a 
cell line derived from an infertile man (3.2.2.1). Upon the advice of Johanna Goldmann 
(PhD-student of Rudolph Jaenisch’s group at the Whitehead Institute for Biomedical 
Research, Cambridge, USA) some parameters within the mRNA reprogramming protocol 
were changed, which provided a shortened reprogamming protocol and finally led to 




Fig. 15: Schematic overview of “Feeder Free” mRNA/miRNA Reprogramming. The Stemgent® mRNA 
Reprogramming System for generation of hiPSCs was modified in several parameters, which are highlighted in 
red. The final “Feeder Free” mRNA/miRNA Reprogramming was performed with target cells seeded on matrigel, 
additional miRNA transfections with miRNA cluster 302-367 on day -1 (d-1) and day 4 (d4) and culture of cells 
with conditioned medium during the whole reprogramming process under hypoxic conditions (37°C, 5% CO2, 
5% O2). These modifications led to a faster emergence of hiPSC colonies. For establishment of stable hiPS cell 
lines further three hiPSC media were tested. d: day; hiPSC-M1, -2, -3: different hiPSC media.  
 
Improvement of reprogramming was achieved by substitution of NuFF feeder layer with 
matrigel coated reprogramming plates, reprogramming in hypoxic environment and additional 
transfections with miRNA cluster 302-367. The modifications in the so called “Feeder Free“ 
mRNA/miRNA Reprogramming are highlighted in Fig. 15. miRNAs are described to modulate 
several ESC functions such as self renewal (Xu et al., 2009) and differentiation as well as 
cell cycle progression (Wang et al., 2008). Additionally Ruiz et al. (2011) showed a positive 
correlation between cell proliferation and reprogramming efficiency. Because the 
overexpression of the miRNA cluster 302-367 is known to increase the mouse iPSC 
generation by effecting the mesenchymal-to-epithelial transition as well as the cell cycle (Liao 
et al., 2011), additional application of this miRNA cluster might increase the proliferation rate 
of target cells, which was the main difference between BJ- and HTF-2 cells during the 
reprogramming process explained above (3.2.2.1). One miRNA 302-367 transfection was 
performed before the start of the transfection series using the hOKSML mRNA cocktail, 
whereas cells were co-transfected using miRNA 302-367 and mRNA cocktail at day 4. All 
transfections were performed in NuFF-C-P + in order to provide additionally NuFF feeder 
layer derived nutrients during reprogramming on matrigel. Using “Feeder Free“ 
mRNA/miRNA Reprogramming well proliferating cells like BJ fibroblasts can be 
reprogrammed within a mRNA transfection series of 11 days. 
First “Feeder Free“ mRNA/miRNA Reprogramming (2nd trial; Tab. 5) was carried out with 
scrotal human fibroblasts (SHF; 7.5 x 104 cells; 1 x 105 cells; Fig. 16 B+C) derived from a 
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patient with an intact spermatogenesis. BJ fibroblasts were used as a reprogramming control 
(2 x 104 cells; Fig. 16 A).  
 
Fig. 16: Morphology changes of BJs and SHF cells during “Feeder Free“ mRNA/miRNA Reprogramming 
(2
nd
 trial). (A-C) The morphology of target cells BJs and SHF, seeded in a density of 2 x 10
4
 cells and 
7.5 x 10
4
 cells / 1 x 10
5
 cells, respectively, was checked on day 0 before start of hOKSML-mRNA transfection 
series. (D-F) Uniform nGFP expression confirmed successful transfection of BJs and SHFs on day 3. Brightfield 
images are shown in inlays. (G-I) Both transfected BJs and SHFs revealed formation of small clusters with 
compact morphology until day 10. SHFs showed a decreased number of attached cells. (J-L)  Final formation of 
iBJ- and iSHF colonies was observed (arrows), whereas SHFs also revealed not fully reprogrammed iSHFs 
(stars). d: day. Scale bars: A-C, J-L: 200 µm; D-I: 100 µm. 
 
The uniform nGFP expression revealed successful transfections in all cell lines tested (Fig. 
16 D-F). During the transfection series SHF- and BJ cells formed small clusters with a 
compact morphology (Fig. 16 G-I), which finally appeared as hiPSCs (Fig. 16 J-L) and 
proofed the functionality of the “Feeder Free“ mRNA/miRNA Reprogramming for generation 
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of patient-derived hiPSCs. Nevertheless, SHF responded to the transfection series with an 
increased apoptosis rate from day 10 onwards, which was visible in the decreased number of 
attached SHF cells in comparison to BJs (Fig. 16 G-L). Moreover SHF cells formed some not 
completely reprogrammed as well as a less number of hiPSC colonies compared to BJ 
fibroblasts (Fig. 16 K+L). iBJ colonies could be picked manually from day 14 onwards and 
cultured in NuFF-C-P - with 20 ng/ml bFGF. During further culture this medium was gradually 
replaced by hiPSC medium 2 (hiPSC-M2; Tab. 6) prepared according to the protocol 
provided by Johanna Goldmann. Picked iBJs were lost before a suitable propagation and 
storage of these cells as well as an evaluation of hiPSC-M2 for culturing the hiPSCs.  
A repetition of “Feeder Free“ mRNA/miRNA Reprogramming (3rd trial; Tab. 5) using two 
different patient cell lines, HTF-2 (1 x 105 cells, intact spermatogenesis; Fig. 17 A) and 
HTF-10 (1 x 105 cells, not intact spermatogenesis; Fig. 17 B), yielded in uniform nGFP 
expression representing successful transfections of both cell lines (Fig. 17 C+D), while only 
HTF-2 transfected cells revealed hiPSC colony formation starting at day 7 (Fig. 17 E). 
HTF-10 cells responded to the transfection series with an increased apoptosis rate from day 
4 onwards and revealed an insufficient cell density for reprogramming at day 7 (Fig. 17 F), 




Fig. 17: Morphology changes of HTF-2- and HTF-10 cells during “Feeder Free“ mRNA/miRNA 
Reprogramming (3
rd
 trial). (A+B) The morphology of target cells HTF-2 and HTF-10, each seeded in a density 
of 1 x 10
5
 cells, was checked on day 0 before the start of hOKSML-mRNA transfection series. (C+D) Uniform 
nGFP expression confirmed successful transfection of both cell lines on day 4. Brightfield images are shown in 
inlays. (E+F) Transfected HTF-2 cells revealed colony formation already on day 7, whereas HTF-10 cells showed 
a highly decreased number of attached cells. d: day. Scale bars: A + B: 200 µm; C-F: 100 µm. 
 
iHTF-2 colonies showed different morphological features. While some iHTF-colonies 
exhibited their typically defined colony edges (Fig. 18 A-C) or still needed time to grow (Fig. 
18 D-F), other colonies did not reveal a compact morphology suggesting an incomplete 
reprogramming process (Fig. 18 G-I). Firstly, iHTF-2 cell culture was performed in 
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NuFF-C-P - with 20 ng/ml bFGF, which was gradually replaced by hiPSC-M2. During culture 
with increased proportion of hiPSC-M2, iHTF-2 colonies revealed morphological changes 
such as fringed edges and brown-colored cell structures representing their spontaneous 
differentiation (Fig. 18 J-L). The use of hiPSC-M2 with FCS and a relatively high bFGF 
concentration (20 ng/ml) probably promotes cell differentiation instead of maintenance of 
induced pluripotency. Gradually substitution of hiPSC-M2 with hiPSC medium 3 (hiPSC-M3; 
Tab. 6) containing KO™ serum replacer and a decreased concentration of bFGF (10 ng/ml) 
was not sufficient to recover iHTF-2 colonies. 
 
 
Fig. 18: Morphology changes of iHTF-2 colonies (3
rd
 trial). (A-C) iHTF-2 colonies with defined colony edges 
representing a characteristic hiPSC morphology. (D-F) Small iHTF-2 colonies, which still needed to mature. (G-I) 
HTF-2 cells, which did not complete the fully reprogramming process. (J-L) iHTF-2 colonies, which underwent 
spontaneous differentiation during culture in hiPSC-M2. d: day. Scale bars: K: 200 µm; L, representative for 
remaining images: 100 µm. 
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A further performance of “Feeder Free“ mRNA/miRNA Reprogramming (4th trial; Tab. 5) 
using four SHF cell lines exhibiting different spermatogenesis phenotypes (Fig. 19 I, 
1 x 105 cells) and BJ fibroblasts as a reprogramming control (2 x 104 cells) led to the 
emergence of hiPSC colonies in all transfected cell lines and finally yielded in the generation 
of three different iSHF cell lines, namely iSHF-3, iSHF-6 and iSHF-13 (Fig. 19 II).  
 
 
Fig. 19: iSHF colonies derived from “Feeder Free“ mRNA/miRNA Reprogramming (4
th
 trial). (I) SHF cell 
lines with different spermatogenesis phenotypes were used for “Feeder Free“ mRNA/miRNA Reprogramming. 
Diagnoses were confirmed by Prof. Schulze, Department of Andrology, University Hospital Hamburg-Eppendorf in 
Hamburg. OA: Obstructive Azoospermia; SCO: Sertoli Cell Only Syndrome; ~: slow proliferation; +: moderate 
proliferation. (II) Brightfield microscopy images showing generated iSHF-3, iSHF -6 and iSHF -13. Scale bars: 
200 µm.  
 
During the transfections series BJ- as well as SHF cells, except SHF-12, revealed a high 
apoptosis rate, especially in the centre of the reprogramming plate from day 6 onwards. 
While this cell density was not sufficient to form hiPSCs, these colonies emerged in BJ- as 
well as SHF-3, -6 and -13 transfected cells predominantly at the border of the reprogramming 
plate starting at day 9. Although the SHF-9 cell line revealed almost no attached cells from 
day 6 onwards, one hiPCS colony emerged, which was not sufficient to establish a stable 
iSHF-9 cell line. SHF-12 became over-confluent during the reprogramming process, which 
had a negatively impact on transfection efficiency leading to a reduced reprogramming 
efficiency identified by a decreased nGFP expression. After splitting of SHF-12 cells (1:2 at 
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day 12), its nGFP expression improved and a few hiPSC colonies emerged, which could not 
be established in iSHF-12 cell lines.  
hiPSC colonies were manually picked from day 12 onwards and cultured in NuFF-C-P - and 
hiPSC-M3 (50:50). After culturing in pure hiPSC-M3 this medium was replaced with hiPSC 
medium 4 (hiPSC-M4; Tab. 6) in order to expose hiPSCs to a reduced bFGF concentration 
of 5 ng/ml and to avoid their spontaneous differentiation observed in the previous 
reprogramming trial. Using this culture condition iSHF-3, iSHF-6 and iSHF-13 could be 
established in culture. A detailed protocol of the finally working “Feeder Free“ mRNA/miRNA 
Reprogramming is described in 2.2.4.11. 
 
3.2.3 Establishment of an efficient cryopreservation method for 
iSHF cells 
Cells, especially hiPSCs, are vulnerable to cell death during freezing and thawing cycles 
resulting in a poor survival rate of hiPSCs after thawing. Therefore, the establishment of an 
efficient cryopreservation method of hiPSCs was necessary for facilitation of storage and 
work with the generated iSHF cells.  
The establishment was carried out by testing different ways of enzymatic cell detachment, 
cell collection, centrifugation, compositions of freezing media and freezing procedures, which 
is summarized in Tab. 7. The course of establishment as well as the protocols for finally 
working cryopreservation of iSHF cells using freezing medium containing KO™-SR and 
DMSO (90:10) supplemented with Y-27632 as well as using CryoStem™ Freezing Medium 




Tab. 7: Testing of different cryopreservation methods for iSHF cells. 
 
+: with incubation of indicated reagent; Col: collagenase; Acu: accutase; hiPSC-M: appropriate hiPSC medium; 
KO™-SR: Knock Out Serum Replacement; Y-27632: ROCK inhibitor. 
 
3.2.4 Characterization of iSHF cell lines 
Characterization of iSHF cell lines iSHF-3, -6 and -13 generated by “Feeder Free“ 
mRNA/miRNA Reprogramming was performed by assessment of AP-staining, the 
expression of pluripotency markers, karyotype analysis as well as teratoma formation. 
iSHF colonies revealed a positive AP-staining and were well distinguishable from the AP 





Fig. 20: Alkaline Phosphatase staining of iSHF cell lines. (A-C) Brightfield microscopy images of iSHF-3, -6 
and -13. (D-I) In contrast to MEF feeder layer, iSHF-3, -6 and -13 are positively stained for AP perceptible from 
the dark brown staining of these cells. D-F provides an overview of culture plate after AP-staining, G-I shows 
AP-positive iSHFs at a higher magnification. AP: Alkaline Phosphatase. Scale bars: 200 µm.  
 
The nuclear marker OCT4 as well as the surface markers SSEA-4, TRA-1-60 and TRA-1-81 
were used to further prove the pluripotency character of the generated iSHFs by 
immunofluorescence staining. The expression of the listed markers was observed in iSHF-3 
(Fig. 21) and iSHF-6 (Fig. 22), while iSHF-13 was exclusively characterized by the positive 
expression of OCT4 and SSEA-4 (Fig. 23). Incubation with IgG antibody was used as 










Fig. 21: Immunocytochemical staining of iSHF-3 colonies with different pluripotency markers. iSHF-3 was 
positively stained for the pluripotency markers OCT4, SSEA-4, TRA-1-60 and TRA-1-81. Representative overlay 
images are shown in F, I, L and O. Incubations with IgG instead of first antibody were used as negative control 
(A-C) and is representative for the following immunocytochemical staining of iSHF-6 (Fig. 22) and iSHF-13 (Fig. 
23). Representative scale bars are indicated within the overlay images. Scale bars: C, F, I: 50 µm; L, O: 20 µm.   
 
Fig. 22: Immunocytochemical staining of iSHF-6 colonies with different pluripotency markers. iSHF-6 was 
positively stained for the pluripotency markers OCT4, SSEA-4, TRA-1-60 and TRA-1-81. Representative overlay 
images are shown in C, F, I and L. Representative incubations with IgG instead of first antibody as negative 
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controlis shown in Fig. 21 A-C. Representative scale bars are indicated within the overlay images. Scale bars: 
50 µm.  
 
Fig. 23: Immunocytochemical staining of iSHF-13 colonies with different pluritpotency markers. iSHF-13 
was positively stained for the pluripotency markers OCT4 and SSEA-4. Representative overlay images are shown 
in C and F. Representative incubations with IgG instead of first antibody as negative control is shown in Fig. 
21 A-C. Representative scale bars are indicated within the overlay images. Scale bars: 50 µm.  
 
Because generation and cultivation of hiPSCs can be associated with karyotypic 
abnormalities (Martins-Taylor and Xu, 2012), karyotype analyses were performed, which 
revealed a normal karyotype for all three generated iSHF cell lines (Fig. 24 A-C). 
Chromosomes from 50 metaphases stained with Giemsa were counted to check for numeric 
abnormalities. The percentage of metaphases with 45 chromosomes was less than 10% in 
iSHF cell lines (Fig. 24 D). 
Teratoma formation represents robust pluripotency of hiPSCs and is accepted as the gold 
standard to assess pluripotency. For this assay hiPSCs are injected into immunodeficient 
NOD/SCID mice and are expected to exhibit a rapid growth of benign tumors consisting of 
cells derived from all three germ layers (2.2.4.9). As a final proof of their pluripotency iSHF-3 
and iSHF-6 were used for this in vivo test. In a first trial five mice were injected with each 
2 x 106 iSHF-3 cells (passage No. 19) and two mice were treated with 1 x 106 and 2 x 106 
iSHF-6 cells (passage No. 23), respectively. No teratoma formation was observed within 
75-92 days after injection into immunodeficient mice. A further teratoma assay using iSHF-3 




Fig. 24: Karyotyping of iSHF cell lines. (A-C) iSHF-3 (P17), iSHF-6 (P14) and iSHF-13 (P16) revealed a normal 
karyotype after the reprogramming process. Representative karyograms are shown. (D) Counting of 









3.3 Co-culture of mouse ESCs with human testicular feeder 
cells 
3.3.1 Preparation of Human Testicular Feeder  
The Human Testicular Feeder (HTF) was derived from Magnetic Activated Cell Sortings 
(MACSortings) with human testicular biopsies from infertile men (3.1; Tab. 2). These biopsies 
were used to enrich human SSCs via MACSorting using a specific antibody against 
α6-Integrin, which is described as a surface marker of murine and human SSCs (Shinohara 
et al., 1999; 2000; Valli et al., 2014). The principle of MACSorting is described in detail in 
3.1.2. 
Within a two-step procedure the digested testicular cell suspension was incubated with a 
specific biotinylated α6-Integrin antibody, which was labelled with MicroBeads binding to 
biotin in a second step. Theoretically, the flow through fraction of this MACSorting should 
contain the somatic cell populations, which are beside the germ cells part of the testis and 
have a supportive role during spermatogenesis. These cells were termed as HTF cells, 
cultured in fibroblast (FB) medium with normal DMEM, 10 % FCS, 2 mM L-glutamine and 
1 mM penicillin/ streptomycin on gelatine coated flasks and passaged at 80-90% confluence 
(2.2.4.3.6; Fig. 25 A). HTF cells at ~80% confluence were used for co-culture with embryonic 
stem cells and a medium change was performed one day before the start of co-culture. The 
co-culture experiments and the analyses were performed predominantly with three HTF cell 
lines derived from MACSortings with human testicular biopsies from three infertile men, 
whose spermatogenesis were completed and classified at modified Johnsen Score 10 (de 
Kretser & Holstein, 1976; Fig. 25 B). 
 
Fig. 25: HTF cell lines used in co-culture experiments. (A) Representative brightfield picture of HTF-2 cells 
derived from MACSorting with testicular biopsy from an infertile man shows the fibroblast morphology of HTF 
cells. Scale bar: 200 µm. (B) Three different HTF cell lines, HTF-1, -2 and -3, were predominatly used for co-
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culture experiments derived from MACSorting with testicular biopsies characterized with a spermatogenesis 
classified at modified Johnsen Score 10. mJ-score: modified Johnsen Score (de Kretser & Holstein, 1976). 
 
3.3.1.1 Characterization of HTF cell lines 
Because HTF cell lines were derived from culturing the flow through fractions, it was 
assumed that these cell lines predominantly consist of human testicular somatic cells. The 
somatic cell populations within the testis and the seminiferous tubules contribute to the SSC 
niche, which is a highly specialized microenvironment for the regulation of SSC self renewal 
and differentiation of SSCs to spermatozoa (1.4). Sertoli cells, leydig cells, peritubular cells 
as well as the interstitium secrete several factors and thus influence the fate of SSCs 
residing at the basement membrane of the tubules (de Rooij, 2009; Oatley and Brinster, 
2012). For characterization of HTF cell lines, qRT-PCR analyses were performed to evaluate 
the expression pattern of marker genes of sertoli-, leydig- and peritubular cells. The analysis 
of several marker genes is necessary, because there are no markers available, which 
exclusively characterize one of these cell populations.  
To validate the origin of HTF cells, we sent RNA derived from all three HTF cell lines, each 
with two different passages, to two collaborators, who already used different established 
germ-, sertoli-, leydig- and peritubular cell markers (Kossack et al., 2013; Flenkenthaler et 
al., 2014). The group of Dr. Neuhaus (née Dr. Kossack; Center of Reproductive Medicine 
and Andrology, University Hospital Münster) analyzed the expression pattern of the sertoli 
cell marker genes FSHR (Follicle-Stimulating Hormone Receptor), INHIBIN and VIM 
(Vimentin) (Fig. 26 A), the leydig cell marker genes P450, LHCGR (Luteinizing 
Hormone/Choriogonadotropin Receptor), 3-β-HSD (3-β-Hydroxysteroid Dehydrogenase) and 
STAR (Steroidogenic Acute Regulatory Protein) (Fig. 26 B) as well as the germ cell marker 
gene MAGE A4 (Melanoma Antigen Family A4) (Fig. 26 C). Human testis samples, provided 
by Dr. Neuhaus’s group, were used as positive controls and for normalization of qRT data. 
Sertoli- and leydig cell marker genes were almost not expressed in the analyzed HTF cell 
lines (Fig. 26). The data for sertoli cell marker gene expression revealed an increased 
expression of VIM in the tested HTF cell lines, which is described to mark not only sertoli 
cells, but also peritubular cells (Tokuda et al, 2007). Among the tested leydig cell marker 
genes STAR showed an increased to moderate expression in HTF cells. Germ cell marker 




Fig. 26: qRT-expression analyses of sertoli-, leydig- and germ cell marker genes in HTF cell lines.  Mean 
values with standard deviations for (A) sertoli cell marker genes FSHR, INHIBIN and VIM, (B) leydig cell marker 
genes P450, LHCGR, 3-β-HSD and STAR and (C) germ cell marker gene MAGE A4 are shown. Each RNA of two 
different cell passages (P) were analyzed: HTF-1: P5, P7; HTF-2: P8, P10; HTF-3: P7, P9. Data were collected by 
the group of Dr. Neuhaus (Münster).  
 
In Prof. Mayerhofer’s group (Department for Anatomy and Cell Biology, University of Munich) 
the expression profile of the peritubular cell marker genes DCN (Decorin), PTX3 
(Pentraxin 3), SMA (Smooth Muscle Actin), CAL (Calponin), AR (Androgen Receptor), GPER 
(G-Protein coupled Estrogen Receptor) and AT1R (Angiotensin II Type I Receptor) in HTF 
cells were examined by qRT-PCR analyses. Human testicular peritubular cells (HTPCs; 
Albrecht et al., 2006), provided by Prof. Mayerhofer’s group, were used as positive controls 
and for normalization of qRT data. All analyzed peritbular cell marker genes were moderate 
to highly expressed in the HTF cell lines (Fig. 27 I). The peritubular cell marker genes PTX3, 
CAL, GPER and AT1R revealed an expression in HTF cells comparable to HTPCs. 
Additionally, HTF cells were positively stained for SMA and VIM in immunocytochemical 
studies, in which these cells showed a heterogeneous expression pattern (Fig. 27 II). 
Consequently, the results of the qRT-PCR analyses and the immunocytochemical stainings 






Fig. 27: Peritubular cell marker expression in HTF cell lines analyzed by qRT-PCR experiments and 
immunocytochemistry. (I) Results of qRT-PCR-expression analyses for peritubular cell marker genes DCN, 
PTX3, SMA, CAL, AR, GPER and AT1R. Mean values with standard deviations are shown. Data were collected 
by Prof. Mayerhofer’s group (Munich). HTPC: Human Testicular Pertibular Cells. (II) Immunocytochemical 
stainings of HTF cells using specific antibodies for SMA and VIM. Representative overlay images are shown in D, 
I and N. Incubations with IgG instead of first antibody were used as negative controls (E, J and O). 








3.3.2 Morphological changes of ESCs co-cultured with HTF cells  
In the present work the ESC line “SSC 12”, generated by Nayernia et al. (2006), was used 
for co-culture experiments. SSC 12 is an ES-RI cell line, established from 
129SV-background (Nagy et al., 1993) containing the premeiotic promoter construct Stra8-
EGFP as well as postmeiotic promoter construct Prm1-DsRed for a double selection strategy 
to establish mSSC lines from mESCs (Nayernia et al., 2006). SSC 12 represents a cell 
population enriched for Stra8 expressing cells by twice FACSortings. Because Stra8 
(Stimulated by Retinoic Acid Gene 8) is a premeiotic germ cell marker (Oulad-Abdelghani et 
al., 1996), but also already expressed in ESCs (Guan et al., 2006), SSC 12 is suggested to 
be a germ cell directed ESC line.  
Co-culture of SSC 12 was performed with HTF cells, which were cultured in FB medium on 
gelatine coated vessels and used for co-culture experiments at ~80% confluence. A medium 
change was performed one day before starting the experiment by adding 1 x 105 SSC 12 
cells diluted in FB medium on the adherent HTF cells. The whole co-culture experiment was 
performed with FB medium (Fig. 28 A). The first medium change was performed three days 
after seeding of SSC 12 cells. Further co-culture comprised medium changes every second 
to third day and passaging at day ten in a ratio of 1:2-1:3 and further medium changes every 
second to third day (2.2.4.3.9). At the very first beginning of co-culture SSC 12 cells showed 
their typical ESC-like morphology. During further culture in FB medium the morphology of the 
ESCs showed differentiating features, characterized by fringed borders and three 
dimensional structures, which finally developed into cell clusters with grape-like structures 






Fig. 28: Experimental outline of co-culture experiments and overview of morphological changes of 
SSC 12 co-cultured with HTF cells. (A) Schematic outline of a co-culture experiment. (B) Brightfield pictures of 
SSC 12 cells co-cultured with HTF-2 cells at different time points of co-culture. Scale bars are indicated within the 
pictures.  
 
Below the putative mSSCs are termed according to the HTF cell line used for co-culture with 
the appendix “-Co”. For example the labelling “HTF-1-Co” specifies the putative mSSCs 
derived from the co-culture of SSC 12 cells with the cell line HTF-1.  
 
3.3.3 Characterization of putative mSSCs derived from co-culture of 
mESCs with HTF cells 
3.3.3.1 Viability of putative mSSCs 
For validation of cell viability the putative mSSCs were analyzed by BrdU incubation, which 
can be incorporated as a thymidine structural analog into replicating DNA in the synthesis 
phase of cell cycle of dividing cells. Therefore BrdU incorporation into DNA is a useful tool to 
label DNA in viable and proliferating cells (Givan, 1992; Leif et al., 2004). The putative 
mSSCs derived from the co-cultures HTF-1-Co, HTF-2-Co and HTF-3-Co underwent a 
MACSorting using the mSSC surface marker antibody α6-Integrin to enrich the putative 
mSSCs as α6-Integrin positive cells in culture. These cells were cultured in FB medium with 
BrdU for 48 h and further analyzed by immunodetection of BrdU positive cells (2.2.4.14; Fig. 
29 I). Several cells within the putative mSSC clusters were immunopositive for BrdU (Fig. 
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29 I C, G, K) indicating the proliferating status of the analyzed cells. No staining was 
detected in the corresponding stainings with IgG (Fig. 29 I D, H, L). The cell viability was 
further confirmed by an Annexin V and 7-AAD (7-Amino-Actinomycin) apoptosis assay 
(2.2.4.13; Khromov et al., 2012). Here freshly α6-Integrin MACSorted putative mSSCs 
derived from the co-cultures HTF-1-Co, HTF-2-Co and HTF-3-Co were incubated with 
Annexin V and 7-AAD. While the Ca2+ dependent protein Annexin V binds to membrane 
phospholipid phosphatidylserine, which is exposed at the outer leaflet of the plasma 
membrane at the latest stage of apoptosis, represents 7-AAD a vital dye, which is excluded 
from viable cells because of their intact membrane. Flow cytometric analysis allows the 
determination of viable, early and late apoptotic as well as dead cell fractions. These 
analyses revealed that approximately 80% of stained co-culture-derived cells were viable 






Fig. 29: Validation of co-culture-derived putative mSSCs viability by BrdU staining and apoptosis assay. 
After MACSorting with α6-Integrin co-culture-derived putative mSSCs (HTF-1-Co, HTF-2-Co and HTF-3-Co) were 
analyzed (I) by BrdU staining for proof of cell viability and proliferation and (II) by apoptosis assay. (I) Staining of 
BrdU positive cells after 48 h incubation with the thymidine analog BrdU. Representative overlay images are 
shown in C, G and K. Incubations with IgG instead of first antibody were used as negative controls (D, H and L). 
Representative scale bars are indicated in the overlay images. Scale bars: 20 µm. (II) Results of flow cytometric 
measurements show the percentage of viable, early and late apoptotic putative mSSCs. Mean values with 




3.3.3.2 Expression patterns of SSC- and PGC marker genes in putative 
mSSCs 
The characterization of co-culture-derived putative mSSCs was performed by staining with 
alkaline phosphatase (AP) as well as immunocytochemical and qRT-PCR analyses of 
phenotypic mSSC markers, which are generally used for the identification of SSCs. 
AP-staining as well as immunocytochemical analysis were performed with putative mSSCs 
co-cultured with HTF cells. The putative mSSCs were positively stained for AP, whereas the 
HTF cells were negative for AP-staining (Fig. 30 B). Additionally the AP-staining revealed the 
high number of mSSC-like cells generated in co-culture (Fig. 30 C). 
 
 
Fig. 30: Alkaline Phosphatase staining of co-culture-derived putative mSSCs. (A) Brightfield microscopy 
image of putative mSSCs derived from HTF-2-Co before AP-staining showed the typical colonies of round cells 
with grape-like structures. (B) In contrast to HTF-2 cells (arrow heads), the putative mSSCs were positively 
stained for AP perceptible from the dark brown staining of the cells (arrows). (C) Overview of culture plate after 
AP-staining demonstrated the high number of putative mSSCs generated in co-culture. AP: Alkaline 
Phosphatase. Scale bars: A: 10 µm; B: 20 µm; C: 100 µm.  
 
Within cell clusters both immunopositive and immunonegative cells could be observed for all 
tested SSC markers OCT4, SALL4 (Sal-Like Protein 4), PLZF and α6-Integrin (Fig. 31). 
OCT4 showed a heterogeneous expression pattern within cell clusters, some cells were 
strongly immunopositive, whereas some remaining cells depicted a weaker staining for 
OCT4 (Fig. 31 C+F). In comparison to the OCT4 expression the SALL4-, PLZF- and 






Fig. 31: Immunocytochemical stainings of putative mSSCs derived from co-culture with HTF-2 cells. 
Immunocytochemical stainings were performed with HTF-2-Co cells using specific antibodies for SSC markers 
(A-F) OCT4, (G-I) SALL4, (J-L) PLZF and (M-O) α6-Integrin. Representative overlay images are shown in the last 
column (C, F, I, L and O). Incubation with IgG instead of first antibody was used as negative control (P-R). 
Representative scale bars are indicated in the overlay images. Scale bars: C, F, I, L, O: 10 µm; R: 20 µm.  
 
A similar staining pattern was observed in co-stainings using antibodies against OCT4 and 
SALL4 as well as OCT4 and DDX4 (). Within cell clusters OCT4 and SALL4 or rather OCT4 
and DDX4 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 4; aliases: VASA) were co-localized in 
some cells (Fig. 32, 4th column), while remaining cells were stained positive for either one or 
none of the markers (Fig. 32; 2nd and 3rd columns). Mostly the staining intensity of markers 
differed in cells showing co-localization. No staining was detected in negative controls using 






Fig. 32: Co-Immunocytochemical stainings of putative mSSCs derived from co-culture with HTF-2. 
Co-Immunocytochemical stainings were performed with HTF-2-Co using specific antibodies for SSC markers 
(A-H) OCT4 / SALL4 and (I-L) OCT4 and DDX4. Representative overlay images are shown in the last column (D, 
H and L). Incubation with IgG instead of first antibody was used as negative control (M-P). Red and green arrows 
indicate cells, which are positive for the respective marker, whereas white arrows indicate those cells that stained 
positive for both markers. Representative scale bars are indicated in the overlay images. Scale bars: D, H, L: 
10 µm; P: 20 µm. 
 
Therefore, the evaluation of the expression pattern of mSSC phenotypic markers by 
immunocytochemistry indicated that the putative mSSC clusters do not represent a 
homogeneous mSSC population. An enrichment of those cells in culture could be achieved 
by MACSorting of the putative mSSCs derived from the co-cultures HTF-1-Co, HTF-2-Co 
and HTF-3-Co using the mSSC surface marker antibody α6-Integrin, followed by an 
immunostaining with α6-Integrin in order to quantify the α6-Integrin expression in putative 
mSSCs after MACSorting. After examination of a total of 500 cells for each cell line regarding 
their α6-Integrin expression (Fig. 33 II), the putative mSSCs derived from the co-cultures 
HTF-1-Co, HTF-2-Co and HTF-3-Co revealed 64-70% α6-Integrin positive cells after 
MACSorting (Fig. 33 I). This comprised a two times higher percentage of α6-Integrin positive 
compared to the starting cell line SSC 12 of co-culture (33%) and even a five times higher 



























































Fig. 33: Enrichment of α6-Integrin positive cells by MACSorting of co-culture-derived putative mSSCs.  
After MACSorting and immunostaining with α6-Integrin a total of 500 cells for HTF-1-Co, HTF-2-Co and HTF-3-Co 
were examined regarding their α6-Integrin expression, respectively. (I) Counting of positive cells revealed a two 
times- and five times increase of α6-Integrin positive cells in the co-culture-derived mSSCs compared to SSC 12 
and ES-RI, respectively. (II) Representative images of α6-Integrin immunostaining with SSC 12, ES-RI, 
HTF-1-Co, HTF-2-Co and HTF-3-Co used for evaluation of α6-Integrin positive cells. Overlay images are shown 
in C, F, I, L and O. Representative overlay images of incubations with IgG instead of first antibody used as 
negative controls are shown in inlays in C, F and I. Representative scale bars are indicated in the overlay images. 
Scale bars: 20 µm. 
 
In addition, qRT-PCR experiments were performed to analyze the expression of a subset of 
mPGC- and mSSC markers in putative mSSCs derived from co-culture (Fig. 34). These 
analyses were carried out with putative mSSCs co-cultured with HTF cells as well as with 
freshly α6-Integrin MACSorted putative mSSCs derived from co-cultures HTF-1-Co, 
HTF-2-Co and HTF-3-Co in comparison to ES-RI cells as well as the starting cell line 
SSC 12. Synthesized cDNA derived from mouse testis was used as positive control, while 
negative controls consisted of the expression analysis in pure HTF cell lines as well as in 
mouse brain and mouse spleen. Recently, Fkbp6 (FK506 Binding Protein 6) and Mov10l1 
(Moloney Leukemia Virus 10-like 1) were identified as genes which are specifically 
expressed in developing fetal PGCs, but not in ESCs and somatic tissues (Sabour et al., 
2011). For this reason the expression of these genes indicates the commitment of cells to the 
germ line lineage and provides the opportunity to discriminate between PGCs and ESCs in 
vivo and in vitro. Independent of preparation of co-culture samples, the results of PGC 
marker gene expression demonstrated a significantly increased expression level of Fkbp6 
and Mov10l1 in cells derived from co-cultures in comparison to the ESC line ES-RI as well as 
to SSC 12 cells (Fig. 34 A). The calculated significances normalized to ES-RI are indicated 
within Fig. 34 A. The expression analysis of Gpr125 (G-Protein-coupled Receptor 125), 
which is a well established germ cell marker and expressed in undifferentiated 
spermatogonia within the testis (Seandel at al., 2007), revealed a moderate expression 






Fig. 34: qRT-PCR expression analyses of PGC marker genes Fkbp6 and Mov10l1 and the SSC marker 
gene Gpr125 in co-cultured cell lines. Mean values with standard deviations for (A) PGC marker genes Fkbp6 
and Mov10l1 and (B) SSC marker gene Gpr125 are shown. Data comprised at least two biological replicates 
before and after MACSorting of putative mSSCs derived from HTF-1-Co, HTF-2-Co and HTF-3-Co. Significant 
increase of marker gene expression in co-culture samples was calculated in comparison to ES-RI and indicated 
with *: p ≤ 0.05, **: p ≤ 0.01; ***: p ≤ 0.001. SSC 12: starting cell line of co-culture. mTestis: positive control; 
mBrain, mSpleen: negative controls.  
 
3.3.3.3 Methylation patterns of imprinted marker genes in putative mSSCs 
The analysis of the methylation status of imprinted genes in putative mSSCs derived from 
co-culture was performed in order to check if these genes reveal the SSC characteristic 
androgenic imprinting pattern. These analyses were carried out in collaboration with Prof. 
Zechner (Institute of Human Genetics, University of Mainz). For this study genomic DNA 
samples were isolated from putative mSSCs co-cultured with HTF cells as well as from 
freshly α6-Integrin MACSorted putative mSSCs derived from co-cultures. Bisulfite 
pyrosequencing of DNA samples as well as data evaluation in comparison to the methylation 
patterns of the co-culture starting cell line SSC 12 was performed by the Zechner group. The 
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methylation status of differentially methylated regions (DMRs) of the paternally imprinted H19 
and Meg3 genes as well as the maternally imprinted Igf2r and Snrpn genes was analyzed 
(Fig. 35).  
 
Fig. 35: Methylation analyses of imprinted genes in co-culture-derived putative mSSCs before and after 
MACSorting with α6-Integrin. The methylation status of (A) the paternally imprinted H19 ICR and Meg3 IG-DMR 
and (B) the maternally imprinted Igf2r DMR2 and Snrpn DMR1 in co-culture-derived putative mSSCs before and 
after MACSorting with α6-Integrin was analyzed by bisulfite pyrosequencing. Mean values with standard 
deviations are shown. Data comprised three biological replicates before MACSorting and two biological replicates 
after MACSorting. Data collection and analysis were performed the Zechner group (Mainz).  
 
The analyses revealed minor differences in methylation levels of imprinted genes between 
putative mSSCs derived from the co-cultures before and after MACSorting with α6-Integrin 
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and the starting cell line SSC 12. In putative mSSCs derived from HTF-1-Co, HTF-2-Co and 
HTF-3-Co the paternally imprinted gene H19 showed a methylation level of ~60% before 
sorting that very slightly increased to levels ~65% after MACSorting with α6-Integrin (Fig. 
35 A). The Meg3 intergenic (IG) DMR displayed a lower methylation level than H19 of ~45% 
that did not change during sorting. Similar observations were made for the methylation 
patterns of the maternally imprinted Igf2r and Snrpn genes (Fig. 35 B). Igf2r showed a 
moderate hypermethylation of its DMR2 (~65% before MACSorting, ~68% after 
MACSorting), while the majority of CpG repeats of the Snrpn DMR1 were moderately 
hypermethylated (~30% before and after MACSorting). The methylation levels of imprinted 
genes in SSC 12 were nearly consistent with those of ESCs described by Zechner et al., 
2009.  
 
3.3.3.4 Derivation of putative mSSCs from HTF-co-cultures with other 
pluripotent stem cells 
Co-culture experiments were also performed with other pluripotent stem cells. The co-culture 
of HTF cells with the wild type ESC line ES-RI (Nagy et al., 1993) and a wild type iPS cell 
line (Wernig et al., 2007) also led to the formation of putative mSSC resembling a grape-like 
structure (Fig. 36 A), which revealed a positive staining for α6-Integrin (Fig. 36 B). This result 
indicated the suitability of the co-culture system for the generation of SSC-like cells. In the 
presented thesis a detailed characterization of SSC-like cells was performed with putative 




Fig. 36: Morphological features of other pluripotent stem cells for the generation of putative mSSCs in 
co-culture experiments. (A) SSC-like cells could be also generated by using wild type ES cell lines ES-RI and 
revealed a similar morphology as putative mSSCs derived from co-culture with SSC 12 (HTF-3-Co SSC 12). 
(B) SSC-like colonies derived from co-culture experiments using a wild type iPS cell line were positively stained 
for α6-Integrin. Scale bars: A: 200 µm; B: 20 µm.  
 
3.3.4 Transplantation of putative mSSCs in germ cell depleted mice 
For functional analysis of cells, co-culture-derived putative mSSCs were transplanted into the 
seminiferous tubules of germ cell depleted mice (2.2.4.8). While the recipient’s endogenous 
spermatogenesis was destroyed by busulfan treatment, subsequent transplantation of 
co-culture-derived putative mSSCs may lead to colonization and repopulation of SSCs within 
the tubules as well as induction and regeneration of spermatogenesis. In general, four to six 
weeks after busulfan treatment mice were mated with females for at least four weeks to 
ensure the infertility of males before their use for transplantations. In the transplantation 
assay, freshly α6-Integrin MACSorted putative mSSCs were either directly transplanted into 
one testis of the host or cultured for 24 hours in StemPro+3 medium on MEF, which was 
removed before transplantation procedure. 30-40 µl of the cell suspension (~1 x 108 cells/ml) 
were injected. The remaining testis was not transplanted and therefore used as an internal 
negative control. Tab. 8 summarizes the performed cell transplantations in germ cell 
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depleted CD-1 and 129SV mice and indicates the analyses, which were performed in order 
to check for colonization of transplanted cells as well as for repopulation of the seminiferous 
tubules.  
 
Tab. 8: Overview of performed cell transplantations in germ cell depleted mice. 
Analysis after transplantation 





Test mating with wild type females for at least 4 weeks  















The first transplantations of putative mSSCs were carried out with germ cell depleted mice of 
CD-1 genetic background (Tab. 8 A). Because a complete spermatogenesis and its 
regeneration after depletion take about 35 days, mice were mated with females 
approximately four weeks after transplantation. Since after several weeks of mating no 
offspring was born as well as no teratoma formation was observed, transplanted mice were 
sacrificed and their testes histologically analyzed by H&E staining. The H&E staining of testis 




Fig. 37: H&E staining of testis sections after transplantation of co-culture-derived putative mSSCs in 
germ cell depleted CD-1 mice. After transplantation of putative mSSCs derived from (A-F) HTF-1-Co and 
(G-J) HTF-2-Co in germ cell depleted CD-1 mice, their testes were histologically analyzed by H&E staining, which 
revealed no regeneration of spermatogenesis in seminiferous tubules. Transplanted and non-transplanted testis 
as an internal negative control were analyzed. H&E staining with CD-1 wild type testis demonstrated normal 
spermatogenesis. #: mouse number. Representative scale bar in K: 50 µm. 
 
Aiming to check whether putative mSSCs derived from co-culture were able to colonize 
within the seminiferous tubules after transplantation, germ cell depleted CD-1 mice were 
transplanted with cell suspension containing the prepared putative mSSCs and sacrificed at 
certain time points after transplantation. The presence of transplanted cells within the testis 
was checked by genotyping PCR on genomic DNA derived from transplanted testes (Tab. 
8 B) as well as immunohistochemistry on testis cryosections (Tab. 8 C) for the transgene 
construct Stra8-EGFP included in the starting cell line SSC 12 of co-culture. While 
immunohistochemical analysis did not lead to any results probably attributed to technical 
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problems to detect EGFP signals on testis cryosections, the presence of Stra8-EGFP-
specific PCR products was observed 7 days after transplantation by genotyping PCR, 
whereas no Stra8-EGFP PCR bands were detected 14 days after transplantation (Fig. 38 A). 
The non-transplanted testis was used as an internal negative control and TP2 (Transition 
Protein 2) -specific PCR was performed as loading control of DNA. Further transplantations 
were performed to narrow down the time span of settling and loss of transplanted cells within 
the seminiferous tubules. These transplantations demonstrated the presence of Stra8-EGFP-
specific PCR products in transplanted testes 6 and 9 days after transplantation by 
genotyping PCR (Fig. 38 B). No Stra8-EGFP-specific PCR bands were detected 12 days 
after transplantation (Fig. 38 B). Consequently, transplanted mSSCs became lost between 
10 and 12 days after transplantations in CD-1 mice. 
 
 
Fig. 38: Proof of Stra8-EGFP-specific PCR products in testes of transplanted germ cell depleted CD-1 
mice by genotyping PCR. Stra8-EGFP genotyping PCR results indicated the presence of Stra8-EGFP positive 
cells (A) 7 days as well as (B) 6 and 9 days after transplantation of co-culture-derived putative mSSCs in 
transplanted testes of germ cell depleted CD-1 mice. Putative mSSCs derived from (A) HTF-1-Co and (B) 
HTF-15-Co were used for transplantation. Fragment sizes of genotyping PCRs are indicated within the figure. 
TP2: PCR for DNA loading control; d: day after transplantation; +: transplanted testis; -: non-transplanted testis; 
PC: positive control with SSC 12 genomic DNA; NC: negative control with H2O.  
 
Because an ES-RI cell line, established from a murine 129SV-background (Nagy et al., 
1993), is the origin of the starting cell line SSC 12 of co-culture, further transplantations of 
putative mSSCs derived from co-culture were performed using germ cell depleted 129SV 
mice in order to exclude any immune response against the transplanted cells within the 
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testis. Genotyping PCR was performed to check the presence of Stra8-EGFP-specific PCR 
products in transplanted testes (Tab. 8 B). After transplantation into germ cell depleted 
129SV mice, Stra8-EGFP PCR bands were detected 6, 9 and 12 days after transplantation 
by genotyping PCR (Fig. 39 A), which was confirmed in three biological replicates. 
Furthermore the presence of Stra8-EGFP-specific PCR products could be confirmed 15 days 
after transplantation in 129SV mice (Fig. 39 B). The non-transplanted testis and TP2 PCR 
were used as an internal negative control and loading control of DNA, respectively. 
 
 
Fig. 39: Proof of Stra8-EGFP-specific PCR products in testes of transplanted germ cell depleted 129SV 
mice by genotyping PCR. Stra8-EGFP genotyping PCR results indicated the presence of Stra8-EGFP positive 
cells (A) 6, 9 and 12 days as well as (B) 15 days after transplantation of HTF-1-Co-derived putative mSSCs in 
transplanted testes of germ cell depleted 129SV mice. Fragment sizes of genotyping PCRs are indicated within 
the figure. TP2: PCR for DNA loading control; d: day after transplantation; +: transplanted testis; -: non-
transplanted testis; PC: positive control with SSC 12 genomic DNA; NC: negative control with H2O.  
 
In order to check whether the presence of Stra8-EGFP-specific PCR products in transplanted 
testes revealed by genotyping PCR corresponded to a possible colonization of transplanted 
cells within the seminiferous tubules, putative mSSCs derived from co-culture were 
transplanted into germ cell depleted 129SV mice and analyzed at the given time points by 
immunohistochemical staining (Tab. 8 C). The staining pattern of SALL4, a pluripotency 
factor, which is expressed in undifferentiated spermatogonia in adult testes (Gassei and 
Orwig, 2013), should offer a valuable clue to a potential colonization of transplanted cells 
within the seminiferous tubules. The analyses of SALL4 staining in histological sections of 
testes prepared 9, 12 and 15 days after transplantation are still in progress.  
In addition, germ cell depleted 129SV mice were mated with females approximately four 
weeks after further transplantations to test for regeneration of spermatogenesis (Tab. 8 A). 
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No offspring was born as well as no teratoma formation was observed after several weeks of 
breeding. Two mice are still in test matings, while one transplanted mouse was already 
sacrificed and its testes histological analyzed by H&E staining, which revealed no 
seminiferous tubules with regenerated spermatogenesis.  
 
3.3.5 In vitro spermatogenesis experiments with putative mSSCs 
derived from co-culture 
3.3.5.1 Molecular marker expression before induction of in vitro  
spermatogenesis 
For further functional analysis, co-culture derived putative mSSCs were used for in vitro 
spermatogenesis experiments in order to monitor if these cells were able to undergo 
differentiation towards haploid male germ cells. Before start of an intended induction of male 
germ cell differentiation, the expression pattern of molecular markers for germ cell 
development were examined in order to check if there was any proof of meiotic or even 
postmeiotic marker gene expression in co-culture samples without induction of differentiation. 
To monitor the initial situation seven independent HTF-2-Co samples were tested for the 
expression of different spermatogenesis marker genes by RT-PCR. Fig. 40 A provides an 
overview of generally used molecular markers for different steps of male germ cell 
differentiation. In each case two marker genes were chosen for the analysis of premeiotic, 
meiotic and postmeiotic state of differentiation (Fig. 40 A). The pure HTF-2 cell line was used 
as an internal negative control. The RT-PCR analysis revealed an expression of premeiotic 
marker genes Stra8 and Vasa (aliases: Ddx4) as well as of meiotic marker genes Ovol1 
(OVO Homolog-like 1) and Sycp3 (Synaptonemal Complex Protein 3) (Fig. 40 B). 
Additionally, the expression of the early postmeiotic gene Acr (Acrosin) was detected, 
whereas Prm1 (Protamine 1) as one of the latest postmeiotic genes was not expressed (Fig. 
40 B). No expression of these marker genes was detected in the pure HTF-2 cell line. These 
RT-PCR results indicated a turning-on of early postmeiotic gene expression in the co-culture 




Fig. 40: RT-PCR expression analyses of spermatogenesis marker genes in co-culture samples of  
HTF-2-Co.  (A) Overview of molecular markers for characterization of different steps of male germ cell 
differentiation. Arrows indicate the marker genes used in the presented RT-PCR expression analyses. Modified, 
Nolte et al., 2007. (B) RT-PCR results showed the expression of premeiotic marker genes Stra8 and Vasa, 
meiotic marker genes Ovol1 and Sycp3 and the early postmeiotic gene Acr. Prm1 expression as one of the latest 
postmeiotic genes was not detected. Fragment sizes of PCR products are indicated within the figure. TP2: PCR 
for murine DNA loading control; TBP: PCR for human DNA loading control; PC: positive control with SSC 12 
genomic DNA; NC: negative control with H2O. 
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3.3.5.2 Molecular marker expression and imprinted gene methylation 
analysis during in vitro spermatogenesis 
Induction of in vitro differentiation is generally performed by application of retinoic acid (RA), 
which is known to be an important regulator of embryonic development (Ross et al., 2000). 
Local levels of RA, which is produced by oxidative reactions from vitamin A (retinol) (Ross et 
al., 2000), are regulated by retinaldehyde dehydrogenases catalyzing the last step of RA 
synthesis and by CYP26 (cytochrome p450, 26 family of enzymes), which degrades RA 
(Abu-Abed et al., 2001; Niederreither et al., 2002; Duester et al., 2003). The RA-dependent 
transcription of premeiotic Stra8 is essential for inducing meiosis (Baltus et al., 2006; 
Anderson et al., 2008). Koubova et al. (2006) proposed that RA signalling and metabolism 
play an important role in initiation of meiosis during embryogenesis. CYP26B1, which is 
exclusively expressed in embryonic testis, is supposed to degrade RA and prevent 
expression of Stra8 resulting in a prevention of meiosis in embryonic testes (Fig. 41). 
Therefore an application of Talarozole (TA; R115866), a specific CYP26-inhibitor in vivo 
(Stoppie et al., 2000), during induction of germ cell differentiation might increase the number 
of cells entering meiosis by inhibiting the CYP26B1-dependent RA degradation. Based on 
this assumption the in vitro induction of differentiation of putative mSSCs derived from co-








Fig. 41: Proposed model for CYP26 in RA signalling and metabolism to prevent initiation of meiosis 
during embryogenesis. CYP26B1 is exclusively expressed in embryonic testis and is supposed to degrade RA 
and prevent expression of Stra8, which finally leads to a block of meiosis initiation in embryonic testes. modified; 
Koubova et al., 2006. 
 
For in vitro differentiation HTF-1-Co, HTF-2-Co and HTF-3-Co were cultured in the presence 
of RA or TA as well as RA and TA and harvested after 5 and 10 days (d5 and d10, 
respectively) of incubation with these reagents. RNA isolation followed by cDNA synthesis 
was performed for expression analysis of spermatogenesis marker genes Stra8, Gpx4 
(Glutathione Peroxidase 4) and Acr by qRT-PCR experiments. Synthesised cDNAs derived 
from mouse testis and HTF cell lines were used as positive and negative control, 
respectively. Additionally, isolated genomic DNA from induced co-culture samples was used 
for analysis of methylation status of imprinted genes. Bisulfite pyrosequencing of samples as 
well as data evaluation in comparison to the methylation pattern of the co-culture starting cell 
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line SSC 12 was performed by the Zechner group (Mainz). All data were compared to 
co-culture samples before induction of differentiation.  
The analysis demonstrated that Stra8 expression can be highly increased by RA application 
as well as by inhibiting the CYP26B1-dependent RA degradation (Fig. 42 A; Fig. 43 A; Fig. 
44 A). Compared to the start of induction, incubation with RA, or TA as well as with both 
reagents induced a significant increase of premeiotic Stra8 expression in HTF-1-Co and 
HTF-2-Co at day 5 and day 10. During induction of differentiation of HTF-3-Co, Stra8 was 
also upregulated, however this upregulation was not statistically significant because of the 
deviations within the tested biological replicates. Moreover, the expression analyses of the 
postmeiotic marker genes Gpx4 and Acr indicated the presence of postmeiotic cells derived 
from HTF-1-Co, HTF-2-Co and HTF-3-Co (Fig. 42 A; Fig. 43 A; Fig. 44 A). While inhibiting 
the CYP26B1-dependent RA degradation caused an upregulation of Gpx4 expression in 
HTF-1-Co, HTF-2-Co and HTF-3-Co at day 5 and in HTF-1-Co and HTF-2-Co also at day 10, 
an increased Acr expression was observed at least at one of the tested time points during 
induction of differentiation. The calculated significances for the comparisons to mRNA levels 
at the start of induction are indicated within the figures (Fig. 42 A; Fig. 43 A; Fig. 44 A).  
During male germ cell differentiation the methylation levels of the paternally imprinted H19 
and Meg3 genes are expected to increase, while the methylation of maternally imprinted 
Igf2r and Snrpn genes should be erased with subsequent maintenance of a largely 
unmethylated state. Compared to the start of induction with RA and TA as well as to the 
co-culture starting cell line SSC 12, the methylation patterns of induced HTF-1-Co, HTF-2-Co 
and HTF-3-Co did not display any trend towards a hypermethylated pattern of H19 and Meg3 
and a hypomethylated pattern of Igf2r and Snrpn that would be indicative for in vitro 
differentiation (Fig. 42 B; Fig. 43 B; Fig. 44 B). Considering all analyzed differentiation 
induced cell lines and corresponding controls, no gross methylation changes were detected 
for all four genes at day 5 and day 10 of differentiation with RA, or TA as well as with both 
reagents. Before and after differentiation, H19 displayed a methylation level ~50-70%, Meg3 
a methylation level ~40-50%, Igf2r a methylation level ~60-70% and Snrpn a methylation 
level of ~30-40%. A slightly increased methylation was only seen for the H19 and Meg3 
genes at day 10 of differentitation of HTF-1-Co, HTF-2-Co and HTF-3-Co with both RA and 





Fig. 42: Analyses of spermatogenesis marker gene expression by qRT-PCR experiments and methylation 
pattern during in vitro differentiation of HTF-1-Co. (A) Results of qRT-PCR-expression analyses for premeiotic 
Stra8 and postmeiotic Gpx4 and Acr. Mean values with standard deviations are shown. Data consists of at least 
two biological replicates. Significant increase of marker gene expression in co-culture samples during 
differentiation was calculated in comparison to HTF-1-Co before start of induction and is indicated with *: p ≤ 0.05, 
**: p ≤ 0.01; ***: p ≤ 0.001. (B) The methylation status of the paternally imprinted H19 ICR and Meg3 IG-DMR and 
the maternally imprinted Igf2r DMR2 and Snrpn DMR1 were analyzed by bisulfite pyrosequencing. Mean values 
with standard deviations are shown. Data collection and analysis were performed by the Zechner group (Mainz). 
SSC 12: starting cell line of co-culture. HTF-1: pure HTF cell line; start: HTF-1-Co before start of induction. d: day 




Fig. 43: Analyses of spermatogenesis marker gene expression by qRT-PCR experiments and methylation 
pattern during in vitro differentiation of HTF-2-Co. (A) Results of qRT-PCR-expression analyses for premeiotic 
Stra8 and postmeiotic Gpx4 and Acr. Mean values with standard deviations are shown. Data consists of at least 
two biological replicates. Significant increase of marker gene expression in co-culture samples during 
differentiation was calculated in comparison to HTF-2-Co before start of induction and is indicated with *: p ≤ 0.05, 
**: p ≤ 0.01; ***: p ≤ 0.001. (B) The methylation status of the paternally imprinted H19 ICR and Meg3 IG-DMR and 
the maternally imprinted Igf2r DMR2 and Snrpn DMR1 were analyzed by bisulfite pyrosequencing. Mean values 
with standard deviations are shown. Data collection and analysis were performed by the Zechner group (Mainz). 
SSC 12: starting cell line of co-culture. HTF-2: pure HTF cell line; start: HTF-2-Co before start of induction. d: day 





Fig. 44: Analyses of spermatogenesis marker gene expression by qRT-PCR experiments and methylation 
pattern during in vitro differentiation of HTF-3-Co. (A) Results of qRT-PCR-expression analyses for premeiotic 
Stra8 and postmeiotic Gpx4 and Acr. Mean values with standard deviations are shown. Data consists of at least 
two biological replicates. Significant increase of marker gene expression in co-culture samples during 
differentiation was calculated in comparison to HTF-3-Co before start of induction and is indicated with *: p ≤ 0.05, 
**: p ≤ 0.01; ***: p ≤ 0.001. (B) The methylation status of the paternally imprinted H19 ICR and Meg3 IG-DMR and 
the maternally imprinted Igf2r DMR2 and Snrpn DMR1 were analyzed by bisulfite pyrosequencing. Mean values 
with standard deviations are shown. Data collection and analysis were performed by the Zechner group (Mainz). 
SSC 12: starting cell line of co-culture. HTF-3: pure HTF cell line; start: HTF-3-Co before start of induction. d: day 
of induction; +: incubated with certain reagent; RA: Retinoic Acid; TA: Talarozole (CYP26-inhibitor).  
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3.3.6 Role of HTF cells in generation of co-culture-derived putative 
mSSCs 
During co-culture ESCs are seeded on mitotically active HTF cells, which are supposed to 
have an impact on the generation of putative mSSCs within this co-culture system. HTF cells 
might secrete important factors, which support the generation of putative mSSC. It is also 
possible that the cell-cell contact between HTF cells and ESCs promote the process of 
mSSC differentiation in co-culture. In order to determine a possible impact of secreted 
factors or the cell-cell contact on mSSC generation, some parameters in co-culture 
experiments were changed, the morphology changes of ESCs were monitored and 
compared with the progress in common co-culture system (Fig. 45). Usually the co-culture 
was performed with SSC 12 seeded on HTF cells, which was cultured in FB medium on 
gelatine coated vessels until ~80% confluence. Cells were cultured further in FB medium and 
SSC 12 revealed morphology changes, which resembled to putative mSSCs after nearly 20 
days of co-culture (Fig. 45 A). Fig. 45 B and C illustrates the experimental design in order to 
examine the role of HTF cells in generation of co-culture-derived putative mSSCs. On the 
one hand SSC 12 was seeded on mitomycin treated MEF (Fig. 45 B) or directly on gelatine 
coated vessels (Fig. 45 C) in order to test if SSC 12 preferred HTF cells, needed any cell line 
or even no cells to attach and differentiate into putative mSSCs. On the other hand the use of 
conditioned (cond) FB medium derived from the culture of pure HTF cell lines should shed 
light on a possible impact of HTF cells’ secreted factors on mSSC generation. For this 
purpose pure HTF was cultured in FB medium, which was filtered once before its further use 
for co-culture (cond FB; Fig. 45 II). Additionally SSC 12 was seeded on vessels and cultured 
in normal ESC culture medium without LIF, which is the usually used medium in 
differentiating experiments, in order to offer comfortable conditions for SSC 12 to attach. 
After one day of culture the medium was changed to FB (Fig. 45 III) or cond FB medium (Fig. 




Fig. 45: Experimental design to determine the role of HTF cells in generation of co-culture-derived 
putative mSSCs. (A) Standard procedure of co-culture of ESCs with HTF cells in FB medium. (B) Co-culture 
experiments performed on mitomycin C treated MEF. (C) Co-culture experiments performed on gelatine coated 
vessels. Co-culture experiments on MEF and gelatine, respectively, were performed using (I) FB medium, (II) 
cond FB medium, (III) one day SSC-LIF medium followed by further culture in FB medium or (IV) cond FB 
medium. FB: Fibroblast medium; cond FB: conditioned FB medium; SSC-LIF: ESC culture medium without LIF; 
MEF: mytomycin treated MEF; d: day.  
 
These different co-culture experiments were performed with HTF-1-Co. The procedure was 
exactly as already described (3.3.2). The morphology changes of SSC 12 were documented 
by taking brightfield images for all tested co-culture conditions one day after seeding of 
SSC 12 as well as every second day of co-culture (Fig. 46). Overall none of the tested 
conditions led to the generation of putative mSSCs derived from initially performed co-culture 
experiments using SSC 12 and HTF cells. Latest at day 14 cells cultured in different 
co-culture conditions were detached from the culture vessel (Fig. 46 IB and IIB). Rarely cell 
attachment of SSC 12 was observed using gelatine coating vessels with all tested medium 
conditions (Fig. 46 II A), while SSC 12 did attach very well to mitomycin C treated MEF 
independent from the used culture medium and enabled culture of SSC 12 till day 12 (Fig. 
46 I B). However, none of these co-cultures using MEF for cell attachment led to a similar 
morphology change and putative mSSC development as observed in the initially performed 
co-culture (Fig. 46 I B, A6). Nevertheless, SSC 12 cultured in cond FB medium revealed a 
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healthier appearance than in FB medium. Altogether, these experiments demonstrated that 
cell attachment was facilitated by offering mitomycin C treated MEF for SSC 12, but it did not 
result in the generation of putative mSSCs. Based on these results HTF cells seem to be 
needed for cell attachment of ESCs as well as for providing important factors for 















Fig. 46: Morphology changes of HTF-1-Co during day 1 and day 22 cultured under different conditions to 
determine the role of HTF cells in generation of co-culture-derived putative mSSCs. HTF-1-Co was cultured 
on (I) MEF and (II) gelatine coated culture vessels. A and B shows morphology changes during day 1- day 10 
and day 12- day 22, respectively. HTF-1-Co was performed as a positive control (A1-A6) revealing the SSC-like 
cells at day 22 (A6, arrows). Furthermore HTF-1-Co was cultured in FB (B1-B6), in cond FB (C1-C6), in SSC 
without LIF with medium change on FB (D1-D6) and in SSC without LIF with medium change on cond FB 
(E1-E6). d: day of co-culture; FB: Fibroblast medium; cond FB: conditioned FB medium; SSC-LIF: ESC culture 

































3.4 In vitro spermatogenesis experiments 
3.4.1 Strategy for Stra8 overexpression during in vitro 
spermatogenesis experiments 
In general the generation of male germ cells derived from stem cells was performed 
according to the strategy, which was established in this institute (Nayernia et al., 2006; Nolte 
et al., 2010). In brief, the strategy bases on the transfection of stem cells with two promoter 
constructs, Stra8-EGFP and Prm1-DsRed, which enable the enrichment of SSC-like cells 
and the identification of haploid germ cells. The promoter construct Stra8-EGFP provides 
EGFP under the promoter control of the premeiotic gene Stra8. EGFP positive cells are 
enriched by two FACSortings and resemble a spermatogonial cell population. Cultivation of 
these cells under differentiating culture conditions yielded in formation of some haploid cells. 
These cells can be detected by DsRed expression, which is driven by the promoter of the 
postmeiotic gene Prm1 (Nayernia et al., 2006; Nolte et al., 2010). Here a potential impact of 
Stra8 on the efficiency and the quality on differentiation of male germ cells should be 
examined by the overexpression of this premeiotic gene during in vitro spermatogenesis. 
These experiments were planned to be carried out with two different cell lines, whose 
generation is specified in Fig. 47. The ESC line SSC 12 already contained the promoter 
constructs Stra8-EGFP and Prm1-DsRed (Nayernia et al., 2006) and could be directly used 
for Stra8 overexpression studies (Fig. 47 A). Moreover ESC lines derived from a double 
transgenic mouse containing premeiotic Stra8-EGFP and meiotic Sycp3-DsRed constructs 
(Smorag et al., 2012) were generated to be used for these experiments (Fig. 47 B). Their use 
provides the advantage that all cells, which might undergo meiosis, can be detected by their 
red fluorescence due to the activation of the Sycp3 promoter. An influence of Stra8 on the in 
vitro spermatogenesis was planned to be examined by its permanent overexpression (Fig. 




Fig. 47: Scheme of the experimental procedure for the generation of male germ cells derived from 
different ESCs. (A) Wild type ESCs were transfected with the promoter construct Stra8-EGFP and two times 
FACSorted for the enrichment of EGFP positive cells, which were further transfected with Prm1-DsRed. This 
stable transfected clonal cell line SSC 12 was already available (Nayernia et al., 2006). (B) ESCs containing 
Stra8-EGFP and Sycp3-DsRed were generated from double transgenic mice and EGFP positive cells were 
collected within two FACSortings.  ESCs described in A and B should be used for Stra8 overexpression studies 
during in vitro spermatogenesis. RA: Retinoic Acid; FACS: Fluorescence Activated Cell Sorting; dTg: double 




Fig. 48: Scheme of experimental procedure for Stra8 overexpression during the generation of male germ 
cells. (A)Two times FACSorted ESCs (Fig. 47) resemble a spermatogonial cell population (SSCs). (B) SSC-like 
cells were transfected with hEF1α-mStra8 construct for stable Stra8 overexpression. (C) Transfected cells should 
be used for Stra8 overexpression studies during in vitro spermatogenesis. SSCs: Spermatogonial Stem Cells; RA: 
Retinoic Acid; ICSI: Intracytoplasmic Sperm Injection. Modified, Nolte et al., 2010. 
 
3.4.2 ES cell lines used for in vitro spermatogenesis experiments 
3.4.2.1 ES cell line SSC 12 (Nayernia et al., 2006) 
The ESC line SSC 12, generated by Nayernia et al. (2006), was used for in vitro 
spermatogenesis experiments. SSC 12 is an ES-RI cell line, established from a murine 
129SV-background (Nagy et al., 1993) and transfected with the premeiotic promoter 
construct Stra8-EGFP and postmeiotic promoter construct Prm1-DsRed (Fig. 49 A). Before 
its use the presence of Stra8-EGFP and Prm1-DsRed in SSC 12 was validated by 
genotyping PCR using primers located in the promoter region of the Stra8 or Prm1 and in the 























Fig. 49: Examination of SSC 12 containing the promoter constructs Stra8-EGFP and Prm1-DsRed. 
(A) Schematic representation of the promoter constructs Stra8-EGFP and Prm1-DsRed. Primers used for 
genotyping PCR are indicated with arrows. kb: kilo base of promoter region. for/rev: forward/reverse primers used 
for genotyping PCR. Modified, Nolte et al., 2010. (B) Genotyping PCR of SSC 12 proved the presence of 
Stra8-EGFP and Prm1-DsRed. Fragment sizes are indicated within the figures. PC: positive control; NC: negative 
control with H2O; bp: base pairs.  
 
3.4.2.2 ES cell lines derived from Stra8-EGFP/Sycp3-DsRed mice 
ES cell lines derived from double transgenic (dTg) Stra8-EGFP and Sycp3-DsRed mouse 
line (Smorag et al., 2012) were generated to be used in in vitro spermatogenesis 
experiments. These transgenic mice provide the premeiotic Stra8-EGFP and meiotic 








Fig. 50: Schematic representation of promoter constructs of double transgenic Stra8-EGFP and 






3.4.2.2.1 Generation of Stra8-EGFP/Sycp3-DsRed ES cell lines 
The dTg Stra8-EGFP and Sycp3-DsRed mouse line (Smorag et al., 2012) was used for the 
generation of Stra8-EGFP/Sycp3-DsRed ES cell lines. In brief, blastocysts were isolated 
from gestating mice at stage 3.5 days post coitum (dpc) and cultured on MEF feeder layer in 
KSOM medium at 37°C and 5% CO2. After outgrowth of the inner cell mass of the 
blastocysts, it was disaggregated and seeded on fresh MEF feeder layer. During further 
culture in ESC medium cells grew in colonies and revealed a mouse ES cell like morphology 
(2.2.4.10).  
 
3.4.2.2.2 Characterization of Stra8-EGFP/Sycp3-DsRed-2 ES cells 
While several ES cell lines could be generated from dTg mice, Stra8-EGFP/Sycp3-DsRed-2 
cells were chosen for further characterization and experimental procedure (Fig. 51 A). Its 
pluripotent character was proven by the detection of OCT4 protein expression using western 
blot analysis. ES-RI was used as a positive control, whereas the negative control CRL-2691, 
a male human fibroblast cell line, did not reveal any expression of the pluripotency marker 
(Fig. 51 B). Furthermore, a male genotype of Stra8-EGFP/Sycp3-DsRed-2 was required for 
its intended use in in vitro spermatogenesis experiments. Aiming to check for its male 
genotype, Stra8-EGFP/Sycp3-DsRed-2 cells were examined for the presence of the 
androgen receptor (AR) and sex determining region of chromosome Y (SRY). Genomic DNA 
of a male wild type mouse was used as a positive control and revealed detection of both 
genes analyzed, whereas Sry could not be detected in female wild type mouse used as a 
negative control. Compared to the controls Stra8-EGFP/Sycp3-DsRed-2 demonstrated a 
male genotype (Fig. 51 C).   
Finally, genotyping PCR confirmed that Stra8-EGFP/Sycp3-DsRed-2 cells indeed derived 
from dTg animals and contained the transgenes Stra8-EGFP and Sycp3-DsRed (Fig. 51 D). 
Analysis was performed according to Smorag et al. (2012) and genomic DNA of a wild type 




Fig. 51: Characterization of the generated ES cell line Stra8-EGFP/Sycp3-DsRed-2. (A) Representative 
brightfield image of the generated ES cell line Stra8-EGFP/Sycp3-DsRed-2. Scale bar: 200 µm. (B) Western blot 
analysis revealed the expression of the pluripotency factor OCT4 in Stra8-EGFP/Sycp3-DsRed-2 cells. Wild type 
ES cell line ES-RI was used as positive control, human fibroblast cell line CRL-2691 as negative control. 
Detection of α-tubulin served as loading control. Molecular weights of proteins are indicated. kDa: kilo Dalton. 
(C) Stra8-EGFP/Sycp3-DsRed-2 cells possessed a male genotype by expressing Ar and Sry. Genomic DNA of 
male and female mice served as controls. Ar: Androgen receptor; Sry: sex determining region of chromosome Y; 
NC: negative control with H2O. (D) Genotyping PCR proved the derivation of Stra8-EGFP/Sycp3-DsRed-2 cells 
from homozygous double transgenic mice. 2Trg: genomic DNA of double transgenic mice; WT: wild type genomic 
DNA; NC: negative control with H2O; trg: transgene. Stra8 trg: genotyping PCR for Stra8 transgene; SYCP trg: 
genotyping PCR for Sycp3 transgene. PCR fragment sizes are indicated within the figures C and D.  
 
3.4.2.2.3 Enrichment of EGFP positive cells by FACSorting 
According to the strategy for the derivation of male germ cells from stem cells, an enrichment 
of EGFP positive (EGFP+) cells resembles a spermatogonial population (Nayernia et al., 
2006; Nolte et al., 2010), which requires a retinoic acid (RA) inducible EGFP expression in 
the used cell line. For validation of RA inducible EGFP expression, 
Stra8-EGFP/Sycp3-DsRed-2 cells were cultured in the presence of RA (10-6 M) for three 
days and checked for EGFP expression by fluorescence microscopy (Fig. 52 I). In 
comparison to non-RA-induced cells, application of RA activated the Stra8 promoter and 
induced the EGFP expression visible in the strong EGFP fluorescence of 
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Stra8-EGFP/Sycp3-DsRed-2 cells. For enrichment of EGFP+ cells 
Stra8-EGFP/Sycp3-DsRed-2 cells were induced with RA for three days and EGFP+ cells 
were collected by FACSorting (Fig. 52 II). The fraction of EGFP+ cells could be raised by 
~32% resulting in a population of ~82% EGFP+ cells (Fig. 52 IIA). These cells were cultured 
on MEF feeder layer in ESC medium containing RA in order to further increase the EGFP+ 
cell population, which should be obtained by a second FACSorting. Here the initial EGFP+ 
cell population revealed ~56% EGFP+ cells, which could be enriched in a fraction consisting 
of ~87% EGFP+ cells by repeated FACSorting (Fig. 52 IIB). These cells were further cultured 
on MEF feeder layer in ESC medium containing RA. ES cells derived from a murine 
C57BL/W background were used as control in FACSorting analyses and 
Stra8-EGFP/Sycp3-DsRed-2 cells before and after FACSortings were cyropreserved in a 




Fig. 52: RA inducible EGFP expression used for FACSortings of Stra8-EGFP/Sycp3-DsRed-2 ES cells. 
(I) Stra8-EGFP/Sycp3-DsRed-2 colonies revealed strong EGFP expression after three days of RA induction. 
-: without RA induction; +: with 10
-6
 M RA induction for three days; RA: Retinoic Acid. Representative scale bars 
are indicated within overlay images. Scale bars: 20 µm. (II) EGFP positive cells were enriched by two 
FACSortings (A + B) of RA induced Stra8-EGFP/Sycp3-DsRed-2 cells. Percentages of EGFP positive cells 
before and after FACSortings are highlighted in red and green, respectively. 
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3.4.3 Generation of Stra8 overexpressing cell lines 
It was shown that male gametes derived in vitro from ES cells were able to activate 
unfertilized oocytes and gave rise to offspring (Nayernia et al., 2006; Nolte et al., 2010). 
Nevertheless, these offspring died prematurely and revealed incorrect reprogramming of 
imprinted genes, which is necessary for normal development. It is suggested that germ cell 
related genes influence meiosis as well as imprinting during spermatogenesis (Yu et al., 
2009; Medrano et al., 2012). The premeiotic gene Stra8 is known to be essential for 
induction of meiosis (Baltus et al., 2006; Anderson et al., 2008) and is suggested to interact 
with chromatin remodelling proteins, which are regulators of imprinting control regions 
(Pantakani, unpublished data). In the presented thesis it should be tested, if a Stra8 
overexpression during in vitro spermatogenesis can enhance the progression of meiosis and 
support correct imprinting.  
 
3.4.3.1 Stable Stra8 overexpression 
3.4.3.1.1 Generation of phEF1α-puro-mStra8  
For stable overexpression of Stra8 cells had to be transfected with a plasmid providing the 
mouse Stra8 (mStra8) ORF (Open Reading Frame) for expression. Due to the already 
included promoter constructs Stra8-EGFP and Prm1-DsRed, which each have a neomycin 
resistance cassette, SSC 12 already possessed a strong resistance towards neomycin. 
Therefore, the expression plasmid phEF1α-puro-mStra8, which contains mStra8 under the 
control of the hEF1α promoter and a puromycin resistance cassette for selection, was 
generated (Fig. 53 A). The plasmid Integrin β1-tev-BHCys (addgene) with the vector 
backbone pEF-puro (phEF1α-puro, ~7400 bp) provided the hEF1α promoter for target gene 
expression as well as the selectable marker puromycin. Correct nucleotide sequences of 
hEF1α promoter and Puromycin gene were validated by sequencing analysis. phEF1α-puro 
was prepared by cutting out the insert integrin (2500 bp) using BamHI/NotI, followed by gel 
extraction and purification of the vector (Fig. 53 B). The ORF of mStra8 (1182 bp) was cut 
out of phEF1α-mStra8 using BamHI/NotI (Fig. 53 C), followed by ligation with phEF1α-puro 
and transformation in DH5α cells. Identification of positive clones was performed by test 
digestions using BamHI/NotI (Fig. 53 D). After linearization with BstI and sterile purification 




Fig. 53: Generation of phEF1α-puro-mStra8 construct. (A) Plasmid map of generated phEF1α-puro-mStra8 
construct, which provides mStra8 driven by the hEF1α promoter as well as a puromycin (Puro) and ampicillin 
(Amp) resistance cassette for cloning and bacteria selection, respectively. mStra8 ORF was cloned into 
BamHI/NotI restriction sites. (B) Extraction of phEF1α-puro. (C) Extraction of mStra8 ORF (1182 bp) from 
phEF1α-mStra8. (D) Validation of correct phEF1α-puro-mStra8 by test digestion using BamHI/NotI. 
(E) Linearization of phEF1α-puro-mStra8 using BstI for stable cell transfection by electroporation. Fragment sizes 
are indicated within the figures. ORF: Open Reading Frame; bp: base pairs.  
 
3.4.3.1.2 Generation of stable Stra8 overexpressing SSC 12 cell lines 
A puromycin tolerance test using SSC 12 was performed to determine the puromycin 
concentrations, which should be used for the selection of successful transfected cells after 
electroporation and further culturing. The test demonstrated that puromycin selection of 
transfected SSC 12 could be performed using 1.25 µg/ml puromycin (selection medium), 
while later established cell lines should be cultured in medium containing 0.75 µg/ml 
puromycin (culture medium) in order to ensure plasmid uptake. After electroporation of 
SSC 12 with phEF1α-puro-mStra8 positive selection of transfected cells was performed with 
ESC culture medium containing puromycin (1.25 µg/ml) for two days. Because of increased 
apoptosis, selection medium was replaced with ESC culture medium without puromycin for 
cell recovery for four days. Growing clones were further cultured in ESC culture medium 
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containing culture concentration of puromycin and processed according standard procedure 
including picking and propagation of single clones (2.2.4.5) and their DNA as well as RNA 
isolation for genotyping and qRT-PCR analyses. 
Genotyping PCR to check for phEF1α-puro-mStra8 by using primers located in the hEF1α 
promoter and mStra8 ORF revealed several clones, which might be successful transfected 
with phEF1α-puro-mStra8 (Fig. 54 I). The clones #11 and #13, which were selected for Stra8 
expression analysis by qRT-PCR, revealed stable Stra8 overexpression and were termed as 
SSC 12/11 and SSC 12/13, respectively. Both cell lines showed an about six to seven fold 
increased Stra8 expression in comparison to ES-RI, which represented the original wild type 
ES cell line used for generation of SSC 12 (Fig. 54 IIA). SSC 12 itself revealed already a 
three times increased Stra8 expression compared to ES-RI (Fig. 54 IIA). Additionally, Stra8 
was about two times higher expressed in SSC 12/11 and SSC 12/13 (Fig. 54 IIB), thus the 
Stra8 overexpressing cell lines SSC 12/11 and SSC 12/13 were further used for in vitro 
spermatogenesis experiments.  
 
Fig. 54: Determination of Stra8 expression in phEF1α-puro-mStra8 transfected SSC 12 cells. (I) Genotyping 
PCR for the construct phEF1α-puro-mStra8 revealed several potential clones after transfection of SSC 12 with 
phEF1α-puro-mStra8. # 11 and # 13, highlighted in red, were selected for Stra8 expression analysis by qRT-PCR. 
Fragment size is indicated within the figure. bp: base pairs; #: clone number; PC: positive control with 
phEF1α-puro-mStra8 DNA; NC: negative control with H2O. (II) SSC 12/11 and SSC 12/13 showed an (A) about 
six to seven times increased Stra8 expression compared to wild type ES cell line ES-RI and (B) about two times 




3.4.4 Stra8 overexpression during in vitro spermatogenesis 
3.4.4.1 Morphological changes of Stra8 overexpressing cells during 
induction of differentiation 
The analysis of an effect of permanent Stra8 overexpression during differentiation of male 
germ cells was performed with the Stra8 overexpressing cell lines SSC 12/11 and SSC 12/13 
in comparison to the originally cell line SSC 12. SSC 12/11 and SSC 12/13 revealed a two 
times increased Stra8 expression compared to SSC 12 (‎3.4.3.1.2). 
To maintain their undifferentiated pluripotent state, ESCs are cultured on MEF feeder layer in 
the presence of the cytokine LIF, whose activation of the JAK/STAT signalling pathway 
regulates the transcriptional expression of pluripotency- and tissue-specific genes 
(Arabadjiev et al., 2012). For induction of in vitro differentiation, cells were seeded on 
gelatine coated vessels und cultured in ESC medium without LIF. Additionally, the 
differentiation medium was supplemented with RA as a widely used reagent for ESC 
differentiation as well as for induction of Stra8 expression. During differentiation morphology 
changes of the cells were documented by taking brightfield images before induction as well 
as every third day after induction (Fig. 55).  
During the first six days of induction SSC 12 and Stra8 overexpressing cell lines SSC 12/11 
and SSC 12/13 did not reveal differences in morphological changes. Cells lost cell their 
ESC-like structure and showed differentiating features characterized by fringed borders at 
day 3 (Fig. 55 D-F) and formation of embryoid body (EB)- like structures at day 6 (Fig. 
55 G-I). After nine days of induction Stra8 overexpressing cell lines SSC 12/11 and 
SSC 12/13 revealed a clearly less number of attached cells including EB-like structures. The 
remaining EB-like structures exhibited a decreased size (Fig. 55 J-L). While at day 12 Stra8 
overexpressing cells SSC 12/11 and SSC 12/13 were rarely attached, SSC 12 revealed cell 
detachment to a minor extend and the remaining EB-like structures increased in their size 
(Fig. 55 M-O). While SSC 12/11 and SSC 12/13 could not be cultured further, SSC 12 could 
be induced until day 15. At this time point some cells including smaller EB-like structures 
were still attached (Fig. 55 P). 
Cells as well as the supernatant, which could contain meiotic cells released into the medium, 
were harvested at the indicated time points. RNA and gDNA was isolated for further analyses 
by RT- and qRT-PCR analyses for the expression of spermatogenesis markers and bisulfite 




Fig. 55: Microscopic documentation of morphological changes of SSC 12 and Stra8 overexpressing cell 
lines SSC 12/11 and SSC 12/13 during in vitro differentiation. SSC 12 and Stra8 overexpressing cell lines 
SSC 12/11 and SSC 12/13 were cultured in differentiation medium for 12 to 15 days. Their morphology was 
Results  
150 
documented with brightfield images each third day. (A-C) Cells before start of in vitro differentiation at day 0. 
(D-F) Cells revealed fringed borders at day 3. (G-I) Cells formed EB-like structures at day 6. (J-L) Stra8 
overexpressing cell lines SSC 12/11 and SSC 12/13 showed a decreased number and smaller EB-like structures 
than SSC 12 at day 9. (M-O) SSC 12/11 and SSC 12/13 showed an increased cell detachment, while EB-like 
structures in SSC 12 further increased in size at day 12. (P) SSC 12 revealed still adhered cells and small EB-like 
structure at day 15. Arrows within images indicate exemplarily EB-like structures. Stra8 OE cell lines: Stra8 
overexpressing cell lines; d: day. EB: Embryoid Body. Scale bars: 200 µm.  
 
3.4.4.2 Analyses of spermatogenesis marker expression during in vitro  
differentiation 
3.4.4.2.1 Immunocytochemical analysis of SSC 12 and Stra8 overexpressing 
cell lines SSC 12/11 and SSC 12/13 
At the indicated days of in vitro differentiation SSC 12 and Stra8 overexpressing cell lines 
SSC 12/11 and SSC 12/13 were checked for the expression of DsRed by microscopy, which 
would indicate an activation of the postmeiotic Prm1 promoter and thus a postmeiotic germ 
cell development. No DsRed-positive cells could be detected at any of the time points 
suggesting that the Prm1 promoter was not activated and cells obviously did not develop into 
haploid male germ cells. Because Prm1 is expressed at the final stage of germ cell 
development, cells undergoing the differentiation process were additionally analyzed by 
immunostaining using DAZL (Deleted In Azoospermia-Like) specific antibody. The RNA 
binding protein DAZL plays an important role during germ cell differentiation and is localized 
in the nucleus of spermatogonia, but translocates into the cytoplasm at the onset of meiosis 
(Reijo et al., 2000). SSC 12 was already DAZL positive at day 3 showing a weak nuclear and 
partly intensive cytoplasmic expression in single cells. During the differentiation process the 
DAZL signal increased clearly, but was mostly restricted to the cytoplasm of cells within the 
EB-like structures until day 12 (Fig. 56). In contrast, DAZL expression was just visible in the 
Stra8 overexpressing cell line SSC 12/11, while SSC 12/13 did not reveal any DAZL 
expression. In SSC 12/11 cells DAZL expression was mostly restricted to the cytoplasm of 
cells within EB-like structures at day 6 (Fig. 57). At this time point of differentiation Stra8 




Fig. 56: DAZL immunostaining of SSC 12 during in vitro differentiation. DAZL immunostaining of SSC 12 at 
day (d) 3, d6, d9 and d12 of in vitro differentiation. During the differentiation process DAZL expression was 
detected weakly in the nuclei and predominantly in the cytoplasm of SSC 12. Immunonegative cells served as an 




Fig. 57: DAZL immunostaining of SSC 12/11 at day 6 of in vitro differentiation. In the Stra8 overexpressing 
cell line SSC 12/11 DAZL expression was just detectable at day 6 of in vitro differentiation revealing mostly a 
cytoplasmic staining. Immunonegative cells served as an internal negative control. Representative scale bar is 
shown in the overlay image. d: day. Scale bar: 10 µm.  
 
Because cytoplasmic DAZL expression indicated that cells entered meiosis, cells should be 
also checked for the formation of the meiosis specific synaptonemal complex using an 
specific antibody against the synaptonemal complex protein 3 (SYCP3). Appearance of 
these structures would be an additional indication of meiotic differentiation. In spite of several 
attempts these analyses did not reveal any results due to unsufficient SYCP3 antibody 
staining. Therefore, the DAZL immunostaining results suggested that SSC 12 and the Stra8 
overexpressing cell line Stra8 12/11 entered meiosis indicated by cytoplasmic DAZL 
expression, but a further progress of meiosis could not be proven by immunostaining 
analyses. 
 
3.4.4.2.2 Expression analysis of postmeiotic genes by qRT-PCR in SSC 12 and 
Stra8 overexpressing cell lines SSC 12/11 and SSC 12/13 
qRT-PCR experiments were performed to analyze the expression of the haploid markers Acr, 
Gpx4 (Glutathione Peroxidase 4) and Prm1 in cells with and without Stra8 overexpression 
during in vitro differentiation. These analyses revealed no expression of Acr and Prm1 at any 
time points of differentiation. In contrast, an upregulation of Gpx4 expression was detected, 
which is known to be expressed in the mitochondria of sperm and indicates a possible tail 
formation within the cells (Nayernia et al., 2004; Nolte et al., 2010). Fig. 58 shows the 
qRT-PCR results for Gpx4 expression in SSC 12 as well as in Stra8 overexpressing cell lines 
SSC 12/11 and SSC 12/13 before and at day 3, day 6 and day 9 of differentiation induction. 
Additionally, cells collected from the supernatant from all cell lines at day 6 and day 9 were 
included in the expression analysis. Because of the increased cell detachment of SSC 12/11 
and SSC 12/13 (Fig. 55 N+O), just the initial cell line SSC 12 could be analyzed at day 12. 
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The calculated significances normalized to each cell line at day 0 are indicated within the 
figures (Fig. 58) as well as the Gpx4 expression in mouse testis and the wild type ES cell line 
ES-RI, which served as a positive and negative control, respectively.  
 
Fig. 58: qRT-PCR expression analysis of the spermatogenesis marker gene Gpx4 during in vitro 
differentiation of SSC 12 and Stra8 overexpressing cell lines SSC 12/11 and SSC 12/13. Mean values with 
standard deviations for Gpx4 expression in adherent and supernatant-derived cells of (A) SSC 12 and Stra8 
overexpressing cell lines (B) SSC 12/11 and (C) SSC 12/13 are shown. Data comprised two biological replicates. 
Significant increase of marker gene expression was calculated in comparison to day 0 of the analyzed cell line 
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and indicated with *: p ≤ 0.05, **: p ≤ 0.01; ***: p ≤ 0.001. ES-RI: wild type ES cell lines served as negative 
control; mTestis: positive control. d: day.  
 
While SSC 12 revealed an increase of Gpx4 expression, which scored with a high 
significance at day 12 (Fig. 58 A), the Stra8 overexpressing cell lines SSC 12/11 (Fig. 58 B) 
and SSC 12/13 (Fig. 58 C) showed a significantly increased Gpx4 expression already at 
day 6 in adherent and supernatant-derived cells. This expression level sustained until day 9 
in supernatant-derived cells of SSC 12/11 and in both analyzed cell types of SSC 12/13. 
Therefore, these qRT-PCR data suggested an earlier onset of Gpx4 expression in Stra8 
overexpressing cells during in vitro differentiation. Additionally, the increased expression of 
cells derived from the supernatant indicated that detached cells entered meiosis.  
 
3.4.4.2.3 In vitro differentiation of SSC 12 and Stra8 overexpressing cell lines 
SSC 12/11 and SSC 12/13 without RA induction 
Based on the qRT-PCR results it was assumed that the process of in vitro differentiation was 
forced in Stra8 overexpressing cell lines by the early induction with RA from day 0. Fig. 59 
shows the expression profile of different spermatogenesis marker genes in SSC 12 and the 
Stra8 overexpressing cell line SSC 12/13 at different passages of in vitro differentiation 
without RA application. Here, different cell passages were analyzed, because the cell lines 
exhibited disparate proliferation rates and had to be passaged at different time points. 
RT-PCR experiments with cDNA derived from mouse testis and the wild type ES cell line 
ES-RI served as controls. Hprt-PCR was performed as a loading control of cDNA. Weak Acr 
positive bands could be detected in passage No. 8 and 11 in adherent SSC 12 cells (Fig. 59; 
yellow stars), while Acr was already detectable in passage No. 1 of SSC 12/13 adherent cells 
(Fig. 59; orange stars) and in supernatant derived cells of passage No. 3 (Fig. 59; red star). 
These results also indicated a forced in vitro differentiation in the Stra8 overexpressing cell 
line SSC 12/13. Further qRT-PCR analyses could give some detailed information about the 




Fig. 59: RT-PCR expression analyses of spermatogenesis marker genes during in vitro differentiation 
without RA induction. RT-PCR results show the expression of premeiotic marker gene DAZL, meiotic marker 
gene Ovol1 and the early postmeiotic gene Acr in SSC 12 and Stra8 overexpressing cell line SSC 12/13 during in 
vitro differentitation without RA induction. Yellow, orange and red stars mark weak detectable PCR fragments in 
SSC 12 and SSC 12/13, respectively. White stars indicate samples without cDNA according to the HPRT-PCR 
result. Fragment sizes of PCR products are indicated within the figure. P: passage number; SN: 
supernatant-derived cells; Stra8 OE cell line: Stra8 overexpressing cell line; NC: negative control with H2O; 
HPRT: PCR for cDNA loading control; bp: base pairs. 
 
3.4.4.3 Methylation profile during in vitro differentiation 
The methylation profile of imprinted genes in cells undergoing in vitro differentiation was 
analyzed by bisulfite pyrosequencing. These analyses were performed in collaboration with 
Prof. Zechner (Institute of Human Genetics, University of Mainz). Genomic DNA was isolated 
at different time points of in vitro differentiation. Further bisulfite pyrosequencing of samples 
as well as data evaluation were performed by Prof. Zechner’s group. Fig. 60 presents the 
methylation status of differentially methylated regions (DMRs) of the paternally imprinted H19 
and Meg3 genes as well as the maternally imprinted Igf2r and Snrpn genes in SSC 12 and 


















































Fig. 60: Methylation analysis of imprinted genes during in vitro differentiation of SSC 12 and Stra8 
overexpressing cell lines SSC 12/11 and SSC 12/13 with RA induction. The methylation status of the 
paternally imprinted H19 ICR and Meg3 IG-DMR and the maternally imprinted Igf2r DMR2 and Snrpn DMR1 were 
analyzed by bisulfite pyrosequencing for (A) mouse sperm as positive control, (B) SSC 12 and the Stra8 
overexpressing cell lines (C) SSC 12/11 and (D) SSC 12/13 during in vitro differentiation with RA induction. Mean 
values with standard deviations are shown. Data comprised two biological replicates and were collected and 
analyzed by Prof. Zechner’s group (Mainz). d: day of differentiation; ICR: Imprinting Control Region; DMRs: 
differentially methylated regions.  
 
The methylation profile of mouse sperm as a positive control was kindly provided by Prof. 
Zechner’s group and depicted the expected hypermethylation of the paternally imprinted H19 
and Meg3 genes (70-90%) and a hypomethylation of the maternally imprinted Igf2r and 
Snrpn genes (~10%) (Fig. 60 A).  
Neither SSC 12 nor the Stra8 overexpressing cell lines SSC 12/11 and SSC 12/13 displayed 
a methylation pattern comparable with mouse sperm. During the differentiation process 
SSC 12 displayed a slight decrease of H19 methylation from 60% to 50% and Meg3 a slight 
increase from 35% to 40%. In contrast, both maternally imprinted genes showed a loss of 
methylation (Igf2r: from 60% to 35%; Snrpn: from 30% to 15%), but only Snrpn nearly 
reached the strongly hypomethylated status present in sperm (Fig. 60 B). The Stra8 
overexpressing cell lines SSC 12/11 (Fig. 60 C) and SSC 12/13 (Fig. 60 D) displayed a very 
similar methylation pattern with an overall increased methylation status of imprinted genes 
compared to SSC 12. H19 showed a loss of methylation from 90% to 70% during 
differentiation and Meg3 an increase of methylation from 50% to 70%. The methylation 
status of maternally imprinted Igf2r (80%) and Snrpn (35%) genes remained almost 






Fig. 61: Methylation analysis of imprinted genes in Stra8 overexpressing cell lines SSC 12/11 and 
SSC 12/13 during in vitro differentiation without RA induction. The methylation status of the paternally 
imprinted H19 ICR and Meg3 IG-DMR and the maternally imprinted Igf2r DMR2 and Snrpn DMR1 were analyzed 
by bisulfite pyrosequencing for the Stra8 overexpressing cell lines (I) SSC 12/11 and (II) SSC 12/13 during in vitro 
differentiation without RA induction. For each cell line (A) adherent (two biological replicates) and (B) 
supernatant-derived cells (one biological replicate) were analyzed. Mean values with standard deviations are 
shown. Data were collected and analyzed by Prof. Zechner’s group (Mainz). start: before start of differentiation; P: 
passage number during differentiation.  
 
Furthermore, the methylation profiles of SSC 12 and Stra8 overexpressing cell lines 
SSC 12/11 and SSC 12/13 without RA application during in vitro differentiation were studied. 
Here, the analyzed time points during differentiation are indicated in passage numbers, 
because the cell lines exhibited different proliferation rates and had to be passaged at 
different days. In addition to adherent cells, also supernatant-derived cells were analyzed. 
Taken together, the imprinted genes in Stra8 overexpressing cell lines SSC 12/11 (Fig. 
61 IA) and SSC 12/13 (Fig. 61 IIA) did not exhibit large differences in their methylation status 
compared to an in vitro differentiation including RA induction. The methylation pattern of 
supernatant-derived cells reflected the methylation status of their corresponding adherent 
cells (Fig. 61 IB + IIB). 
Compared to the in vitro differentiation including RA induction, the adherent SSC 12 cells 
showed a remarkably increased methylation of the paternally methylated H19 ICR 
(70%-80%) as well as the maternally methylated Igf2r  DMR2 (60%) and Snrpn DMR1 
(40%), whereas the Meg3 IG-DMR displayed as similar methylation pattern (Fig. 62 A). As in 
Stra8 overexpressing cell lines supernatant-derived SSC 12 cells reflected the methylation 




Fig. 62: Methylation analysis of imprinted genes in SSC 12 cells during in vitro differentiation without RA 
induction. The methylation status of the paternally imprinted H19 ICR and Meg3 IG-DMR and the maternally 
imprinted Igf2r DMR2 and Snrpn DMR1 were analyzed by bisulfite pyrosequencing for (A) adherent (two 
biological replicates) and (B) supernatant-derived SSC 12 cells (one biological replicate). Mean values with 
standard deviations are shown. Data were collected and analyzed by Prof. Zechner’s group (Mainz). start: before 
start of differentiation; P: passage number during differentiation.  
 
3.4.4.4 Emergence of blastocyst-like structures during in vitro differentiation 
During induction of differentiation cells revealed peculiar morphological features, which 
resembled blastocyst-like structures (Fig. 63). These morphological changes were observed 
in Stra8 overexpressing cell lines SSC 12/11 and SSC 12/13 in a much greater extent than in 
SSC 12 cells. These cell structures appeared from day 7 of cell differentiation and reached 
their highest number at day 9 followed by detachment from the culture vessel. These cells 




Fig. 63: Emergence of blastocyst-like structures at day 9 of in vitro differentiation. Brightfield images 
showing blastocyst-like structures, indicated with arrows, in SSC 12 and Stra8 overexpressing cell lines SSC 
12/11 and SSC 12/13 at day 9 of in vitro differentiation. A vacuolated cytoplasm with a nucleus aside the cell 
membrane can be clearly identified in magnifications of single cells (J-L). Stra8 OE cell lines: Stra8 
overexpressing cell lines. Scale bars: A-C: 100 µm; D-G: 50 µm; H-I: 50 µm + 1.6 x; J-L: Magnifications of single 
cells in G-I.  
 
DAPI staining of these cells revealed no apoptotic features such as membrane blebbing or 
nuclear fragmentation (Fig. 64). Also small sealed membrane vesicles representing apoptotic 





Fig. 64: DAPI-Staining of SSC 12/11 cells at day 9 of in vitro differentiation. DAPI staining of SSC 12/11 cells 
revealed a vacuolated cytoplasm with a nucleus aside the cell membrane without any nuclear fragmentation 
indicating no apoptotic processes at day 9 of in vitro differentiation. Scale bar: 10 µm.  
 
An apoptosis assay as well as electron microscopy analysis was performed for further 
characterization of these cell types. 
 
3.4.4.4.1 Apoptosis assay on SSC 12 cells and Stra8 overexpressing cell lines 
SSC 12/11 and SSC 12/13 
An Annexin V and 7-AAD based apoptosis assay (2.2.4.13; Khromov et al., 2012) was 
performed in order to exclude definitively apoptotic processes of these cells during 
differentiation (Fig. 65). Fig. 65 A confirmed the existence of blastocyst-like structures before 
SSC 12 and Stra8 overexpressing cell lines SSC 12/11 and SSC 12/13 were harvested at 
day 8 of differentiation induction and incubated with Annexin V and 7-AAD. While the Ca2+ 
dependent protein Annexin V binds to membrane phospholipid phosphatidylserine, which is 
exposed at the outer leaflet of the plasma membrane at the latest stage of apoptosis, 
represents 7-AAD a vital dye, which is excluded from viable cells because of their intact 
membrane. Flow cytometric analysis allows the determination of viable, early and late 
apoptotic as well as dead cell fractions. The evaluation of the apoptosis assay, shown in Fig. 
65 B, revealed no fraction of Annexin V stained cells. Nevertheless, the detection of 7-AAD 
positive cells did not reveal an increased fraction of dead cells within Stra8 overexpressing 
cells compared to SSC 12 at the analyzed time point of differentiation. While the initial cell 
line SSC 12 as well as the Stra8 overexpressing cell line SSC 12/13 possessed a fraction of 
22% dead cells, SSC 12/11 showed even a decreased proportion of 12% dead cells (Fig. 
65 B, highlighted in red). Overall 76-86% of the analyzed cells were viable (Fig. 65 B, 
highlighted in green). Thus an increased apoptosis rate due to Stra8 overexpression during 
in vitro differentiation could be excluded and consequently the blastocyst-like structures 




Fig. 65: Validation of cell viability of SSC 12 cells and Stra8 overexpressing cell lines SSC 12/11 and 
SSC 12/13 at day 8 of in vitro differentiation by apoptosis assay. (I) Brightfield images show blastocyst-like 
structures, indicated with white arrows, derived from SSC 12 and Stra8 overexpressing cell lines SSC 12/11 and 
SSC 12/13 at day 8 of in vitro differentiation. Scale bars: 50 µm. (II) Results of flow cytometric measurements 
after Annexin V and 7-AAD staining show the percentage of viable (highlighted in green) and dead (highlighted in 
red) cells in the analyzed cell lines at day 8 and confirmed the viability of the majority of the cells. Stra8 OE cell 
lines: Stra8 overexpressing cell lines.  
 
3.4.4.4.2 Electron microscopy analysis on Stra8 overexpressing cell line 
SSC 12/13 
For further characterization, electron microscopy analysis was performed exemplarily with 
the Stra8 overexpressing cell line SSC 12/13 and should provide an indication of the cell type 
showing blastocyst-like structures.  
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After induction of differentiation SSC 12/13 cells were isolated from the supernatant at day 8 
as well as adherent cells harvested at day 9 and fixed for electron microscopy analysis 
(2.2.3.7). Further processing, electron microscopy as well as data interpretation was 
performed by Prof. Dr. Andreas Meinhardt, Department of Anatomy and Cell Biology at the 
University of Giessen. Prof. Meinhardt interpreted the data as followed: all in all the cells did 
not show any features for meiotic or postmeiotic differentiation, whereas their existence could 
not be completely excluded, if their occurrence is less than 5% (Fig. 66 A-C; E-G). Semi thin 
cell sections analyzed by light microscopy did not reveal any sperm tail structures or 
acrosomes (Fig. 66 D+H). Cells isolated from the supernatant were smaller than the adhered 
cells and contained numerous small bodies with one quarter of the cell size. These bodies 
were not homogenous, but revealed bright and darker areas. Moreover, these cells exhibited 
several small vacuoles with or without a membrane defined content, whereas vacuoles with 
membranes resembled autophagosomes indicating cell stress. Cells with big vacuoles were 
predominantly visible in semi thin sections. In contrast, adherent cells were larger with a 
decreased number of vacuoles and autophagosomes. A very well distinct rough endoplasmic 
reticulum indicated an intensive protein translation in the cells, but no characteristic features 























































Fig. 66: Electron microscopy analysis of supernatant and adherent SSC 12/13 cells at day 8 and day 9 of 
in vitro differentiation. (A-C; E-G) Electron microscopy and (D, H) light microscopy images of semi thin sections 
of supernatant-derived and adherent SSC 12/13 cells. Cells shown in D and H were stained with Toluidine Blue. 
Processing of cells, electron microscopy as well as data interpretation was performed by Prof. Dr. Andreas 
Meinhardt, Department of Anatomy and Cell Biology at the University of Giessen. Arrows: mitochondria; arrow 





4.1 Restoration of male fertility  
The treatment options for male infertility are crucial defined by the underlying cause of the 
impaired infertility (1.1). The current available reproductive therapies are not suitable to treat 
all infertility cases and require experimental approaches in the research, which may result in 
new fertility options (1.1; Fig. 2, bottom). The first part of the discussion focuses on two 
therapeutical approaches using patient-derived testicular material and iPSCs to treat male 
infertility, which were aimed at in the presented thesis. After a conclusion of the pros of these 
sought approaches, the discussion of this part will be closed with the description of an in vitro 
spermatogenesis approach using mouse embryonic stem cells (ESCs) in order to obtain 
important information for the improvement of therapeutical approaches to restore male 
infertility.   
 
4.1.1 Usage of patient-derived testicular material 
Several therapeutical approaches make use of testicular material from the patient himself 
(1.1; Fig. 2; orange and blue boxes). These approaches provide that the patient possess at 
least SSCs and the underlying cause of his infertility effects later stages of the 
spermatogenesis. Here the culture of patient-derived SSCs is one of the promising approach 
and offers various opportunities for the treatment of male infertility (1.1; Fig. 2; bue boxes). 
One idea behind is the isolation of the patient’s SSCs, their expansion in culture and further 
in vitro stimulation to generate male germ cells followed by ICSI (1.1). In order to follow this 
therapeutical approach one aim of the presented thesis was the generation of proliferating 
human SSC cell lines from testicular biopsies derived from infertile men, who underwent a 
TESE. The established human SSCs should be further used for direct in vitro differentiation 
into haploid male germ cells. Although the isolation of SSCs and their long-term culture have 
already been shown in various species (1.3), the same procedures using human tissue is a 
well known issue and to date, there is no reliable protocol available for the establishment of 
in vitro proliferating human SSC cell lines. Unfortunately, this difficulty was also confirmed in 
the presented thesis (3.1). Despite several attempts, including testing of different 
combinations of feeder layers, culture media and conditions (3.1.3), an enrichment of 
putative human SSCs could not be exceeded and no stable proliferating cell line could be 
established. This failure is due to several factors. Although several phenotypic markers of 
mouse and human SSCs are described in the literature and also used for the isolation of 
these cells using different cell sorting approaches (Guo et al., 2014), there is still a lack of 
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reliable markers to exclusively detect undifferentiated spermatogonia. Here, the surface 
marker α6-Integrin was used for MACSorting procedures, which is described as a SSC 
surface protein and an accepted marker used for human SSC isolation by other groups 
(Shinohara et al., 1999; 2000; Valli et al., 2014). Nonetheless, α6-Integrin is not exclusively 
expressed by SSCs, but also detected in human sertoli and leydig cells (He et al., 2010). 
Thus, the usage of this marker can just lead to an enrichment and not to a pure SSC cell 
population. We suppose the successful enrichment of putative human SSCs in the performed 
experiments based on their grape-like structure (3.1.3.1, Fig. 5; 3.1.3.2, Fig. 6, Fig. 8), which 
is characteristic of SSCs, and their positive immunostaining for the described SSC marker 
PLZF (3.1.3.5, Fig. 10; He et al., 2010). Here, the best results were achieved by culturing 
isolated SSCs in StemPro+3 medium (Smorag et al., 2012) on gelatine coated plates at 
normoxia (3.1.3.2). In this context it is astonishing that the use of matrigel coated plates did 
not further improve the cultivation of human SSCs (3.1.3.3). Compared to gelatine, matrigel 
additionally provides several extracellular matrix derived factors to facilitate cell attachment 
and proliferation. But the question arises why the cultivation of human SSCs beyond their 
enrichment after MACSorting was not successful. Here passaging of putative human SSCs 
on new culture plates was the most critical step. The efficiency of cell attachment as well as 
further proliferation of the passaged SSCs was very low and finally resulted in the loss of 
isolated SSCs (3.1.3.4). In prospective attempts to establish proliferating human SSC cell 
lines an improvement might be achieved by culturing or passaging these cells on 
patient-derived testicular cells. As already seen in SSC cultures on gelatine coated plates, 
isolated human SSCs prefer growing on their natural testicular feeder developed during 
culture (3.1.3.2, Fig. 7). The principle of MACSorting offers the opportunity to use the flow 
through fraction containing patient-derived testicular cells, which might provide appropriate 
natural factors to keep cells in culture. Further analyses of this so called Human Testicular 
Feeder (HTF) were performed in context of co-culture experiments and are discussed later in 
4.2.2.  
Additionally, the material delivery as well as the isolation procedure complicate the 
establishment of long-term human SSC cultures. Testicular biopsies are available limitedly 
and supplied in small fractions of tissue material for cell isolation approaches, whereat SSCs 
anyway represent just 0.03% of all germ cells (Tegelenbosch and de Rooij, 1993) and the 
isolation via MACSorting additionally implies a certain loss of cells by using columns. The 
lack of biopsy delivery also limits the opportunities to test different parameters. Furthermore, 
study-to-study variations in biopsy quantity and quality must not be undervalued and were 
also recognizable in the presented thesis (3.1.3.2, Fig. 6).  
The efforts to establish proliferating human SSC cell lines were stopped after several 
unsuccessful attempts, so that the intended experiments for direct in vitro differentiation of 
Discussion  
168 
human SSCs into haploid male germ cells could not be performed. Here, it was originally 
planned to use protocols adopted from Eguizabal et al (2011) and Easley et al. (2012), who 
applied complex differentiation culture media to force the progression of human iPSCs 
through meiosis and to obtain haploid male germ cells.  
In brief, to complete the list of experimental approaches to overcome male infertility by using 
patient-derived testicular material: in vitro expanded SSCs could also be used for 
autotransplantation into the patient’s testes to achieve a repopulation and to recover 
spermatogenesis. Considering the various reports of successful SSC transplantations in 
several species (Schlatt et al., 2002; Honaramooz et al., 2003a, b; Izadyar et al., 2003b; 
Mikkola et al., 2006; Kim et al., 2008; Richardson et al., 2009), pioneered by Brinster and 
Zimmermann in 1994, a clinical translation of this approach should be feasible in the near 
future. Moreover, researchers intensively work on the reprogramming of human SSCs into 
pluripotent cell lines without any genetic modifications according to similar reports in mice 
(1.3). These human multipotent germline stem cells (hMGSCs) could be further used for in 
vitro differentiation of haploid germ cells followed by ICSI. The use of testicular tissue itself 
could offer the opportunities of xenotransplantations (Geens et al., 2006; Wyns et al., 2008), 
organ cultures (Sato et al., 2013) as well as autotransplantations (Schlatt et al., 1999; 
Hermann et al., 2012), whereat these experimental approaches are not discussed further in 
this context (1.1, Fig. 2, orange boxes).  
 
4.1.2 Usage of patient-derived iPSCs  
Pluripotent stem cells are an unique tool for the in vitro differentiation of SSCs for 
transplantations as well as haploid male germ cells for ICSI applications (1.1, Fig. 2, red and 
yellow boxes; 1.2). In general differentiated cells are able to regain a pluripotent cell status 
by somatic cell nuclear transfer, fusion with a pluripotent cell or reprogramming to iPSCs.  
The generation of iPSCs was a groundbreaking achievement in the stem cell research and 
offers great potential for clinical applications in regenerative and reproductive medicine 
(Takahashi and Yamanaka, 2006; Takahashi et al., 2007). iPSCs represent pluripotent stem 
cells, which are derived from non-pluripotent cells by artificial manipulation and resemble 
ESCs as natural pluripotent stem cells in many features including their indefinite self-renewal 
and differentiation potential, epigenetic pattern and expression of pluripotency marker genes. 
During the reprogramming process pluripotency related transcription factors like Oct3/4, 
Sox2, Klf4 and c-Myc, also known as Yamanaka factors according to the pioneer of the iPSC 
technology (Takahashi and Yamanaka, 2006), are forced expressed to induce pluripotency in 
the target cells. Initially integrative virus systems including retroviruses (Takahashi and 
Yamanaka, 2006; Park et al., 2008) and lentiviruses (Stadtfeld et al., 2008a) were used to 
achieve an ectopic overexpression of the mentioned factors. But since the use of integrative 
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methods bears the risk of genomic integration and tumorigenicity, researchers have 
intensively worked on the development of reprogramming methods, which allows 
theoretically clinical application of iPSCs without any safety concerns for the patient. Up to 
now the generation of iPSCs was reported using non-integrating vector systems including 
adenoviruses (Stadtfeld et al., 2008b) and non-viral plasmids (Okita et al., 2008) as well as 
non-DNA based approaches using recombinant proteins (Kim et al., 2009; Zhou et al., 2009) 
and RNAs including modified mRNAs (Warren et al., 2010) and miRNAs (Miyoshi et al., 
2011). Nevertheless, most of these methods were not applicable to all target cells and 
revealed a lower efficiency and process compared to integrative viral systems.  
Among these non-integrative approaches the mRNA based reprogramming is the most 
promising method, which bases on the repeated delivery of synthetic modified mRNA 
encoding for the pluripotency associated transcription factors and their translation in the 
cytoplasm of cells. This yields in the generation of iPSCs within nearly 20 days with high 
reprogramming kinetics and efficiencies, thereby avoiding any genomic integration or 
insertional mutagenesis. Only a physiological reprogramming method without the application 
of any compounds would be superior to this approach, which is still a challenge to be 
established.  
A successful mRNA reprogramming is known to be technical complicated including the 
preparation of synthetic mRNAs and a precisely procedure of the mRNA transfection series. 
In the presented thesis patient-derived iPSCs were generated with the Stemgent® mRNA 
Reprogramming System, which provides a set of all components needed for the generation 
of hiPSCs from adult human fibroblasts by mRNA reprogramming. We aimed at the 
generation of male patient-specific hiPSCs, which revealed different underlying causes for 
the patient’s infertility (3.2), and their further differentiation to human SSCs (1.1, Fig. 2, red 
boxes). Finally scrotal human fibroblast (SHF) cell lines derived from infertile men were 
established in culture and selected for reprogramming experiments, because of their 
marginal exposure to external factors (3.2.1). Unfortunately, the offered kit was not sufficient 
to generate hiPSCs from the chosen target cells, predominantly because of their moderate 
proliferation rate, and had to be adapted yielding in a “Feeder Free” mRNA/miRNA 
Reprogramming (3.2.2.2). Considering that there was no practical knowledge in generation 
and culturing of hiPSCs available in the institute, it took finally a total of four reprogramming 
trials including several modifications within the protocols in order to successful reprogram 
SHF cells from infertile men by mRNA applications (3.2.2; Tab. 5) and to establish their 
cultivation and cryopreservation (3.2.3, Tab. 7). Because of the quite late stage of the 
practical work for the presented thesis, the hiPSCs’ property of low proliferation and the need 
to establish appropriate differentiation protocols, it was unlikely to achieve the final goal of in 
vitro differentiation of the generated iSHF cells into human SSCs in the remaining time. 
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Therefore, at this time the focus of the presented thesis was placed on the establishment and 
characterization of a co-culture system for the generation of putative SSCs from mouse ES 
cells (3.3; 4.2). Nevertheless, the further development of experimental approaches based on 
the use of patient-derived testicular tissue (4.1.1) and iPSCs is of great importance for 
treatment of male infertility, which is illustrated and discussed briefly in the following section.  
 
4.1.2.1 The advantages of experimental approaches to treat male infertility 
The currently available reproductive therapies do not offer any opportunity for infertile men to 
father children from their own genetic material, when they not produce any functional sperm 
caused by any reason, which could be extracted by different techniques for ART (1.1). This 
difficulty could be solved with the already described experimental approaches using 
patient-derived testicular material or iPSCs. If an arrest during spermatogenesis is the 
underlying cause of infertility, this cause might be overcome during in vitro differentiation of 
human SSCs or haploid male germ cells. Moreover, in vitro approaches offer the opportunity 
to correct a genetic defect in the father’s genome, which might be a risk for the newborn. 
Genome engineering could be done by traditional homologous recombination or ZFN (Zinc-
Finger Nucleases), TALEN (Transcription-Activator Like Effector Nuclease) and CRISPR 
(Clustered Regularly Interspaced Short Palindromic Repeats)/Cas based methods (Richard, 
2015). In contrast to approaches using patient-derived testicular material, the iPSC 
technology is also advantageous for men, who reveal no natural SSCs at all, because it is a 
promising method to differentiate from any cell type patient-specific SSCs for transplantation 
or haploid male germ cells for ART to father biological children. 
 
4.1.3 In vitro approach of spermatogenesis using mouse ESCs 
Important knowledge for the prospective derivation of male gametes of hiPSCs to treat male 
infertility derives from basic research of in vitro differentiation experiments using mouse 
ESCs, which can provide important information about in vitro gametogenesis and epigenetic 
reprogramming. 
In our institute one experimental approach was established for the first time yielding in the 
production of living offspring using haploid male germ cells derived from mouse ESCs or 
maGSCs (Nayernia et al., 2006; Nolte et al., 2010). In brief, this established in vitro 
differentiation protocol bases on a two step selection system using each a premeiotic and 
postmeiotic reporter construct, called Stra8-EGFP and Prm1-DsRed, respectively. The 
retinoic acid (RA) inducible expression of EGFP under the promoter control of the premeiotic 
gene Stra8 (Stimulated by Retinoic Acid Gene 8) was used to enrich a SSC resembling 
population by two FACSortings. The in vitro differentiation of these cells was induced by 
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familiar tools. After embryoid body (EB)- like structure formation upon cell culturing on 
gelatine coated dishes without LIF for several passages, cells were induced with RA for up to 
seven days. Differentiation of haploid male germ cells was detected by Ds-Red expression 
indicating an activation of the postmeiotic Prm1 promoter. The authors assumed that the RA 
induced cells resembled PGCs (Primordial Germ Cells), while haploid male germ cells were 
released to the medium and collected within the supernatant for ICSI experiments, which 
resulted in offspring originated from in vitro generated male gametes. The growth 
abnormalities and the prematurely death within five days to five month after birth of the 
progeny reflected the result of improper epigenetic reprogramming in the in vitro-derived 
sperm. After a genome wide demethylation in PGCs, androgenic de novo methylation of 
paternal specific imprinting marks have to occur during spermatogenesis. This epigenetic 
reprogramming process mediated by methyltransferases is described in detail in the second 
part of the discussion (4.2.5). However, methylation analyses using bisulfite pyrosequencing 
revealed that the paternally imprinted H19 gene was just partly re-established during in vitro 
differentiation. The authors hypothesized that the disturbed establishment of paternal-specific 
methylation pattern led to phenotypic abnormalities in the offspring, which revealed aberrant 
imprinting patterns in several analysed tissues (Nayernia et al., 2006; Nolte and Zechner, 
unpublished data). 
For a successful application of in vitro-derived gametes to treat male infertility, it is of great 
importance to overcome the problem of improper epigenetic reprogramming during in vitro 
spermatogenesis. One idea bases on the overexpression of germ cell related genes, which 
are associated with the meiotic process and might have an impact on genomic imprinting (Yu 
et al., 2009; Medrano et al., 2011). The already mentioned premeiotic gene Stra8 is a 
promising candidate gene to achieve the desired improvement and is further presented in the 
following section.  
 
4.1.3.1 Stra8- a promising gene for improvement of in vitro 
spermatogenesis? 
The RA responsive and premeiotic germ cell marker gene Stra8, which was first discovered 
in P19 embryonal carcinoma cells (Bouillet et al., 1995), is expressed in ESCs as well as in 
premeiotic spermatogonia of adult males and premeiotic follicles of adult females 
(Oulad-Abdelghani et al., 1996; Menke et al., 2003; Zhou et al., 2008a,b). Because of its 
limited expression in pluripotent cells and the downregulation during differentiation, Stra8 is 
suggested to have a regulatory function in controlling the balance between pluripotency and 
differentiation of ESCs (Nolte, unpublished data). In ESCs STRA8 was shown to shuttle 
between the cytoplasm and the nucleus (Tedesco et al., 2009) suggesting a putative role for 
the regulation of protein activity important for cell proliferation and signal transduction 
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(Gama-Carvalho and Carmo-Fonseca, 2001; Fried and Kutay, 2003). The STRA8 protein 
possesses a highly evolutionary conserved helix-loop-helix domain localized at the 
N-terminus (Tedesco et al., 2009), which can be linked to protein-protein interactions 
(Norton, 2000) and may comprise functional sequences for the active shuttle of proteins 
between nucleus and cytoplasm (Black et al., 2001). Within its helix-loop-helix domain the 
STRA8 protein is endowed with a functional nuclear localization signal (NLS) indicating a 
putative binding of STRA8 to DNA and acting as a transcription factor or at least as a 
transcriptional co-regulator (Tedesco et al., 2009). Apart from its role in ESCs, Stra8 is 
crucial for the initiation of meiosis of germ cells in both males and females (Bowles et al., 
2006; Koubova et al., 2006; Anderson et al., 2008). Male and female Stra8-deficient mice are 
infertile with severe defects in gametogenesis leading to a meiotic arrest (Baltus et al., 2006; 
Koubova et al., 2006; Mark et al., 2008) indicating that the decision to enter meiosis is 
determined by RA induction of Stra8 preceding premeiotic DNA replication. Moreover it is 
suggested that STRA8 interacts with chromatin remodelling proteins like SETD8 and 
ARID4B (Pantakani, unpublished data), which are regulators of imprinting control regions 
(ICRs; Wu et al., 2006; Pannetier et al., 2008). Concerning these functions of STRA8, it was 
hypothesized that an overexpression of Stra8 might enhance the progression of meiosis and 
support correct imprinting during in vitro spermatogenesis.  
These experiments were intended to be performed with the available cell line SSC 12 
derived from the work of Nayernia and co-workers (2006), which was already endowed with 
both reporter constructs Stra8-EGFP and Prm1-DsRed (3.4.2.1). Additionally, for this 
purpose a new ESC line, Stra8-EGFP/Sycp3-DsRed, was generated (3.4.2.2), which derived 
from a double transgenic mouse containing premeiotic Stra8-EGFP and meiotic 
Sycp3-DsRed constructs (Smorag et al., 2012) and provides the advantage that all cells, 
which might undergo meiosis, are red fluorescent due to the activation of their Sycp3 
promoter. Because of time limitation, finally the in vitro spermatogenesis experiments were 
carried out with two stable Stra8 overexpressing cell lines, SSC 12/11 and SSC 12/13, which 
derived from the transfection of SSC 12 with a Stra8 overexpressing construct (3.4.3) and 
revealed a two times increased Stra8 expression compared to SSC 12 (3.4.3.1, Fig. 54). The 
potential effect of Stra8 overexpression on the process of in vitro spermatogenesis was 
analysed in comparison to the original cell line SSC 12. 
 
4.1.3.2 The impact of Stra8 on the process of meiosis and epigenetic 
reprogramming during in vitro spermatogenesis 
A stable Stra8 overexpression during in vitro differentiation, which was induced with 
generally used tools including cultivation of cells on gelatine coated dishes and medium 
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without LIF and supplemented with RA, was indeed accompanied by changes in cell 
morphology as well as in molecular and methylation profile (3.4.4).  
The effect of Stra8 overexpression comprised obviously morphology changes yielding in a 
major cell detachment within nine days and a prematurely end of induction in comparison to 
the original cell line SSC 12 (3.4.4.1, Fig. 55). An expression analysis of the postmeiotic 
marker gene Gpx4, which is known to be expressed in the mitochondria of sperm and 
indicates a possible tail formation (Nayernia et al., 2004; Nolte et al., 2010), indicated a more 
rapid and stronger increase of Gpx4 mRNA expression in Stra8 overexpressing cell lines 
normalized to their non-induced state (3.4.4.2.2, Fig. 58) and thereby their earlier entry into 
and progress through the meiotic process. This corresponded to the assumption that Stra8 
might have the potential to accelerate and enhance the progression of meiosis during in vitro 
differentiation. However, the initiation of haploid cell production could not be conclusively 
supported on protein level using immunostaining analyses (3.4.4.2.1, Fig. 56, Fig. 57). Also 
an electron microscopy analysis of one of the Stra8 overexpressing cell lines did not reveal 
any evidence for meiotic or postmeiotic structures during in vitro differentiation (3.4.4.4.2, 
Fig. 66). Moreover, no Ds-Red positive cells were detected within emerged EB-like structures 
derived both from SSC 12 and Stra8 overexpressing cell lines suggesting the absence of 
haploid cells due to the obvious lack of promoter activitation of the postmeiotic gene Prm1. 
The absence of Prm1-DsRed positive cells contradicts the outcome of the original in vitro 
differentiation protocol (Nayernia et al., 2006; Nolte et al., 2010), in which the authors 
detected Prm1-DsRed positive cells emerged from Stra8-EGFP positive cells within the 
EB-like structures, which were further released into the supernatant. Considering the 
immense number and size of EB-like structures also emerged in Stra8 overexpressing cell 
lines, a DsRed detection was strongly expected. Former studies suggested that Stra8 
expression preceding premeiotic DNA replication defined the entry of male germ cells into 
meiosis (Baltus et al., 2006) and is just possible during a narrow time span strictly controlled 
by RA and thereby the Stra8 expression considering the stage-specific expression of STRA8 
protein in male mice localized in pre-leptotene as well as in early leptotene spermatocytes 
(Oulad-Abdelghani et al., 1996; Zhou et al., 2008a, b). Because this comprises 
spermatocytes in three different stages (VII-VIII), premeiotic DNA replication and entry into 
meiosis are thought to proceed more synchronously rather than over the three different 
stages during exogenous treatment with RA (Zhou et al., 2008b). Based on these findings it 
is possible that Stra8 expression, which is essential for the onset of meiosis (Zhou et al., 
2008b), was too strong in Stra8 overexpressing cell lines during in vitro differentiation with 
RA induction resulting in an increased cell detachment after nine to twelve days of induction 
indicative of progressive apoptosis. However, it is worth to note that the viability of cells after 
eight days of induction was still validated using an apoptosis assay (3.4.4.4.1, Fig. 65). 
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Presumably after this time point the cells were overcharged by the expression of 
endogenous Stra8 and stable transfected Stra8. In vitro experiments without additional RA 
induction further revealed an early onset of postmeiotic marker expression using RT-PCR 
experiments (3.4.4.2.3, Fig. 59). Considering that these results have to be confirmed by 
qRT-PCR experiments, they further indicated that already a two times increased Stra8 
expression in the Stra8 overexpressing cell lines might lead to an overloading of 
differentiating cells.  
The absence of Prm1-DsRed positive cells, representing haploid male germ cells, derived 
from in vitro differentiated SSC 12 cells could be attributed to a slight, but required deviation 
from the original protocol. While the original protocol scheduled a cultivation of cells on 
gelatine coated vessels in medium without LIF for up to ten passages before RA induction 
(Nayernia et al., 2006; Nolte et al., 2010), this was not feasible with the Stra8 overexpressing 
cell lines because of the already described cell detachment. Consequently, this hints at the 
importance of this step for a successful in vitro differentiation of haploid male gametes from 
SSC 12. This can be also one explanation for the fact that SSC 12 did not reveal a 
methylation profile of imprinted genes similar to that observed by Nayernia and colleagues 
(2006) during in vitro spermatogenesis with RA induction (3.4.4.3). The paternally imprinted 
H19 and Meg3 genes did not exhibit an androgenic hypermethylated pattern, H19 even 
displayed a slight decrease of methylation. However, the methylation status of the maternally 
imprinted Igf2r and Snrpn genes tended to decrease over the course of in vitro differentiation 
and result in the hypomethylation expected for male germ cells. 
Nevertheless, a comparison with the methylation patterns in Stra8 overexpressing cells 
during in vitro spermatogenesis clearly indicated an impact of Stra8 on the epigenotype, 
although it did not finally yield in a correct androgenic pattern of imprinted genes. The Stra8 
overexpression was accompanied by an overall increased methylation level in all analyzed 
genes compared to SSC 12 (3.4.4.3). H19 was strongly hypermethylated and displayed a 
slight decrease over the course of differentiation, while Meg3 showed a clear increase 
towards a hypermethylation. Both paternally imprinted genes clearly exhibited an androgenic 
epigenotype. However, the maternally imprinted genes did not undergo the essential 
demethylation and especially Igf2r rather showed a hypermethylation than the 
hypomethylation expected for sperm. The methylation patterns with or without RA induction 
were comparable indicating that the effect was due to the stable Stra8 overexpression.  
These data supported the hypothesis that a permanently increased expression of the pre-
meiotic gene Stra8 indeed had an effect on the genomic imprinting during in vitro 
spermatogenesis. However, it did not yield in a correct androgenic imprinting pattern, but the 
problem was rather shifted from the paternally to the maternally imprinted genes, which did 
not reveal the essential in vitro demethylation. But the in vitro reprogramming of imprinting 
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marks is a well-known problem, especially in the in vitro derivation of male gametes from 
ESCs yielding in sperm, which was not fertile and did not give rise to healthy offspring 
(Toyooka et al., 2003; Daley, 2007). Regarding the problematical in vitro epigenetic 
reprogramming, the group of Shinohara (2009) published an interesting study, in which they 
presented a GDNF-supported culture system for the development of mature SSCs from in 
vitro cultured fetal mouse germ cells (Lee et al., 2009). Although the methylation patterns of 
cultured SSCs were stable, the progeny derived from cultured cells revealed growth 
abnormalities and presumably irreversible genomic imprinting defects in male as well as 
female germ cells for at least four generations. The authors suggested that the functional 
SSCs did not gain the ability for a correct epigenetic reprogramming during germline 
development yielding in abnormal offspring. These data clearly illustrated that even a 
successful maintenance of a correct methylation pattern in in vitro cultured SSCs can not 
ensure a correct epigenetic reprogramming during germline development. Considering these 
findings it is highly questionable, if the process of a proper epigenetic reprogramming can be 
recapitulated completely at all in an in vitro system both using in vivo isolated germ cells as 
well as in vitro generated germ cells derived from pluripotent cells with the ability to give rise 
to healthy and fertile offspring without any heritable epigenetic defect. It is suggested that 
“subtle changes in the microenvironment of gonocytes interfered with the DNA methylation 
process, which coincided with the culture initiation” (Davis et al., 1999, 2000; Lees-Murdoch 
et al., 2003; Lee et al., 2009). 
Despite these concerns, researchers will further work on the improvement of in vitro 
spermatogenesis with a special focus on the preservation of proper genomic imprinting 
persisting for subsequent generations. With regard to the appropriate approach in the 
presented thesis using the overexpression of a premeiotic gene, a temporary instead of a 
stable overexpression of proteins like STRA8 should be considered in order to improve this 
process in vitro. The doxycycline-inducible protein expression system could be used for the 
induction of STRA8 expression at certain time points during in vitro spermatogenesis 
experiments (Fig. 67 A). The generation of the required construct (Fig. 67 B), the validation 
of its functionality in transfected NIH 3T3 cells and identification of stable transfected SSC 12 
clones were performed in cooperation with students during their practical courses, but the 
effect of inducible STRA8 expression during in vitro spermatogenesis could not be tested 




Fig. 67: Doxycycline-inducible protein expression system for time-specific induction of STRA8 
expression. (A) Scheme of the doxycycline-inducible protein expression system. In the absence of doxycycline 
or tetracycline (Tet) a Tet repressor (TetR) binds to Tet operator binding sites, which are located downstream of 
the TATA box of the CMV promoter, and inhibits transcription of Stra8. Gene expression is activated by addition 
of doxycycline or tetracycline. The added reagent binds to TetR, which results in a confirmation change of TetR, 
its dissociation from the CMV promoter and allows Stra8 expression. Modified, Stegmeier et al., 2005. 
(B) Plasmid map of generated pEBTetD-mStra8 construct, which provides the open reading frame of mStra8 
driven by the CMV promoter, its tetracycline repressor (TetR) as well as a puromycin (Puro) and ampicillin (Amp) 
resistance cassette for cloning and bacteria selection, respectively. mStra8 was cloned at KpnI/NotI restriction 
sites and linearized with FspI. 
 
4.1.3.3 Stra8 overexpression promotes the formation of blastocyst-like 
structures 
The in vitro differentiation experiments were accompanied by the development of striking cell 
structures (3.4.4.4). They emerged predominantly in Stra8 overexpressing cell lines both with 
and without RA induction, but were present in a greater extent in RA-induced cultures. These 
structures were also observed to a minor extent in the differentiating original cell line SSC 12 
(3.4.4.4, Fig. 63). However, in the culture of SSC 12 these structures were first identified 
after their occurrence in the Stra8 overexpressing cell lines, which caused an intend search 
in SSC 12 cultured cells. At the time point of in vitro differentiation revealing the hugest 
extent of these structures, the viability of these cells was proven by an apoptosis assay as 
well as no nuclear fragmentation as an indicator for apoptosis could be observed (3.4.4.4.1, 
3.4.4.4, Fig. 64; 3.4.4.4.1, Fig. 65). An electron microscope analysis did not provide any 
detailed information about the cell type (3.4.4.4.2, Fig. 66). So the type of these viable 
structures remained unclear.  
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In the context of different experimental studies the researchers presented structures, which 
revealed a morphology closely resembling to the cells predominantly emerged during the in 
vitro differentiation of Stra8 overexpressing cell lines (Fig. 68 A). The generation of these 
structures was predominately described as the formation of a blastocyst as the result of a 
fertilization of oocytes. 
 
 
Fig. 68: Comparison of blastocyst-like structures. (A) In vitro differentiation of Stra8 overexpressing cell lines 
gave rise to blastocyst-like structures. Here a SSC 12/13-derived blastocyst-like structure is shown. Scale bar: 
50 µm. (B) Blastocysts derived from ICSI experiments. Scale bar: 100 µm. Hayashi et al., 2011. (C) Blastocyst-
like structures in vitro derived from ESCs. Scale bar: 30 µm. Hübner et al., 2003.  
 
Hayashi and colleagues (2011) generated mouse primordial germ cell-like cells from ESCs 
and iPSCs, transplanted them into germ cell depleted mice and used the produced mature 
sperm for ICSI experiments, which led to the formation of the mentioned blastocysts and 
finally gave rise to offspring (Fig. 68 B). But this experimental approach yielding in blastocyst-
like structures completely differs from the in vitro spermatogenesis experiments carried out in 
the presented thesis. However, the group of Prof. Schöler (Max Planck Institute for Molecular 
Biomedicine, Münster) presented a protocol for the derivation of oocytes from mouse ESCs 
and found several structures resembling blastocysts after more than 40 days in culture (Fig. 
68 C; Hübner et al., 2003). Provided that the structures emerged in Stra8 overexpressing 
cells indeed reflect blastocysts, their development could be therefore due to processes of 
parthenogenesis or self-fertilization. The first alternative would require the derivation of 
oocytes, while the latter alternative would require the development of both male and female 
gametes during the performed in vitro spermatogenesis experiments. Generally, the 
male-to-female sex reversal could already be demonstrated in the in vitro derivation of sperm 
from female ESCs as well as of oocytes from male ESCs (Kerkis et al., 2007; Eguizabal et 
al., 2011), which is probably due to improper regulated expression of single genes (Colvin et 
al., 2001; Hübner et al., 2003). The derivation of oocytes from male ESCs can be caused by 
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an improper SRY expression leading to the entry of male PGCs into oogenesis (Tilmann and 
Capel, 2002).  
At this point it is very important to emphasize that these possible explanations of 
parthenogenesis or self-fertilization for the development of blastocyst-like cells during the in 
vitro experiments are hypothetical and no data were collected, which provided clear evidence 
for these hypotheses, because the work of the presented thesis was further focused on a 
co-culture system for the generation of putative SSCs from mouse ESCs, which is discussed 
in the following second part.   
  
4.2 A co-culture system using HTF cells for the generation of 
putative SSCs from mouse ESCs 
The second part of the discussion will focus on the establishment of a co-culture system for 
the derivation of putative SSCs from co-culturing mouse ESCs and HTF cells. From a brief 
insight in the somatic cell signalling within the seminiferous tubules arises the 
characterization of the HTF cells, which is further discussed in regard to its features and 
potential to be used in co-culture systems. After a comparison of the here presented 
co-culture system with already described models, the characterization of the 
co-culture-derived SSC-like cells and its results are discussed based on currently available 
and appropriate analyses. Finally, hypotheses regarding the potential driving forces in the 
co-culture system will be presented. 
 
4.2.1 Regulation of spermatogenesis by somatic cell signalling 
The process of spermatogenesis within the seminiferous tubules of the testis is a highly 
regulated mechanism, which is mainly influenced by auto-, endo- and paracrine signalling of 
testicular cells. Especially the SSC niche, consisting of sertoli cells within the seminiferous 
tubules, the basement membrane and interstitial cells provide key factors for a growth factor 
milieu, which determines the fate of SSCs regarding their self-renewal, proliferation and 
differentiation into haploid male germ cells (1.4). Up to now the molecular mechanisms are 
not completely understood, but several studies in different species, especially in rodents, 
provide some insight into the somatic cell signalling within the testis. 
The secreted products targeting SSCs, germ cells as well as other testicular cells can be 
roughly divided into self-renewal and proliferation as well as differentiation and 
spermiogenesis promoting factors (Huleihel et al., 2007; de Rooij, 2009). The outstanding 
role of sertoli cells, which represent the only somatic cell type within the seminiferous 
tubules, is clearly recognizable in the great number of their secreted factors: GDNF (Glial cell 
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line Derived Neurotrophic Factor), bFGF (basic Fibroblast Growth Factor) and LIF (Leukemia 
Inhibitory Factor) play an important role in the self-renewal and proliferation of SSCs, while 
SCF (Stem Cell Factor), activin A, BMP4 (Bone Morphogenetic Protein 4), IGF-I/II (Insulin-
like Growth Factor-I/II), ABP (Androgen Binding Protein), inhibin and follistatin are involved in 
the differentiation process (Huleihel et al., 2007; de Rooij, 2009). Additionally, sertoli cells 
supply the testicular cells with binding and transport proteins (Sylvester, 1993), extracellular 
matrix and functional proteins (Russel and Peterson, 1985), proteases and their inhibitors 
(Fritz et al., 1993) and energy substrates (Groetegoed and Den Boer, 1987; Huleihel et al., 
2007). Secretion of LIF and IGF-I/II was also proven for leydig cells, which further participate 
in the self-renewal and proliferation of SSCs by the production of CSF-1 (Colony-Stimulating 
Factor 1). Besides activin A, IGF-I/II and inhibin, leydig cells also secrete PDGF (Platelet-
Derived Growth Factor) affecting the differentiation. However, the main task of leydig cells is 
the testosterone production in the testis, which is necessary for both self-renewal and 
differentiation of SSCs (Huleihel et al., 2007; de Rooij, 2009). The peritubular cells support 
the supply of GDNF (Spinnler, 2010), LIF and CSF-1 (Huleihel et al., 2007; de Rooij, 2009).  
In several studies this knowledge was used for an in vitro recapitulation of the SSC 
microenvironment in order to maintain and expand SSCs under in vitro culture conditions. 
The different approaches are based mostly either on the use of media supplemented with 
growth factors on feeder layer of non-testicular origin or on the SSC co-culture with testicular 
cells. Research groups developed defined culture systems using minimum essential media 
or advanced media like StemPro®-34 SFM, which are further supplemented with various 
growth factors such as GDNF, bFGF, LIF and others to provide comparable nourishment as 
in the in vivo niche (Sadri-Ardekani et al., 2009; Kanatsu-Shinohara et al., 2011). Some of 
these culture conditions were also used with non-testicular monolayers beneath the SSCs 
consisting of MEF (Murine Embryonic Fibroblasts), STO (SIM mouse embryo-derived 
thioguanine and oubain resistant) cells or Vero cells (Kanatsu-Shinohara et al., 2003; Kubota 
et al., 2004b). Another approach is based on the idea to utilize cells of testicular origin for a 
co-culture system to mimic the SSC niche more naturally by providing the cells’ own 
produced factors. However, mostly the used media are also additionally supplemented with 
growth factors. Co-cultures mostly make use of sertoli cells, which is self-evident with regard 
to their outstanding role in production of SSC niche factors, as mentioned above (Huleihel 
and Lunenfeld, 2004; Baazm et al., 2013). Nevertheless, up to now a limited number of 
studies also used a mixture of somatic constituents of the SSC niche such as sertoli and 
peritubular cells (Khajavi et al., 2014; Mäkelä et al., 2014). In the presented thesis, human 
testicular feeder (HTF) cells were used for co-culture experiments, which were derived from 
MACSortings using human testicular biopsies from infertile men (3.3.1). Because the 
flow-through fraction of the MACSorting was used (3.1.2, Fig. 4), it was assumed that this 
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cell population included different testicular cells and its analysis is further discussed in the 
following section.   
 
4.2.2 HTF cells reveal a peritubular cell character 
For the determination of cell types supporting the used co-culture system, the HTF cells 
should be tested for the occurrence of the main somatic cells of the testis: the sertoli-, leydig- 
and peritubular cells, which were most likely present in the HTF originated from flow-through 
fractions of MACSortings with testicular biopsies (3.3.1). The characterization of HTF cells 
was complicated by the lack of specific markers for the identification of certain testicular 
somatic cells. To date, there are no markers available, which exclusively select one particular 
testicular somatic cell type. Nevertheless, in the literature there are accepted markers, whose 
detection using immunostaining or qRT-PCR experiments for expression analyses is 
acknowledged to prove the presence of sertoli-, leydig- as well as peritubular cells in different 
species. Sertoli cells are commonly proofed by the expression of FSHR (Follicle-Stimulating 
Hormone Receptor; Albert et al., 2012) or VIMENTIN (Langenstroth et al., 2014; Mäkelä, et 
al., 2014), whereas the latter protein is also an often used marker for peritubular cells 
(Langenstroth et al., 2014). Besides VIMENTIN, peritubular cells are usually described by the 
expression of SMA (Smooth Muscle Actin; Welsh et al., 2009; Albert et al., 2012; Kossack et 
al., 2013; Langenstroth et al., 2014), while leydig cells are often characterized by the 
presence of LHCGR (Luteinizin Hormone/Choriogonadotropin Receptor; Welsh et al., 2009; 
Kossack et al., 2013) or 3-β-HSD (3-β-Hydroxysteroid Dehydrogenase; Rebourcet et al., 
2014). Thereby looking at several studies it is not unusual to use only one of these markers 
in order to verify the appropriate cell type. Because a mixture of testicular cells was 
expected, in the presented study several in the literature accepted testicular cell markers 
were used in order to ensure a more detailed molecular description of the HTF cells (3.3.1.1). 
Therefore, the list of analyzed markers was extended and additionally to the above 
mentioned markers the expression patterns of the sertoli cell-associated marker INHIBIN, the 
leydig cell-associated markers P450 and STAR (Steroidogenic Acute Regulatory Protein; 
Landreh et al., 2014) as well as of the peritubular cell associated markers DECORIN (Adam 
et al., 2011), PENTRAXIN 3 (Flenkenthaler et al., 2014), CALPONIN (Welter et al., 2013), 
AR (Androgen Receptor; Welsh et al., 2011), GPER (G-Protein Coupled Oestrogen 
Receptor; Sandner et al., 2014) and AT1R (angiotensin II type I receptor; Welter et al., 2014) 
were analysed by qRT-PCR experiments (3.3.1.1, Fig. 26, Fig. 27). Tab. 9 provides an 
overview of the analyzed markers for the characterization of the HTF cells and the 
corresponding results indicating a peritubular cell character.  
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Tab. 9: Results of the characterization of HTF cells using markers for sertoli-, leydig- and peritubular 
cells.  
Analyzed marker Expressed in… 




Lipid droplets + + - n.a. - * 
FSHR + - - - n.a. 
Inhibin + - - - n.a. 
Vim + - + ++ + 
3-β-HSD - + - - n.a. 
LHCGR - + - - n.a. 
STAR - + - ++ n.a. 
AR - - + + n.a. 
AT1R - - + ++ n.a. 
Calponin  - - + ++ n.a. 
Decorin  - - + + n.a. 
GPER  - - + ++ n.a. 
Pentraxin 3  - - + ++ n.a. 
SMA - - + + + 
FSHR: Follicle-Stimulating Hormone Receptor; Vim: Vimentin; 3-β-HSD: 3-β-Hydroxysteroid Dehydrogenase; 
LHCGR: Luteinizin Hormone/Choriogonadotropin Receptor; STAR: Steroidogenic Acute Regulatory Protein; AR: 
Androgen Receptor; AT1R: Angiotensin II Type I Receptor; GPER: G-Protein Coupled Oestrogen Receptor; SMA: 
Smooth Muscle Actin; HTF: Human Testicular Feeder; qRT: analyzed by qRT-PCR experiments; IC: analyzed by 
immunocytochemical staining; *: analyzed by Oil Red Staining performed by Farzaneh Rafi Manzelat (Master 
student); +: moderately expressed; ++; highly expressed, comparable to used positive control; -: not expressed; 
n.a.: not analyzed.  
 
The expression pattern of the peritubular cell markers PENTRAXIN 3, CALPONIN, GPER 
and AT1R was comparable to in vitro cultured human testicular peritubular cells (HTPCs; 
Albrecht et al., 2006), which were used as positive control (3.3.1.1, Fig. 27). Moreover, 
VIMENTIN revealed an increased expression compared to human testis sample as a positive 
control (3.3.1.1, Fig. 26). Because also the other peritubular cell markers were at least 
moderately expressed in the HTF cells (3.3.1.1, Fig. 27), these data indicated a peritubular 
cell character of the HTF cells. Even if the mRNA of SMA was just moderately detected, the 
heterogeneous immunostaining for SMA and VIMENTIN in the immunocytochemical studies 
further support the peritubular cell background of the HTF cells (3.3.1.1, Fig. 27).  
This assumption was further validated by the expression patterns of sertoli- and leydig cell 
markers, which, with exception of STAR, were not comparable with the human testicular cells 
used as a positive control (3.3.1.1, Fig. 26). Furthermore, an Oil Red Staining, which can be 
used to stain lipid droplets within the cytoplasm as characteristic features of sertoli- and 
leydig cells (Sonne et al., 2009; Riboldi et al., 2012), indicated the absence of these cells in 
the HTF cells. Fig. 69 shows exemplarily the staining reaction of HTF-2 cells with the Oil Red 
reagent as well as the negative control incubated with PBS performed by the master student 
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Farzaneh Rafi Manzelat (“Production of in vitro sperm as a new horizon in treating male 
infertility by reprogramming of human somatic cells derived from infertile men”; 2014). 
 
Fig. 69: Oil Red Staining of HTF-2 cells for the identification of lipid droplets in leydig- and sertoli cells. 
HTF-2 cells were stained with Oil Red to identify cytoplasmic lipid droplets as typical features for leydig- and 
sertoli cells. Mouse leydig cells (MA-10) and sertoli cells (15P-1) were used as positive controls, whereas here the 
lipid droplets could only be detected in leydig cells (arrow). However, HTF-2 cells did not reveal Oil Red stained 
lipid droplets and showed a different morphology than the positive controls. Incubation with PBS served as a 
negative control. The experiment was performed by the master student Farzaneh Rafi Manzelat (“Production of in 
vitro sperm as a new horizon in treating male infertility by reprogramming of human somatic cells derived from 
infertile men”; 2014). Scale bars: 100 µm. 
 
Mouse leydig cells MA-10 and sertoli cells 15P-1 were used as positive controls. Cytoplasmic 
lipid droplets were observed in leydig cells, while no staining was monitored in sertoli cells 
(Fig. 69). Although both cell lines are immortalized, it is possible that the cell line 15P-1 
reveals a weakened sertoli cell-like character after its transformation that may result in the 
lack of lipid droplets. Nevertheless, HTF-2 cells were not positively stained by Oil Red and 
revealed a different morphology than the positive controls. These finding supports the 
qRT-PCR data, which did not reveal an expression of sertoli- and leydig cell markers and 
indicate the absence of sertoli- and leydig cells in the HTF cells.  
Because the data reveal a peritubular cell character of the HTF cells, it is worth to have a 
closer look on the role of peritubular cells, which have been underestimated for a long time 
(Mayerhofer, 2013). In men these thin, spindle-shaped cells form together with extracellular 
matrix proteins the wall of the seminiferous tubules consisting of several layers, whereat the 
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inner layers reveal a smooth muscle phenotype and the outer layers are characterized by a 
connective phenotype (Davidoff et al., 1990). Here SMA, VIMENTIN and CALPONIN, which 
have been found to be expressed in the HTF cells (Tab. 9), are important structural proteins. 
Besides CALPONIN, numerous factors such as endothelin 1 (Romano et al. 2007), PDGF 
(Romano et al., 2006), prostaglandins (Tripiciano et al., 1998), neurotransmitters (Miyake et 
al., 1986) and hormones (Yamamoto et al., 1989) regulate the contraction and relaxation of 
peritubular cells for the active transport of sperm. The maintenance of a stable wall is of 
great importance for fertility concerning the cases of infertile men with a remodelled and 
thickened wall of their seminiferous tubules (Schell et al., 2010; Welter et al., 2013). Besides 
proteins important for the skeletal system and vasculature development, human peritubular 
cells are thought to contribute to the inflammatory network and SSC signalling pathways 
(Flenkenthaler et al., 2014). The peritubular cells also influence other testicular cells by their 
production and secretion of extracellular matrix proteins, signalling factors and antioxidant 
proteins (Mayerhofer, 2013) and expression of different receptors, for example GPER 
(Sandner et al., 2014) and AT1R (Welter et al., 2014), which are also expressed in the HTF 
cells (Tab. 9). Angiotensin II, the agonist of AT1R, is suggested to be involved in sperm 
transport and inflammatory processes. Besides the nuclear receptors ESR1 and ESR2 
(Estrogen Receptor 1 and 2, respectively), GPER is the third estrogen receptor expressed 
within the testis and has an inhibitory effect on the proliferation of peritubular cells (Sandner 
et al., 2014). Moreover, peritubular cells secrete the important neurotophic factors NGF 
(Nerve Growth Factor; Schell et al., 2008) and GDNF (Spinnler et al., 2010). While studies in 
rodents suggest an involvement of NGF in meiosis, its role in the human testis is not yet 
determined (Seidl et al., 1996; Perrard et al., 2007). GDNF is known to be a crucial factor for 
the self-renewal of SSCs and is expressed in rodents as well as in human testis (Oatley and 
Brinster, 2012).  
Many insights into the role of peritubular cells within the SSC niche in men were and are still 
provided by an adequate primary in vitro culture system of adult human peritubular cells, 
which was developed by the group of Prof. Mayerhofer (Albrecht et al., 2006). They 
established a culture method for these cells derived from adult patients with obstructive 
azoospermia but normal spermatogenesis, termed as HTPCs, as well as with 
non-obstructive azoospermia with impaired spermatogenesis and testicular fibrosis, labelled 
as HTPCFs. Although such cellular models are not able to recapitulate the in vivo situation 
exactly, since their availability HTPCs are preferentially used to analyze human peritubular 
cells, because rodents do not represent the best model considering the morphological 
differences between the seminiferous tubules’ wall of these species (Mayerhofer, 2013). 
Albrecht and colleagues (2006) cultured their established HTPCs in minimal medium 
consisting of DMEM supplemented with 10% FCS without any antibiotics and were able to 
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grow them for at least nine passages with proliferation at slow pace. These culture conditions 
and growing behaviour is comparable to the HTF cells, which were also cultured in minimal 
medium, but additionally contains the antibiotics penicillin/streptomycin (FB medium; 3.3.1). 
HTF cells revealed a moderate proliferation for at least 10 to 12 passages, but it decreased 
markedly with further increasing number of passages.  
Based on experiments with HTPCs, Sandner and colleagues (2014) describe that the GPER, 
also expressed in the HTF cells (Tab. 9), is linked to the proliferation of peritubular cells and 
their apoptosis. They incubated HTPCs with a nonsteroidal agonist, which exclusively 
activates GPER when applied in certain concentrations and led to a significantly reduction of 
adherent HTPCs within 24 hours of incubation. Using life cell video imaging the stop of 
proliferation, morphology changes and the detachment of HTPCs were recorded indicating 
the initiation of apoptosis. This process could be inhibited by the prior addition of a GPER 
selective antagonist. Based on these results the application of a GPER selective antagonist 
in the culture medium for HTF could be one possibility to maintain a sufficient proliferation 
rate of HTF cells during the co-culture, which seemed to be an important parameter for a 
successful derivation of SSC-like cells from ESCs in the co-culture system (4.2.6). However, 
here it would be very important to exclude any effect from the inhibition of the GPER on the 
generated putative SSCs. 
Moreover, using the HTPC in vitro model Spinnler et al. (2010) could show a constitutive 
GDNF production of HTPCs, which further support the GDNF level supplied by sertoli cells 
and thereby contribute to the growth factor milieu of the SSC niche. Considering the 
peritubular cell character of the HTF cells used in the co-culture system presented in this 
thesis, it is assumed that GDNF, probably secreted by the HTF cells, plays a decisive role, 
which is discussed later in more detail (4.2.6). Nevertheless, in further analyses it should be 
looked closely at the products secreted by the HTF. Based on the hypothesis that GDNF is 
the driving force in the presented co-culture system, immunofluorescence staining of GDNF 
in cultured HTF cells could be used to validate its presence in these cell lines. Moreover, the 
expression level of GDNF during the period of co-culture could be investigated using 
qRT-PCR analyses. 
Based on the hypothesis that the production of defined factors for the SSC niche by 
peritubular cells is dependent on testosterone, Chen et al. (2014) showed that this hormone, 
in vivo produced by leydig cells (Quigley et al., 1995), regulates the GDNF expression in 
mouse peritubular cells. Using a primary culture of adult mouse peritubular cells they 
confirmed the induction of GDNF expression by testosterone on the mRNA and protein level. 
Culturing of mouse peritubular cells in serum free DMEM/12 medium supplemented with 
10 ng/ml testosterone led to a maximal accumulation of GDNF in the medium after 48 hours 
of incubation. A halfvolume of medium was replaced every 12 hours in order to maintain a 
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constant supply of testosterone. Assuming that GDNF indeed has an effect in the co-culture 
system introduced in this thesis, application of testosterone to the medium during co-culture 
might further improve the efficiency of the generation of SSC-like cells from mouse ESCs. Up 
to now studies on the expression of AR for testosterone in germ cells are controversial and 
could not identify exactly the AR expressing germ cell types (Vornberger et al., 1994; 
Johnston et al., 2001), but the anti-androgen flutamide could be used in order to verify a 
possible testosterone-dependent effect on HTF cells’ secretion pattern within the co-culture 
system. 
Moreover, using a secretome analysis, the naturally secreted factors of the HTF cells could 
be determined and could reveal other crucial factors, which might have forced the generation 
of putative SSCs from mouse ESCs in the co-culture.  
 
4.2.3 Co-culture system using mouse ESCs with HTF cells- about 
similarities and differences with other co-culture approaches 
At this point a comparison of the here presented co-culture system with already described 
co-culture approaches is appropriate, but only conditionally feasible. In the presented thesis 
the usage of mouse ESCs cultured on HTF cells aimed at the generation of putative mouse 
SSCs, while other studies used co-culture approaches primarily for the in vitro culturing of 
isolated SSCs (1.4). The co-culture of mouse ESCs and HTF cells combines actually two 
different approaches for the in vitro generation of SSCs: the unique potential of ESCs to 
differentiate into any cell type including germ cells (1.2) as well as the co-culture with 
testicular cells to recapitulate the in vivo SSC niche (1.4; 4.2.1). The fact that this system 
included a co-culture of cells derived from two different species has to be also considered in 
comparing the co-culture approaches. In the following the comparison is focused on the 
different used cell monolayers beneath the germ cells as well as medium compositions used 
in in vitro co-cultures, which aimed at the self-renewal and survival of in vivo isolated SSCs 
and are mostly corresponding to the co-culture using mouse ESCs and HTF. 
In the presented co-culture system the HTF was used as a feeder layer during the whole 
period of co-culture. Expression analyses revealed a peritubular cell character for these cells 
(4.2.2) and even an intensive database search did not yield in any already published studies, 
which exclusively used peritubular cells for co-culturing of SSCs. As already mentioned 
above co-culture systems make often use of non-testicular cells. Mitomycin C treated 
embryonic fibroblasts such as MEF and STO are prevalently used for the in vitro 
maintenance of in vivo isolated SSCs. Nagano et al. (1998) showed that the survival of 
mouse SSCs could be supported by their cultivation on STO feeders yielding in an ex vivo 
culture for nearly four month. The functionality of the in vitro cultured mouse SSCs was 
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proven by their contribution to the regeneration of spermatogenesis in transplantation 
assays. Using a 7-day culture system, Nagano and colleagues (2003a) revealed that the 
stem cell maintenance is dependent from the type of feeder layer, which is used. The study 
demonstrated that also mitomycin C treated NIH-3T3 fibroblasts or mutant embryonic 
fibroblasts expressing no or a reduced level of Steel factor, which has been shown to have 
an impact on the survival and proliferation of certain types of spermatogonia (Yoshinaga et 
al., 1991; de Rooij et al., 1999), yield in a survival of cultured SSCs comparable to STO 
feeder cultures finally examined in their colonization activity in transplantation assays. 
However, the cultivation of SSCs on certain fibroblasts had a significantly positive effect on 
the cell survival and the final outcome of colonized cells following transplantations (Nagano 
et al., 2003a). Interestingly, the group also tested different mitotically inactive sertoli cell lines 
as one testicular cell type for the in vitro maintenance of SSCs. While two sertoli cell lines, 
namely MSC-1 and 15P-1, yielded in SSC survival comparable to the use of STO feeder, 
other cell lines, such as SF7 and TM4, resulted even in a significantly decreased colonization 
activity. This result was surprisingly in regard to the hypothesis that sertoli cells, representing 
the most important contributor to the SSC niche (1.4; 4.2.1), should support the in vitro 
culture of SSCs. Nagano and colleagues (2003a) suggested that the sertoli cell lines SF7 
and TM4 especially supported the differentiation of spermatogonia, which finally yielded in 
stem cell loss in the in vitro culture (Griswold, 1995; Nagano et al., 2003a). 
In the last year, Mäkelä and colleagues published an interesting in vitro co-culture system 
using the proliferative and migratory properties of testicular cells in order to overcome the 
poor viability of SSC-like cells ex vivo (Mäkelä et al., 2014). This work revealed that the use 
of proliferating primary cells, like HTF cells, might be advantageous for the in vitro culture of 
SSCs compared to co-cultures using mitotically inactive feeder cells like STO, MEF or even 
sertoli cells presented by Nagano et al. (2003a). The following comparison highlights the 
overlapping and differences of culture conditions and cell development in the co-culture 
systems presented in this thesis and published by Mäkelä and co-workers (2014). They used 
small fragments of mouse seminiferous tubules, from which somatic cells spread out 
characterized as sertoli- and peritubular cells by marker expression analyses, whereas the 
presence of leydig cells was just provable within the first two weeks of culture. After one to 
two weeks of culture, spermatogonial cells were detected by the expression of the ubiquitous 
spermatogonial cell marker MAGE-B4 (Österlund et al., 2000). As Mäkelä and colleagues, 
the co-culture system presented in this thesis was also based on the use of primary and 
proliferative testicular cells characterized by a peritubular cell character, but the analyses did 
not reveal the presence of sertoli- and/or leydig cells (4.2.2). The use of a simple culture 
medium during the whole culture period is one more commonality of both co-culture systems, 
which forewent the addition of any growth factors to the culture medium just consisting of 
Discussion  
187 
essential medium supplemented with 10-15% FCS. The used culture medium contrasts with 
other media compositions used in sertoli free mouse and human SSC culture systems 
(Kanatsu-Shinohara et al., 2003; Kubota et al., 2004b; Kanatsu-Shinohara et al., 2005; 
Sadri-Ardekani et al., 2009; Kanatsu-Shinohara et al., 2011). Generally, in these studies the 
SSCs were cultured on mitomycin C treated feeder or different coated flasks with medium 
consisting of minimal essential medium or advanced medium such as StemPro®-34 SFM, 
which were further supplemented with various factors such as GDNF, bFGF, EFG, LIF and 
serum. These studies had the use of a very coordinated medium in common, whereas the 
compositions and concentrations of supplements could differ slightly among the studies. In 
comparison to these media, the culture medium used by Mäkelä and co-workers (2014) and 
in the here presented co-culture system was very simple and cost effective for the cultivation 
of mouse SSCs suggesting that the sertoli- and peritubular cells took over the supply with 
growth factors nutrients, which were provided by the supplemented media used in the other 
studies. 
During their co-culture, Mäkelä et al. (2014) identified MAGE-B4 positive cells in areas with 
high cell densities. Also the formation of SSC-like cells in the co-culture using mouse ESCs 
and HTF cells was primarily observed in grape-like structures near local HTF cell 
aggregates. Moreover, Mäkelä and colleagues (2014) could finally prove the undifferentiated 
state of their co-culture-derived mouse SSCs in transplantation assays and confirmed that 
even after at least four weeks in ex vivo culture the SSCs remain their spermatogenic 
differentiation potential. This final proof could not be obtained using the co-culture-derived 
putative mouse SSCs in the presented thesis, whereat the possible reasons are discussed 
later in detail (4.2.5). Moreover, the use of sertoli- and peritubular cells were sufficient to 
culture spermatogonia for at least five weeks (Mäkelä et al., 2014). Using HTF cells as a 
nearly confluent monolayer putative mouse SSCs could be propagated at least three weeks 
with a maximal expansion to five weeks. This was strongly dependent on the proliferation 
rate of the HTF cells. A decreased proliferation rate was accompanied by a reduced 
formation of SSC-like cells, which finally yielded in the detachment of these cells. The 
extended culture observed by Mäkelä et al. (2014) could be attributed to their combined use 
of primary sertoli- and peritubular cells. From rodent studies it is known that these cell types 
form tight cell structures (Tung and Fritz, 1980; Skinner et al., 1985; Hadley et al., 1990), 
which were identified as cell clusters and cord-like structures with a diameter of 200-700 mm 
by Mäkelä et al. (2014) and grew during co-culture, while a stagnation of co-culture was 
observed when these formations were completed. Although also similar cell clusters, 
obviously consisting of HTF cells, were also observed in the here introduced co-culture 




They hypothesized that GDNF secretion by sertoli cells was the driving force in their 
co-culture system. A GDNF concentration, comparable to those, which have been used in 
supplemented media of sertoli free mouse and human SSC cultures (Kanatsu-Shinohara et 
al., 2005; Sadri-Ardekani et al., 2009; Kanatsu-Shinohara et al., 2011), was detected by an 
ELISA assay and could be further stimulated by FSH treatment indicating the functionality of 
the primary sertoli cells. This corresponds to the findings of Nagano et al. (2003a), who 
demonstrated that the addition of GDNF to the culture medium significantly improves the 
SSC survival in vitro. Considering the peritubular cell character of the HTF (4.2.2) and the 
ability of HTPCs to secrete GDNF (Spinnler et al., 2010; 4.2.2), it is assumed that GDNF 
played also an important role for the generation of SSC-like cells during co-culture of mouse 
ESCs and HTF cells. The GDNF signalling pathways supporting SSC self-renewal and 
maintenance is discussed later in detail (4.2.6). Nevertheless, especially the work of Mäkelä 
and colleagues highlights the importance to clarify the presence of GDNF, its concentration 
and possible enhanced production stimulated by other reagents in the co-culture system 
using mouse ESCs and HTF. As already mentioned above immunfluorescence stainings and 
qRT-PCR expression analyses could be used to localize GDNF within the HTF and 
determine the GDNF levels, respectively (4.2.2). The usage of a GDNF enzyme linked 
immunosorbent assay (ELISA) according to Mäkelä and colleagues (2014) could be used to 
detect the course of GDNF concentration during the progress of co-culture. Moreover, FSH 
can stimulate the GDNF production of mouse sertoli cells (Mäkelä et al., 2014), but up to now 
this was not shown for HTPCs, particularly since the presence of FSH receptors in HPTCs 
could also not be proven to date (Spinnler et al., 2010). As already mentioned Chen et al. 
(2014) demonstrated the testosterone induced GDNF production by mouse peritubular cells. 
However, this could also not be proven in HTPCs until now, but it would be worth to test the 
influence of testosterone in HTF cells considering that HTPCs indeed possess the essential 
ARs (Mayerhofer, 2013). Considering this knowledge from the literature, the growth factor 
GDNF turns out to be one of the driving forces within the co-culture system using mouse 
ESCs and HTF. Before a more detailed overview about the possible driving forces is 
presented, the result of this co-culture system in form of putative SSCs derived from mouse 
ESCs should be discussed in the view of methods, which are in the literature accepted for 
the characterization of germ cells. 
 
4.2.4 Characterization of co-culture-derived SSC-like cells based on 
currently available methods 
In mice, SSCs are thought to be a subpopulation of the undifferentiated spermatogonia, 
which are classified into single (As), paired (Apr) and aligned (Aal) A-type spermatogonia 
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according to the number of cells connected by cytoplasmic bridges (Fig. 70; Kanatsu-
Shinohara and Takashi Shinohara, 2013). Apr spermatogonia can divide into chains 
consisting of up to 16 Aal cells. These cells eventually differentiate within six divisions into 
spermatocytes and finally in mature spermatozoa, thereby passing the differentiating A1 to 
A4, intermediate and type B spermatogonial state. The naturally process of spermatogenesis 
in mice takes 35 days. The As cells are characterized by their ability to self-renew and to 
produce Apr spermatogonia, which give rise to Aal cells. SSCs are considered to be the 
self-renewing As spermatogonia, but transplantation studies suggest that just 10% of these 


















Fig. 70: Scheme of cell types during mouse spermatogenesis. In mice, undifferentiated spermatogonia 
consist of single (As), paired (Apr) and aligned (Aal) A-type spermatogonia. Aal can enter the process of 
differentiation into male gametes, which comprises differentiated A1-A4, intermediate and B-type spermatogonia 
followed by maturation from spermatocytes to mature spermatozoa. Undifferentiated as well as differentiating 
spermatogonia are connected by cytoplasmic bridges. Kanatsu-Shinohara and Takashi Shinohara, 2013. 
 
In the present study, during co-culture with HTF cells the ESCs underwent morphological 
changes, which finally yielded in grape-like structures (3.3.2, Fig. 28; Fig. 71 A). This 
compact cell morphology is described to be characteristic for in vitro cultured SSCs and is 
remarkably similar among rodent and non-rodent species (Fig. 71 B-F). In the literature the 
description of these in vitro cultured cells, isolated from the specie’s testis using testicular cell 
suspensions or cell sorting procedures, is unfortunately not consistent and comprises 
designations such as SSCs, germline stem cells, germ cells or cells named according to the 
used sorting marker. Based on their characteristic shape the co-culture-derived cells were 
termed as putative SSCs or SSC-like cells in the presented thesis. The viable and 
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proliferating state of these cells was further proven by an apoptosis- and BrdU assay 
(3.3.3.1).  
 
Fig. 71: : In vitro cultured germ cells reveal a similar morphology. (A) SSC-like cells derived from co-culture 
of mouse ESCs with HTF cells cultured in DMEM medium supplemented with 10% FCS and 1% 
penicillin/streptomycin. Scale bar: 40 µm. (B) Cultured mouse SSCs, named as germline stem cells. Scale bar: 
50 µm. Sato et al., 2013. (C) Thy-1 positive cells cultured on STO feeder in serum-free medium supplemented 
with GDNF, soluble GFRα1 and bFGF. Thy-1, a marker for undifferentiated spermatogonia (Kubota et al., 2003), 
was used for enrichment by MACSorting. Scale bar: 50 µm. Kubota et al., 2004b. (D) Epcam (Epithelial Cell 
Adhesion Molecule) positive cells cultured on STO feeder in serum-free medium supplemented with GDNF, 
GFRα1, bFGF and/or LIF. Epcam was used for enrichment of A-type spermatogonia (van der Wee et al., 2001) 
Scale bar: 100 µm. Ryu et al., 2005. (E) Adult marmoset testicular cells cultured in MEMα medium containing 
10% FCS and 1% penicillin/streptomycin. Authors detected the germ cell marker MAGE A4 (Melanoma-
Associated Antigen 4; Aubry et al., 2001; Eildermann et al., 2012b) in the cultured cells. Scale bar: 50 µm. 
Langenstroth et al., 2014. (F) Human testicular cells cultured on uncoated dishes in MEMα medium containing 
10% FCS and 1% penicillin/streptomycin. Cultured cells were positive for the germ cell markers VASA (Toyooka 
et al., 2000; 2003) and MAGE A4. Scale bar: 100 µm. Kossack et al., 2013.  
 
Further characterization of co-culture-derived putative SSCs was complicated by the 
deficiency of markers, which exclusively detect SSCs and distinguish them from ESCs at the 
molecular level, representing the original cell type used in the here presented co-culture 
system. Although the origin of ESCs is not yet clearly determined, several studies suggest 
that ESCs may have a germ cell origin based on their common molecular properties with 
other pluripotent cells (for review: Zwaka and Thomson, 2005). Until now in vitro-derived 
germ cells can just be inadequately characterized by the expression analyses of marker 
genes, which are detectable in both pluripotent and germ cells. A comparative systematic 
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expression analysis of germ cell- and premeiotic markers revealed comparable expression 
levels of germ cell-associated genes such as Stella and Fragilis and premeiotic associated 
genes such as Piwil2, Dazl and Vasa on mRNA as well as on protein level in ESCs and 
various germline-derived pluripotent cells (Xu et al., 2011). The close relationship between 
ESCs and germ cells was also shown by several groups, which were able to convert ESCs 
into primordial germ cell (PGC) like cells as well as germ cell-like cells using certain in vitro 
culture conditions (Hübner et al., 2003; Toyooka et al., 2003; Geijsen et al., 2004). Also 
pluripotent cells can be derived from PGCs as well as SSCs indicating that germline cells 
have a pluripotency memory and the potential to regain this unique pluripotent state (Matsui 
et al., 1992; Kanatsu-Shinohara et al., 2004; Guan et al., 2006). The expression of several 
marker genes such as Oct4, Stella, Fragilis, Vasa and Dazl is shared by ESCs and germ 
cells including PGCs and SSCs (Toyooka et al., 2000; Geijsen et al., 2004; Kehler et al., 
2004; Cauffmann et al., 2005). Therefore, a reliable molecular characterization of these cells 
derived from ESCs is still very challenging. However, because up to now researchers 
evaluate their in vitro-derived germ cells molecularly on the basis of the expression analyses 
of germ cell-associated genes, this strategy for characterization was also pursued in the 
presented thesis. The review by Phillips and co-authors (2010) provides an overview of 
general germ cell markers used for sorting procedures as well as characterization analyses 
of rodent As spermatogonia to elongated spermatids. The performed analyses for the 
characterization of the SSC-like cells and the corresponding results are summarized in Tab. 
10. Preferentially, markers were used for analyses, which can be used to detect or enrich As 
spermatogonia, whose status was confirmed by spermatogonial stem cell transplantation 
assays (Phillips et al., 2010).  
 
Tab. 10: Results of the characterization of SSC-like cells. 
Analyzed marker Expressed in… 
in vivo SSCs co-culture-derived 
SSC-like cells 
  IC qRT 
AP + + n.a. 
α-6-Integrin* + + n.a. 
Gfrα1* + n.a. n.a. 
Gpr125* + n.a. + 
Ngn3* + n.a. n.a. 
Oct4* + + n.a. 
Plzf* + + n.a. 
Ddx (Vasa) + + n.a. 




AP: Alkaline Phosphatase; Gfrα1: GDNF Familiy Receptor α1; Gpr125: G-Protein-coupled Receptor 125; Ngn3: 
Neurogenin 3; Oct4: Octamer-Binding Transcription Factor 4 ; Plzf: Promyelocytic Leukemia Zinc Finger Protein; 
Ddx (Vasa): DEAD (Asp-Glu-Ala-Asp) Box Polypeptide 4 (aliases: Vasa) ; Sall4: Sal-Like Protein 4; SSC: 
Spermatogonial Stem Cell; qRT: analyzed by qRT-PCR experiments; IC: analyzed by immunocytochemical 
staining; +: expressed; n.a.: not analyzed. *: detect or enrich As spermatogonia, confirmed by spermatogonial 
stem cell transplantation assays (Phillips et al., 2010).  
 
Immunocytochemical analyses using different markers confirmed the germ cell character of 
the co-culture derived SSC-like cells (3.3.3.2; Tab. 10). The analysed cells expressed OCT4, 
which is known as a key regulator of pluripotency in ESCs (Niwa et al., 2000). In the testis 
this factor is preferentially expressed in As spermatogonia and essential for the self-renewal 
of SSCs (Pesce et al., 1998; Dann et al., 2008; He et al., 2009) suggesting an 
undifferentiated spermatogonial state of the SSC-like cells derived from the co-culture. This 
assumption was further supported by the positive staining for PLZF and SALL4. PLZF is 
expressed in undifferentiated spermatogonia As, Apr and Aal and seems to play an important 
role in SSC self-renewal, because Plzf mutant mice revealed a progressive loss of germ cells 
yielding in male infertility (Buass et al., 2004; Costoya et al., 2004). PLZF can interact directly 
with SALL4 (Hobbs et al., 2012), which is consequently also expressed in As, Apr and Aal 
spermatogonia (Gassei and Orwig, 2013). Additionally, the co-culture-derived SSC-like cells 
revealed a moderate expression of Gpr125, which is a further marker for undifferentiated 
spermatogonia within the seminiferous tubules (Seandel et al., 2007). The presence of 
undifferentiated spermatogonia within the co-culture-derived cell population was also 
supported by the performance of in vitro differentiation experiments (3.3.5), which revealed 
an upregulated expression of the postmeiotic markers Gpx4 and Acrosin and thereby 
confirmed that at least some co-culture-derived cells can be induced to enter the 
differentiation process. However, this assumption bases on qRT-PCR experiments and the 
proof of appropriate postmeiotic markers on protein level was not provided within the 
presented thesis. Moreover, the methylation pattern of paternally and maternally imprinted 
genes H19 and Meg3 as well as Snrpn and Igf2r did not reveal any convincing trend towards 
an androgenic imprinting pattern (3.3.3.3), which would comprise methylated paternally and 
demethylated maternally imprinted genes (Kanatsu-Shinohara et al., 2004). Therefore, at this 
point a precise statement regarding a successful in vitro differentiation of postmeiotic cells 
from co-culture-derived cells is not possible.  
Further analyses revealed an expression of the SSC surface marker α6-INTEGRIN and the 
ATP-dependent RNA helicase VASA. The expression of both germ cell-associated proteins 
is not restricted to undifferentiated spermatogonia, but also detectable to the level of 
spermatocytes and round spermatids, respectively (Shinohara et al., 1999, 2000; Toyooka et 
al., 2000; 2003), indicating the presence of differentiating spermatogonia within the 
co-culture-derived cell population. This assumption was further supported by the expression 
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pattern of molecular markers for germ cell development, which revealed a turning-on of early 
postmeiotic gene expression in the co-culture system without any exogenous induction of 
germ cell differentiation (3.3.5). However, the expression of the early postmeiotic genes 
Gpx4 and Acrosin was just analyzed on the mRNA level by RT-PCR analysis.  
These results indicated a co-culture-derived cell population consisting of undifferentiated and 
differentiating spermatogonia. But considering the already mentioned deficiency of definitive 
markers for the characterization of spermatogonia, SSCs can just be unequivocally identified 
using a transplantation assay developed by Brinster and Zimmermann (1994). This functional 
SSC assay bases on the microinjection of testicular cell suspensions containing the putative 
SSCs into the seminiferous tubules of germ cell depleted mice. These mice can be 
generated by busulfan treatment, which destroys the endogenous spermatogenetic activity 
(Bucci and Meistrich, 1987). The stem cell activity of transplanted SSCs is proven by the 
regeneration and maintenance of spermatogenesis within the transplanted testis (Brinster 
and Zimmermann, 1994). Generally, a transplantation is supposed to be accompanied by a 
rapid loss of SSCs and a colonization of just 10% of transplanted cells, which need up to one 
week to home within their niche and start propagation (Nagano, 2003b). In order to finally 
proof their SSC phenotype, co-culture-derived cells were used for transplantation assay 
(3.3.4). Because FACS- and MACSortings using appropriate surface markers are suitable 
approaches to enrich stem cells within a testicular cell suspension obtaining nearly one stem 
cell in 15 total cells (Kubota et al., 2003, 2004a), the co-culture-derived SSC-like cells 
underwent a MACSorting using the surface marker α6-Integrin before cell transplantation 
procedure. Simultaneously this sorting served for removal of HTF cells before transplantation 
to exclude any interference of these somatic cell types. Unfortunately, the transplanted mice 
did not regain fertility indicating the absence of functional male gametes. Because the 
naturally fertilization is a well-known problem because of immotile sperm produced during re-
established spermatogenesis using in vitro generated SSCs (Nayernia et al., 2006; Nolte et 
al., 2010), the transplanted testes were checked for regenerated spermatogenesis by H&E 
staining finally confirming the absence of any sperm production (3.3.4, Fig. 37). This is in 
contrast to other studies, in which SSC-like cells derived from ESCs could successfully 
initiate and complete spermatogenesis in germ cell depleted mice upon transplantation 
providing the final proof of functional in vitro generated germ cells (Hayashi et al., 2011). 
These results clearly suggest that the co-culture-derived SSC-like cells did not represent 
functional SSCs, because they were not capable to regenerate spermatogenesis. However, 
using genotyping PCR analyses the presence of transplanted cells could be proven within 
the testis at least 15 days upon transplantation (3.3.4, Fig. 39), but these results did not allow 
any conclusion regarding the viability or colonization of transplanted cells within the tubules. 
A possible colonization of transplanted cells could be checked by immunohistochemical 
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analyses using markers for undifferentiated spermatogonia. At the moment appropriate 
analyses are performed using a SALL4 specific antibody to check for colonized 
spermatogonia within the seminiferous tubules up to 15 days upon transplantation. Up to the 
time of thesis submission, these analyses were not yet completed, but the so far examined 
stainings did not reveal any SALL4 positive cells on testis sections. Moreover, an EGFP-
specific antibody could be used to check for the homing of transplanted cells within the 
seminiferous tubules, thereby taking advantage of the reporter construct Stra8-EGFP within 
the ESCs used for co-culture experiments.  
Nevertheless, it is worth to note that no teratoma formation was observed upon 
transplantation using co-culture-derived cells, although mice were partially analyzed two 
month after transplantation prior a fruitless phase of test mating (3.3.4). Considering the ESC 
based origin of co-culture-derived cells used for transplantation assays, this fact indicated 
that the ESCs experienced some kind of development during co-culture. If cells had been still 
exhibited ESC character, they would have initiated teratoma formation according to their 
unique differentiation potential. Using comparative transplantation experiments, Brinster and 
Avarbrock (1994) observed no sign of spermatogenesis, but testicular and/or abdominal 
tumor formation within 30 days upon injections of ESCs into mouse seminiferous tubules. 
Transplantation of co-culture-derived SSC-like cells did not regenerate spermatogenesis 
indicating that these cells were not able to home within the SSC niche in germ cell depleted 
mice, but they also did not initiate teratoma formation suggesting that ESCs experienced a 
differentiation process in the co-culture. Here the assumption arose that the 
co-culture-derived cells resembled germ cell precursor cells, which will be further discussed 
in the following section. 
 
4.2.5 The co-culture-derived cell population reveals a predominantly 
primordial germ cell character 
In mice, pluripotent cells of the proximal epiblast are the origin of germ cells, which arise from 
founder cells at embryonic day E6.0-6.5 forming a distinct cell cluster at E7.25 known as 
primordial germ cells (PGCs). These PGCs further migrate to the developing hindgut 
endoderm, reach the mesentery at E9.5 and colonize at the genital ridges of the developing 
gonads at E11.5, where the sexually bipotential cells experience sex-determination and enter 
either the spermatogenic or oogenic pathway for production of gametes (Fig. 72; Saitou and 




Fig. 72: Scheme of germ cell development in mice. The major events during male germ cell development are 
highlighted in red. The primordial germ cells (PGCs) represent the precursors of male and female germ cells. 
They start migrating at around embryonic day E7.5 from the proximal epiblast (A) and colonize at E11.5 in the 
genital ridges (B). After an erasure of their genomic imprints (C), PGCs experience a sex-determination (D). Germ 
cells with a male cell fate regain paternally imprints during their differentiation into gonocytes (E). E: embryonic 
day; P: postnatal day. Modified, Saitou and Yamaji, 2012.  
 
During their migration and proliferation in the gonad the PGCs undergo a comprehensive 
epigenetic reprogramming including an erasure of somatic genomic imprinting by DNA 
demethylation (Yamahazi et al., 2003). Imprinting represents a monoallelic expression status 
of a subset of genes and is essential for a normal embryonic development. The 
parental-specific allele expression is defined by epigenetic modifications such as DNA 
methylation in the differentially methylated region (DMR) of the imprinting control region 
(ICR) of the gene. The gene transcription is influenced by nucleotide sequences enriched 
with 5-methylcytosines at CpG dinucleotides termed as CpG islands, which are transferred 
by DNA methyltransferases. Mostly the repressed allele is methylated, while the active allele 
is unmethylated at its DMRs (Bartolomei et al., 1993; Ferguson-Smith et al., 1993; Stöger et 
al., 1993; Bird et al., 2002). Somatic DMRs acquire their methylation status after fertilization, 
while germline DMRs gain this status during gametogenesis. During further germline 
development the demethylated PGCs undergo a sex-specific de novo DNA methylation of 
ICRs of maternally and paternally inherited chromosomes, which is triggered by the de novo 
methyltransferase DNMT3A and its stimulatory protein DNMT3L (Bourc’his et al., 2001; 
Kaneda et al., 2004; Jia et al., 2007). This establishment of parental-specific imprints occurs 
during late fetal development in the male and in early postnatal phase of females (Hajkova et 
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al., 2002, 2008; Lucifero et al., 2004). Around E12.5-13.5 male PGCs exhibit the onset of 
resetting of the paternal imprinting marks, which is completed at the level of gonocytes. 
Consequently, functional SSCs reveal a hypermethylated status of paternally imprinted 
genes such as H19 and Meg3, while maternally imprinted genes such as Snrpn and Igf2r 
exhibit a hypomethylated pattern.  
An analysis of the methylation status of imprinted genes using bisulfite pyrosequencing did 
not reveal such an androgenic and SSC characteristic methylation pattern in 
co-culture-derived cells (3.3.3.3). Moreover, these cells did not show significant differences in 
their methylation levels compared to the starting ESCs, while the latter one conformed 
approximately to already described methylation patterns of undifferentiated male ESCs 
(Zechner et al., 2009). ESCs have been shown to reveal methylation levels comparable to 
somatic cells (Geijsen et al., 2004; Zechner et al., 2009). Furthermore, Hajkova and 
colleagues (2002) confirmed a somatic methylation pattern for PGCs during their migration 
phase. Considering these findings, the results of the methylation studies suggest a PGC 
status of co-culture-derived cells before the onset of epigenetic reprogramming and the 
beginning of imprinting erasure. This assumption can also be linked to the already described 
positive immunostaining results (4.2.4, Tab. 10): OCT4 was shown to be expressed in PGC 
and is necessary for their survival (Schöler et al., 1989; Kehler et al., 2004). Additionally 
SALL4, VASA and α6-INTEGRIN are also expressed in PGCs (Toyooka et al., 2000; 
Durcova-Hills et al., 2008; Morita-Fujimura et al., 2009; Eildermann et al., 2012). Moreover, 
the PGC character of co-culture-derived cells was substantiated by significantly increased 
expression of Fkbp6 and Mov10l1 (3.3.3.2, Fig. 34), which are supposed to be “the 
long-missing tool for the in vitro derivation of functional gametes from pluripotent stem cells“ 
(Sabour et al., 2011). Using gene expression microarrays with male and female PGCs of 
E11.5 to E18.5, the group of Prof. Schöler identified these genes among 11 germ cell-related 
genes to be highly expressed in PGCs, while ESCs revealed a low expression level. In 
contrast to other markers these germ cell-associated genes allow a discrimination between 
germ cells and pluripotent cells. The low or absent expression in somatic cells indicated a 
role of these genes in reproduction and fertility. Nevertheless, it has to be noted that the 
authors also detected high expression levels of these genes in mouse spermatogonial cells 
(Sabour et al., 2011).  
Based on these data it is hypothesized that the cells, derived from the co-culture of mouse 
ESCs with HTF cells, represent a mixed cell population with a predominantly PGC character 
and presumably a small fraction of undifferentiated and differentiating spermatogonia. A final 
characterization of the co-culture-derived cells could be done by a comparative single cell 
transcriptome analyses in order to assess the gene regulating network, which determines the 
phenotype, physiology and behaviour of cells (Tang et al., 2011). For a definitive cell 
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classification, the co-culture-derived cells should be compared to naturally PGCs and SSCs, 
the co-culture starting ESC cell line, wild type ESCs as well as somatic cells.  
However, the assumption that undifferentiated spermatogonia represented a relatively small 
proportion within the co-culture-derived cell population offers a possible explanation for the 
unsuccessful transplantation assays. According to Nagano (2003b) germ cell transplantation 
is anyway accompanied by a major loss of transplanted SSCs during their homing process, 
which requires their attachment to the recipient’s sertoli cells, the migration to their final 
position at the basement membrane of the seminiferous tubules and their local survival. The 
migrating process takes approximately seven days and implies a loss of 75% of transplanted 
SSCs within the first day and finally just 12% SSCs reach the basement membrane and 
initiate self-renewal. The author mentioned inefficient adhesion of transplanted cells to sertoli 
cells, their low survival rate during migration and an eventually inappropriate SSC niche as 
possible reasons for this SSC degradation upon transplantation (Nagano, 2003b). 
Considering this additional tremendous loss of cells after transplantation, it is assumed that 
the possibility was very low that the minor fraction of undifferentiated spermatogonia in the 
co-culture-derived cells survived in an appropriate amount in order to repopulate the 
seminiferous tubules. 
 
4.2.6 What are the driving forces in the co-culture system? 
In the presented thesis the co-culture of mouse ESCs and HTF cells turned out to be a 
robust and reproducible system for the derivation of a cell population revealing a primordial- 
and spermatogonial cell character, what might be attributed to different factors. 
Certain growth factors such as GDNF, bFGF and CSF-1 were shown to be key regulators for 
the self-renewal and proliferation of SSCs and progenitor spermatogonia. Among the 
essential factors within the SSC niche GDNF is the most considered cytokine, which was 
recently shown to be constitutively released by in vitro cultured human peritubular cells 
(Spinnler et al., 2010). Based on the predominantly peritubular cell character of the HTF cells 
(4.2.2), it is hypothesized that GDNF is one crucial cue within the here presented co-culture 
system. GDNF is a member of the TGF-ß (Transforming Growth Factor-β) superfamily 
binding to receptor complexes consisting of GFRα1 (GDNF Familiy Receptor α1) and c-Ret 
proto-oncogene, a transmembrane tyrosine kinase receptor (Sariola and Saarma, 2003; 
Buageaw et al., 2005). The receptor is expressed in undifferentiated As, Apr and Aal 
spermatogonia of mice (Hofmann, 2008; Grisanti et al., 2009), but also in SSCs from 
primates and humans (Maki et al., 2009; Wu et al., 2009) and indicates that GDNF signalling 
is of great importance for the preservation of SSCs in various mammalian species. Upon 
GDNF binding, SSCs respond by the activation of different pathways including 
phosphatidylinositol 3-kinase/serine-threonine kinase AKT family (PI3K/AKT), Src family 
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kinase (SFK) and Ras/Erk 1/2 signaling mechanisms (Braydich-Stolle et al., 2007; Oatley et 
al., 2007; He et al., 2008; Phillips et al., 2010). Oatley and co-authors (2007) suggested that 
PI3K/Akt is involved in SSC survival, while genes for SSC self-renewal are regulated by SFK 
signalling. Using microarray analyses in GDNF deficient cultures of self-renewing mouse 
SSCs, six target genes of the GDNF signalling pathways could be identified including the 
genes Bcl6b (B Cell CLL/Lymphoma 6 Member B), Egr2 (Early Growth Response 2), Egr3 
(Early Growth Response 3), Etv5 (Ets Variant 5), Lhx1 (LIM Homeobox 1) and Tspan8 
(Testraspanin 8) (Oatley et al., 2006). Up to now the reduction or even loss of the 
transcriptional repressor BCL6b could be linked to an impaired self-renewal potential of 
SSCs and spermatogenesis using mouse in vitro and in vivo experiments, respectively 
(Oatley et al., 2006). Considering that several “in vivo and in vitro studies clearly indicate that 
GDNF is a key player responsible for maintaining SSCs by regulating their self-renewal” 
(Meng et al., 2000; Naughton et al., 2006; Oatley and Brinster, 2008; Spinnler, 2010), it is not 
unreasonable to conclude a major role of GDNF presumably secreted by the HTF cells in the 
here introduced co-culture system. The required preconditions for a functional GDNF 
signalling in the co-culture are fulfilled: (1) GDNF is known to be constitutively released by in 
vitro HTPCs (Spinnler et al., 2010) and is presumably secreted by the HTF cells representing 
predominantly human peritubular cells in the co-culture, (2) GDNF can have an effect on 
mouse ESCs (Reyes et al., 2008) and (3) mature GDNF is highly evolutionally conserved 
indicating that human GDNF can mediate GDNF signalling in mouse cells (Grimm et al., 
1998; Gao et al., 2011).  
Further studies showed that in vitro culturing of SSCs can be greatly enhanced by the 
addition of the growth factors bFGF and CSF-1, but in contrast to GDNF a supplementation 
of culture medium with just one of these both factors was not sufficient to achieve a 
comparable support of SSC maintenance in culture and consequently these factors are 
thought to act in combination with GDNF (Kubota et al., 2004b; Oatley et al., 2009). 
However, occurrence of bFGF in the co-culture system is likely unreasonable, because up to 
now its production is attributed to sertoli cells (Mullaney and Skinner, 1992), which are very 
likely not present in the HTF cells used in co-culture experiments (4.2.2). In contrast to this, 
an influence of CSF-1, which was shown to be localized in mouse leydig (Ryan et al., 2001) 
and peritubular cells (Shima et al., 2004), is possible by supporting the maintenance of the 
SSC phenotype in vitro (Oatley et al., 2009). An impact of CSF-1 on co-culture requires the 
production of this growth factor by the HTF cells, but to date a CSF-1 secretion could not be 
confirmed yet for human peritubular cells, so that a possible impact of CSF-1 in the 
co-culture system can just be assumed.   
Last year the group of Prof. Mayerhofer published their interesting results of a secretome 
analysis using their established in vitro HTPC culture (4.2.2; Albrecht et al., 2006; 
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Flenkenthaler et al., 2014), in which they identified various secreted proteins contributing to 
the skeletal system and vasculature development, inflammatory network and SSC fate. 
Interestingly, they found the TGF-β signalling pathway is significantly enriched in the 
analyzed secretome and hypothesized that HTPCs play an important role “in the 
development and maintenance of testicular functions by secreting several proteins that act 
through the multistage TGF-β signal transduction pathway in close interplay with surrounding 
Sertoli and Leydig cells” (Flenkenthaler et al., 2014). Although the bone morphogenetic 
protein 4 (BMP4) was not found in this published secretome analysis, it is worth to have short 
look at this ligand of the TGF-β family, which is known to be crucial for the transcriptional 
regulation of PGC specification (Lawson et al., 1999) and differentiation of spermatogonia 
(Pellegrini et al., 2003). These mouse studies revealed the expression of BMP4 receptors in 
proliferating and migrating PGCs as well as postnatal dividing spermatogonia suggesting an 
important role of BMP4 signalling in the production of gametes throughout male life. The 
PGC fate concerning their formation, survival and differentiation is determined by BMP4 
downstream targets such as Smad1 and Smad5 (Okamura et al., 2005). In mice, BMP4 is 
produced by sertoli cells (Pellegrini et al., 2003). Considering the assumption that the 
co-culture-derived cell population revealed a predominantly PGC character containing a 
small fraction of undifferentiated and differentiating spermatogonia (4.2.5), BMP4 can 
hypothetically act as a PGC and spermatogonia inducing factor in the co-culture system. This 
hypothesis presumes a secretion of BMP4 by human peritubular cells, and then also by HTF 
cells. Although it should be recalled that BMP4 was not found in the secretome analysis by 
Flenkenthaler and colleagues (2014), this concern is slightly relativized by the fact that the 
group also did not mention any GDNF supply in the analyzed secretome, although HTPCs 
have shown to be a constitutively producer of this growth factor also belonging to the TGF-β 
family (Spinnler et al., 2010). A potential effect of GDNF on PGCs within the 
co-culture-derived cell population cannot be discussed as no literature is currently available, 
which document any GDNF-specific receptors on the surface of PGCs.  
The HTF cells themselves seem to be a considerable factor within the co-culture system and 
are necessary for both the ESC attachment at the start and for the supply of essential factors 
during the co-culture. The so called SSC-like cells could not be generated by using gelatine 
or MEF feeder coated culture vessels without or in combination with conditioned culture 
medium derived from the culture of pure HTF cells providing secreted factors (3.3.6). This 
indicates that the derivation of SSC-like cells did not need any cell line for cell attachment as 
well as not just the HTF released factors within the conditioned medium, but was dependent 
on the presence of HTF cells as well as its secreted factors. Attempts to perform equivalent 
co-cultures using mouse ESCs with mouse testicular feeder (MTF) cells were unsuccessful 
and failed presumably because of the non-proliferating cells derived from testicular cell 
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suspensions. MTF cells could not be propagated beyond passage number two. The rapidly 
decreasing proliferation of primary rodent testicular cells is a well known issue (Mäkelä et al., 
2014). In contrast to HTF cells, the MTF cells did not derive from MACSorting using mouse 
testis tissue. However, it can be assumed that these cells would not be more proliferative. 
The long-term culture of co-culture-derived SSC-like cells seemed to be limited by the slowly 
decreasing proliferation of the HTF cells during proceeding co-culture (4.2.3), which was 
accompanied by a reduced occurrence of SSC-like cells. This could be attributed to the less 
supply of cells for cell attachment as well as of secreted nutrients and factors. Considering 
that HTF cells represented primary cell lines, the decline in proliferation was not surprising. 
This limiting factor at advanced co-culture might be overcome by seeding co-culture-derived 
cells on HTF cells from lower passages. It is assumed that the usage of primary testicular 
cells resembles mostly the in vivo condition thereby providing natural secreted factors. 
Considering that the in vivo SSC niche is not a rigid environment, but rather a dynamical and 
flexible system providing thereby an accurately controlled growth factor milieu (1.4; 4.2.1), it 
could be advantageous to avoid any external influence on this more or less natural 
environment in the co-culture provided by predominantly peritubular cells of the HTF. 
 
4.3 Future perspectives 
Pluripotent stem cells and their unique potential to differentiate into any cell type including 
germ cells determine the research field of reproductive biology aiming at the establishment of 
reproducible and reliable protocols for the in vitro derivation of male and female germ cells. 
But why are so many researchers interested in the in vitro generation of germ cells? The 
availability of such protocols will offer the general opportunity to study the process of 
gametogenesis including meiosis and to use this knowledge for the development of 
approaches to treat infertility. Moreover, in vitro spermatogenesis experiments can provide 
some insight into the intracellular mechanisms of SSCs, their self-renewal, survival and 
differentiation into haploid male germ cells, which might further contribute to a better 
understanding of underlying self-renewal mechanisms of other stem cell populations and 
general stem cell biology.  
The reproducible and robust co-culture system, established in the presented thesis, might 
provide a good model for basic research in regard to the mechanisms regulating PGCs, 
SSCs and their entry into the differentiation process as well as the capability of pluripotent 
cells to generate germ cells in vitro. Because it is assumed that the co-culture-derived cells 
represent a mixed population of PGCs, undifferentiated and differentiating spermatogonia, a 
transcriptome analysis might provide some insight into the regulatory network of germ cells. 
The unlimited access to these cell types derived from the co-culture system allows the 
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investigation of molecular cell processes in more detail. Even if this system is characterized 
by its high reproducibility, there are potential options to further optimize its efficiency. 
Because the HTF cells presumably possess a significant role in this system, the preservation 
of its sufficient proliferation rate during co-culture would be surely beneficial for a prolonged 
maintenance of the co-culture-derived cells in culture. This could be mediated by a selective 
inhibition of GPER, which is linked to the proliferation of HTPCs and their apoptosis (Sandner 
et al., 2014). A prolonged culture might be accompanied by an increased differentiation of 
mouse SSCs, whose fraction within the co-culture-derived cell population is supposed to be 
rather small. This differentiation could be further supported by the use of a modified culture 
medium. The factors bFGF and CSF-1 are described as important regulators for the in vitro 
culture of SSCs acting in combination with GDNF (Kubota et al., 2004b; Oatley et al., 2009), 
which is assumed to be the driving force in the presented co-culture system. The addition of 
bFGF and CSF-1 to the culture medium might support the derivation and maintenance of 
SSCs from ESCs. 
The transplantation assay remains the final proof of the existence of SSCs derived from 
co-culture experiments. The transplantations carried out within the presented thesis did not 
result in repopulation of the seminiferous tubules, but genotyping PCR analyses for the 
reporter construct Stra8-EGFP contained in the ESCs used for co-culture experiments 
indicated the presence of transplanted cells within the testis at least 15 days post 
transplantation. An EGFP-antibody staining on testis sections could be used in order to 
validate a colonization of transplanted cells in the seminiferous tubules at least in the 
indicated time frame. However, considering the suggested minor fraction of undifferentiated 
spermatogonia within the co-culture-derived cells as well as the major loss of cells during 
germ cell transplantation and the homing process of SSCs (Nagano, 2003b), it would be 
worth to test further a more accurate transplantation technique in order to ensure a better 
and increased cell delivery and thereby cell number to colonize in the testis. This could 
eventually lead to regeneration of spermatogenesis in at least some seminiferous tubules 
and would represent the functional proof of co-culture-derived SSCs.  
Knowledge of important intracellular signalling pathways of SSCs obtained by such in vitro 
culture systems will further help to develop culture systems, which are suitable for the in vitro 
culture, promotion of self-renewal and rapid expansion of isolated SSCs. Although the 
cultivation of SSCs derived from various species has been already successfully performed, 
the absence of a reliable protocol for cultivation and expansion of human SSCs illustrates the 
difficulty to transfer this knowledge to human, which was also present in this thesis. Here, the 
researchers are faced with several problems including the lack of specific markers for human 
SSCs, the limited availability of human testis material for SSC isolation and study-to-study 
variations in biopsy quantity and quality. Considering that only the first mentioned difficulty 
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might be solved in the next years, the establishment of a human SSC long term culture 
system will remain challenging. Consequently, its intended use to treat male infertility using 
cultured human SSCs for repopulation of the patient’s testis or for their in vitro differentiation 
into male gametes for assisted reproduction treatments (ART) will require tremendous load 
of experimental work to evaluate proper culture conditions. However, using the MACSorting 
approach, cultivation of isolated human SSCs on the flow-through fraction derived from the 
sorting procedure representing predominantly peritubular cells might support their 
maintenance and proliferation in culture. As observed in the presented thesis, isolated 
human SSCs preferred growing on their natural testicular feeder developed during culture, 
which might provide appropriate natural factors and be more beneficial compared to the use 
of medium supplemented with various growth factors. The separation of somatic and germ 
cells displays a contrary approach for the establishment of human SSC cultures. As recently 
shown for the isolation and cultivation of putative marmoset SSCs, this separation might be 
crucial for the establishment of SSC cultures (Langenstroth et al., 2014). Considering the 
similarities of marmosets’ and humans’ testis, this approach might be also promising.  
The prospective successful application of human SSCs for treatment of male infertility is 
additionally faced with the finding in mouse studies that SSCs under in vitro culture 
conditions fail to undergo proper epigenetic reprogramming indicated by abnormalities in 
their genomic imprinting, which can result in abnormal offspring development. Male germ 
cells could be also derived from different pluripotent cells, but normal and healthy offspring 
revealing proper methylation patterns of their imprinted genes could just be obtained when 
the process of gametogenesis was resumed in vivo. Consequently, beside the establishment 
of stable human SSC cultures, the setting of a proper epigenetic reprogramming under ex 
vivo conditions reflects an additional major challenge on the way to their application in 
reproductive medicine. Generally, it is highly questionable, if the complex process of 
epigenetic reprogramming can be completed properly under in vitro conditions. The attempt 
for an improvement of this process during mouse in vitro spermatogenesis presented in this 
thesis illustrated that the methylation pattern can indeed be influenced by the overexpression 
of a putative imprinting control gene such as Stra8. Here a temporary instead of a stable 
overexpression of STRA8 using a doxycycline-inducible protein expression system should be 
tested next in order to improve epigenetic reprogramming in vitro. Further the identification of 
imprinting control genes and their regulation might help to improve the establishment of 
correct imprinting marks during in vitro spermatogenesis, which is a mandatory precondition 
for the application of in vitro derived gametes in ART.  
The use of iPSCs for the in vitro generation of germ cells offers infertile men the opportunity 
to father biological children independent from the underlying cause of their infertility and 
circumvent simultaneously the ethical and immunological limitations regarding the use of 
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ESCs. A potential application of human iPSCs in reproductive medicine requires iPSC 
generation methods without any persisting risk of cancer development. These non-integrative 
reprogramming methods are often accompanied by reduced efficiencies of human iPSC 
generation. Currently, the mRNA-based reprogramming, which was utilized in the presented 
thesis, represents the most promising method. Nevertheless, also their application in 
treatment of infertility and in general regenerative approaches is faced with problems 
considering tumorigenicity and epigenetic defects. For these reasons the development of 
reliable pre-transplant screenings are indispensable for the application of human iPSCs in 
ART. However, it is worth to look at the differentiation potential of the iSHF cell lines 
generated in the presented thesis and their ability to differentiate into germ cells using either 
a medium or a two step selection-based strategy. Using media-based differentiation 
approaches, cultivation of iSHF cells in complex culture media adopted from Eguizabal et al. 
(2011) and Easley et al. (2012) might lead to their progression through meiosis and gamete 
formation. The two step selection system based on premeiotic and postmeiotic transgenes 
for mouse in vitro spermatogenesis according to Nayernia et al. (2006) could be also applied 
to hiPSCs. Considering a putative limited transfection efficiency of hiPSCs with the reporter 
constructs, the chances of success of this differentiation protocol could be maybe reduced. 
Provided a successful application of one of these approaches with iSHF cells derived from 
infertile men, it is interesting to look, if the underlying cause of patient’s infertility can be 
overcome during the in vitro differentiation process.  
Moreover, the co-culture system established in the presented thesis could be applied for the 
differentiation of human germ cells. As the suitability of the co-culture system with different 
mouse pluripotent stem cells could be shown in the presented thesis, it is worth to test if 
co-culturing of iSHF cells with HTF cells in normal fibroblast medium could lead to similar 
morphology changes resembling SSCs. Here the low proliferation rate of hiPSCs has to be 
considered as a potential limiting factor for the success of this approach.  
In summary, the recapitulation of spermatogenesis in vitro and its application in ART is a 
promising method to treat male infertility, but is still faced with major problems. Some 
problems might be solved by intensive basic research. Considering the huge amount of data 
for long term culture of SSCs derived from various species, sooner or later a protocol for the 
long term culture of human SSCs will surely be available. In contrast, it is highly questionable 
if problems concerning the risk of tumorigenicity of pluripotent cells and the improper 
epigenetic reprogramming during in vitro spermatogenesis can be completely solved to 




Currently different in vitro experimental approaches make use of the unique potential of 
pluripotent cells in order to produce functional sperm aiming at the establishment of new 
treatment opportunities for male infertility.  
The establishment of proliferating human spermatogonial stem cell (SSC) lines and their in 
vitro differentiation into haploid male germ cells represents one of these approaches and was 
tried to succeed in the presented thesis. The isolation of human SSCs from testicular 
biopsies from infertile men was performed using the Magnetic Activated Cell Sorting 
(MACSorting) technique for the SSC surface marker α6-Integrin and succeeded several 
times in the enrichment of putative SSCs, which were characterized by their grape-like 
structures characteristically for SSCs and a positive staining for the germ cell marker PLZF. 
In a total of 15 attempts, culturing of isolated human SSCs was tried to be improved by 
testing different media compositions, seeding on MEF, gelatine or matrigel coated culture 
vessels as wells as culturing under normoxia or hypoxia. The cultivation in StemPro+3 
medium on gelatine coated vessels under normoxia turned out to provide appropriate culture 
conditions for the enrichment of human SSCs after MACSorting, but unfortunately a stable 
and proliferating human SSC line could not be established for further in vitro differentiation 
experiments.  
Because other studies also revealed great difficulties in the establishment of long term 
human SSC cultures, a further experimental approach aimed at using human pluripotent 
stem cells for in vitro differentiation of human SSCs. For the derivation of patient-derived 
human induced pluripotent stem cell (hiPSC) lines, 25 scrotal human fibroblast (SHF) cell 
lines derived from infertile men with different spermatogenesis phenotypes were collected in 
a cell bank. For the generation of hiPSCs from moderate proliferating human fibroblasts a 
modified so called “Feeder/Free” mRNA/miRNA reprogramming was successfully developed 
and finally yielded in the derivation and establishment of three iSHF cell lines iSHF-3, iSHF-6 
and iSHF-13 derived from infertile men revealing different spermatogenesis phenotypes. 
These iSHFs were characterized by common tools to proof their pluripotency. iSHFs were 
positively stained for the Alkaline Phosphatase and at least for two pluripotency markers 
OCT4 and SSEA-4, revealed no karyotypic abnormalities and are now suitable for the start of 
in vitro differentiation experiments. 
Various mouse studies proved the derivation of haploid male germ cells from pluripotent 
stem cells, but revealed especially improper genomic imprinting often yielding in unhealthy 
offspring. Here, the in vitro differentiation strategy, which was established in this Institute 
(Nayernia et al., 2006), should be improved by the overexpression of the premeiotic gene 
Stra8 (Stimulated by Retinoic Acid Gene 8). These experiments were planned to be carried 
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out with the original cell line SSC 12 representing an embryonic stem cell (ESC) line derived 
from transfection of the wild type ES cell line ES-RI with a Stra8-EGFP reporter construct 
followed by an enrichment of Stra8 overexpressing cells by two Fluorescence-Activated Cell 
Sortings (FACSorting) (Nayernia et al., 2006) as well as with the ESC line 
Stra8-EGFP/Sycp3-DsRed-2. The latter one was newly generated from double transgenic 
Stra8-EGFP/Sycp3-DsRed mice in the presented thesis and was shown to reveal a typical 
ES cell morphology, a male genotype and an OCT4 expression on protein level. An 
enrichment of Stra8 expressing cells was also performed by twice FACSortings. Two Stra8 
overexpressing cell lines SSC 12/11 and SSC 12/13 were generated by stable transfection of 
SSC 12 with the generated Stra8-overexpressing construct phEF1α-puro-mStra8 and 
possessed a two times increased stable Stra8 expression compared to SSC 12. Finally, in 
vitro spermatogenesis experiments using SSC 12/11 and SSC 12/13 cells indicated an 
earlier entry into and progress through the meiotic process analyzed on mRNA level of the 
postmeiotic marker Gpx4, whereas no meiotic or postmeiotic structures could be detected on 
the protein level using immunostaining analyses and electron microscopy. Stra8 
overexpressing cells revealed an overall increased methylation level of imprinting genes 
indicating that Stra8 indeed has an effect on epigenetic reprogramming. Paternally imprinted 
H19 and Meg3 genes tend to an androgenic imprinting pattern, while the maternally 
imprinted Igf2r and Srnpn genes failed to undergo the essential demethylation in 
differentiating Stra8 overexpressing cells.   
A further part of the presented thesis focused on the development of a reproducible and 
robust co-culture system for the derivation of mouse SSCs. For this purpose the transgenic 
mouse ES cell line SSC 12 was co-cultured with mitotically active human testicular feeder 
(HTF) cells in normal fibroblast culture medium without any growth factors. HTF cells were 
characterized for testicular somatic cells on mRNA and partially on protein level, and did 
express neither the sertoli cell markers FSHR and INHIBIN nor leydig cell markers such as 
3-β-HSD and LHCGR. Because they revealed a moderate to high expression of peritubular 
cell markers AR, AT1R, CALPONIN, DECORIN, GPER, PENTRAXIN 3, SMA and 
VIMENTIN, HTF cells possessed a predominant human peritubular cell character. The 
co-culture-derived cells were called putative mouse SSCs because of their grape-like cell 
morphology, which is characteristic for SSCs according to the literature. The appearance of 
these structures was very efficient as well as robustly reproducible and could also be 
generated using mouse wild type ES-RI cells and wild type iPSCs suggesting a general 
suitability of the co-culture system for the derivation of putative SSCs. The generation of 
SSC-like cells failed, if MEF feeder layer, gelatine coated vessels or HTF-conditioned 
medium was used for co-culture experiments indicating a key role of the HTF cells.  
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The viability and proliferation of putative mouse SSCs was proven by apoptosis and BrdU 
assays. The SSC-like cells were positively stained for Alkaline Phosphatase and the germ 
cell markers α6-INTEGRIN, OCT4, PLZF, DDX4 (aliases: VASA) and SALL4. Moreover, 
putative mSSCs revealed a moderate expression of the later germ cell marker Gpr125 and 
an increased expression of the primordial germ cell (PGC) marker Fkbp6 and Mov10l1 on 
mRNA level. The induction of differentiation of co-culture-derived cells revealed partly an up-
regulation of postmeiotic markers Gpx4 and Acrosin indicating the onset of the meiotic 
process detectable on the mRNA level. The analyzed imprinted genes H19, Meg3, Igf2r and 
Snrpn revealed rather a somatic than androgenic methylation pattern, which was not 
significantly different from the starting ES cell line indicating that the imprint erasure had not 
yet occurred. Transplantations of cells into germ cell depleted testes of busulfan treated mice 
did not result in a repopulation of the seminiferous tubules, but the detection of 
Stra8-EGFP-PCR constructs, contained in SSC 12 used for co-culture experiments, 
indicated the presence of transplanted cells for at least 15 days within the testis post 
transplantation. These whole data lead to the hypothesis that the co-culture of mouse ESCs 
with HTF cells yielded in a mixed cell population with a predominantly PGC character and 
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